{
    "64403ab057b1c7a31500004d_001": [
        {
            "text": "two",
            "probability": 0.9983099484519387,
            "start_logit": 6.091302394866943,
            "end_logit": 4.206696510314941
        },
        {
            "text": "two suprachoroidal injections of CLS-TA at 0 and 12 weeks",
            "probability": 0.0010148213373592908,
            "start_logit": 6.091302394866943,
            "end_logit": -2.684654712677002
        },
        {
            "text": "two suprachoroidal injections",
            "probability": 0.00043641063522249795,
            "start_logit": 6.091302394866943,
            "end_logit": -3.528538942337036
        },
        {
            "text": "two suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks,",
            "probability": 0.00010015219998045761,
            "start_logit": 6.091302394866943,
            "end_logit": -5.000431537628174
        },
        {
            "text": "two suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks",
            "probability": 4.264458356991937e-05,
            "start_logit": 6.091302394866943,
            "end_logit": -5.854222297668457
        },
        {
            "text": "two suprachoroidal",
            "probability": 3.738675801822287e-05,
            "start_logit": 6.091302394866943,
            "end_logit": -5.985805988311768
        },
        {
            "text": "NCT02595398), a phase III trial with two",
            "probability": 1.9513921462368706e-05,
            "start_logit": -4.7513885498046875,
            "end_logit": 4.206696510314941
        },
        {
            "text": "two suprachoroidal injection",
            "probability": 1.8219938385672968e-05,
            "start_logit": 6.091302394866943,
            "end_logit": -6.704606056213379
        },
        {
            "text": "two suprachoroidal injections of CLS-TA",
            "probability": 1.1698915747540991e-05,
            "start_logit": 6.091302394866943,
            "end_logit": -7.1476263999938965
        },
        {
            "text": "ClinicalTrials.gov Identifier: NCT02595398), a phase III trial with two",
            "probability": 4.754305863886234e-06,
            "start_logit": -6.163465976715088,
            "end_logit": 4.206696510314941
        },
        {
            "text": "phase III trial with two",
            "probability": 2.320678235299981e-06,
            "start_logit": -6.880657196044922,
            "end_logit": 4.206696510314941
        },
        {
            "text": "a phase III trial with two",
            "probability": 1.7596562155986902e-06,
            "start_logit": -7.157398223876953,
            "end_logit": 4.206696510314941
        },
        {
            "text": "PEACHTREE trial (ClinicalTrials.gov Identifier: NCT02595398",
            "probability": 1.815925330953418e-07,
            "start_logit": -3.8699254989624023,
            "end_logit": -1.3518846035003662
        },
        {
            "text": "NCT02595398",
            "probability": 7.521136103690727e-08,
            "start_logit": -4.7513885498046875,
            "end_logit": -1.3518846035003662
        },
        {
            "text": "suprachoroidal injections of CLS-TA at 0 and 12 weeks",
            "probability": 3.920725927190131e-08,
            "start_logit": -4.070058822631836,
            "end_logit": -2.684654712677002
        },
        {
            "text": "ClinicalTrials.gov Identifier: NCT02595398",
            "probability": 1.832424177263385e-08,
            "start_logit": -6.163465976715088,
            "end_logit": -1.3518846035003662
        },
        {
            "text": "Recent results from the PEACHTREE trial (ClinicalTrials.gov Identifier: NCT02595398",
            "probability": 1.8134478907640562e-08,
            "start_logit": -6.17387580871582,
            "end_logit": -1.3518846035003662
        },
        {
            "text": "suprachoroidal injections",
            "probability": 1.6860568746718987e-08,
            "start_logit": -4.070058822631836,
            "end_logit": -3.528538942337036
        },
        {
            "text": "NCT02595398),",
            "probability": 9.717227290739271e-09,
            "start_logit": -6.79779052734375,
            "end_logit": -1.3518846035003662
        },
        {
            "text": "the PEACHTREE trial (ClinicalTrials.gov Identifier: NCT02595398",
            "probability": 9.570330660126356e-09,
            "start_logit": -6.813023090362549,
            "end_logit": -1.3518846035003662
        }
    ],
    "6411b678201352f04a000036_001": [
        {
            "text": "acquired",
            "probability": 0.9830589488560092,
            "start_logit": 7.500622272491455,
            "end_logit": 6.371344089508057
        },
        {
            "text": "the acquired",
            "probability": 0.008991041761729907,
            "start_logit": 2.8061819076538086,
            "end_logit": 6.371344089508057
        },
        {
            "text": "In contrast to the acquired",
            "probability": 0.0061016859546501965,
            "start_logit": 2.418518304824829,
            "end_logit": 6.371344089508057
        },
        {
            "text": "acquired form",
            "probability": 0.001416344396815345,
            "start_logit": 7.500622272491455,
            "end_logit": -0.17124581336975098
        },
        {
            "text": "acquired form of prosopagnosia",
            "probability": 0.0002509363437984913,
            "start_logit": 7.500622272491455,
            "end_logit": -1.9018809795379639
        },
        {
            "text": "contrast to the acquired",
            "probability": 5.6342691800600255e-05,
            "start_logit": -2.2663495540618896,
            "end_logit": 6.371344089508057
        },
        {
            "text": "acquired form of prosopagnosia we studied the congenital",
            "probability": 4.529744655263093e-05,
            "start_logit": 7.500622272491455,
            "end_logit": -3.6138296127319336
        },
        {
            "text": "acquired form of prosopagnosia we studied the congenital form",
            "probability": 2.6758750501462145e-05,
            "start_logit": 7.500622272491455,
            "end_logit": -4.140218734741211
        },
        {
            "text": "the acquired form",
            "probability": 1.2953863688009781e-05,
            "start_logit": 2.8061819076538086,
            "end_logit": -0.17124581336975098
        },
        {
            "text": "to the acquired",
            "probability": 1.1604044158175342e-05,
            "start_logit": -3.8464484214782715,
            "end_logit": 6.371344089508057
        },
        {
            "text": "In contrast to the acquired form",
            "probability": 8.791017795069705e-06,
            "start_logit": 2.418518304824829,
            "end_logit": -0.17124581336975098
        },
        {
            "text": "Prosopagnosia is the inability to recognize someone by the face alone in the absence of sensory or intellectual impairment.",
            "probability": 4.468403893119796e-06,
            "start_logit": 2.448756694793701,
            "end_logit": -0.8781834244728088
        },
        {
            "text": "the inability to recognize someone by the face alone in the absence of sensory or intellectual impairment. In contrast to the acquired",
            "probability": 2.8568263736438774e-06,
            "start_logit": -5.248090744018555,
            "end_logit": 6.371344089508057
        },
        {
            "text": "the acquired form of prosopagnosia",
            "probability": 2.295059873320492e-06,
            "start_logit": 2.8061819076538086,
            "end_logit": -1.9018809795379639
        },
        {
            "text": "inability to recognize someone by the face alone in the absence of sensory or intellectual impairment. In contrast to the acquired",
            "probability": 1.8817160449078957e-06,
            "start_logit": -5.665617942810059,
            "end_logit": 6.371344089508057
        },
        {
            "text": "Prosopagnosia is the inability to recognize someone by the face alone in the absence of sensory or intellectual impairment. In contrast",
            "probability": 1.878577539756687e-06,
            "start_logit": 2.448756694793701,
            "end_logit": -1.7446998357772827
        },
        {
            "text": "In contrast",
            "probability": 1.8226226361341934e-06,
            "start_logit": 2.418518304824829,
            "end_logit": -1.7446998357772827
        },
        {
            "text": "acquired form of prosopagnosia we",
            "probability": 1.6440754659113057e-06,
            "start_logit": 7.500622272491455,
            "end_logit": -6.929902076721191
        },
        {
            "text": "In contrast to the acquired form of prosopagnosia",
            "probability": 1.5575208040660398e-06,
            "start_logit": 2.418518304824829,
            "end_logit": -1.9018809795379639
        },
        {
            "text": "prosopagnosia",
            "probability": 8.900698697224665e-07,
            "start_logit": 1.858967661857605,
            "end_logit": -1.9018809795379639
        }
    ],
    "6411b678201352f04a000036_002": [
        {
            "text": "autosomal dominant",
            "probability": 0.954726947510335,
            "start_logit": 5.854727745056152,
            "end_logit": 5.615358829498291
        },
        {
            "text": "autosomal dominant mode of inheritance",
            "probability": 0.01783442462192254,
            "start_logit": 5.854727745056152,
            "end_logit": 1.6350640058517456
        },
        {
            "text": "Congenital",
            "probability": 0.008668934711574249,
            "start_logit": 6.263711929321289,
            "end_logit": 0.5046951770782471
        },
        {
            "text": "inherited in an autosomal dominant",
            "probability": 0.006989731849985448,
            "start_logit": 0.9377445578575134,
            "end_logit": 5.615358829498291
        },
        {
            "text": "an autosomal dominant",
            "probability": 0.004759639276673421,
            "start_logit": 0.5534742474555969,
            "end_logit": 5.615358829498291
        },
        {
            "text": "in an autosomal dominant",
            "probability": 0.003954923183323477,
            "start_logit": 0.3682635426521301,
            "end_logit": 5.615358829498291
        },
        {
            "text": "autosomal dominant mode of inheritance.",
            "probability": 0.001534496954008599,
            "start_logit": 5.854727745056152,
            "end_logit": -0.817863941192627
        },
        {
            "text": "There is evidence that it can be inherited in an autosomal dominant",
            "probability": 0.0008358538353011666,
            "start_logit": -1.1859991550445557,
            "end_logit": 5.615358829498291
        },
        {
            "text": "inherited in an autosomal dominant mode of inheritance",
            "probability": 0.0001305691078806249,
            "start_logit": 0.9377445578575134,
            "end_logit": 1.6350640058517456
        },
        {
            "text": "autosomal dominant mode",
            "probability": 0.00011640538197025665,
            "start_logit": 5.854727745056152,
            "end_logit": -3.396743059158325
        },
        {
            "text": "an autosomal dominant mode of inheritance",
            "probability": 8.891068606446258e-05,
            "start_logit": 0.5534742474555969,
            "end_logit": 1.6350640058517456
        },
        {
            "text": "in an autosomal dominant mode of inheritance",
            "probability": 7.387848387689187e-05,
            "start_logit": 0.3682635426521301,
            "end_logit": 1.6350640058517456
        },
        {
            "text": "can be inherited in an autosomal dominant",
            "probability": 6.647943311743906e-05,
            "start_logit": -3.717560291290283,
            "end_logit": 5.615358829498291
        },
        {
            "text": "dominant",
            "probability": 5.099517952371546e-05,
            "start_logit": -3.9827218055725098,
            "end_logit": 5.615358829498291
        },
        {
            "text": "evidence that it can be inherited in an autosomal dominant",
            "probability": 3.7831041094285165e-05,
            "start_logit": -4.281322956085205,
            "end_logit": 5.615358829498291
        },
        {
            "text": "Con",
            "probability": 3.19713839408134e-05,
            "start_logit": 6.263711929321289,
            "end_logit": -5.097964763641357
        },
        {
            "text": "auto",
            "probability": 3.0130558054451097e-05,
            "start_logit": 5.854727745056152,
            "end_logit": -4.748281955718994
        },
        {
            "text": "Congenital prosopagnosia (cPA)",
            "probability": 2.6958805481061846e-05,
            "start_logit": 6.263711929321289,
            "end_logit": -5.268496036529541
        },
        {
            "text": "it can be inherited in an autosomal dominant",
            "probability": 2.5304136580113183e-05,
            "start_logit": -4.68348503112793,
            "end_logit": 5.615358829498291
        },
        {
            "text": "There is evidence that it can be inherited in an autosomal dominant mode of inheritance",
            "probability": 1.5613859291912508e-05,
            "start_logit": -1.1859991550445557,
            "end_logit": 1.6350640058517456
        }
    ],
    "6411b678201352f04a000036_003": [
        {
            "text": "acquired",
            "probability": 0.8005916923986166,
            "start_logit": 8.33240795135498,
            "end_logit": 6.346415042877197
        },
        {
            "text": "acquired prosopagnosia",
            "probability": 0.1694944705648307,
            "start_logit": 8.33240795135498,
            "end_logit": 4.79388427734375
        },
        {
            "text": "prosopagnosia",
            "probability": 0.029826588348083934,
            "start_logit": 6.594987869262695,
            "end_logit": 4.79388427734375
        },
        {
            "text": "acquired prosopagnosia following a large unilateral right-hemispheric lesion in frontal,",
            "probability": 3.1215014486875483e-05,
            "start_logit": 8.33240795135498,
            "end_logit": -3.8057920932769775
        },
        {
            "text": "acquired prosopagnosia following a large unilateral right-hemispheric lesion in frontal",
            "probability": 2.140431447868685e-05,
            "start_logit": 8.33240795135498,
            "end_logit": -4.183098793029785
        },
        {
            "text": "acquired pro",
            "probability": 1.0055203773351289e-05,
            "start_logit": 8.33240795135498,
            "end_logit": -4.938601016998291
        },
        {
            "text": "Here we report a follow-up examination on M.T., suffering from acquired",
            "probability": 5.60365481258686e-06,
            "start_logit": -3.5372793674468994,
            "end_logit": 6.346415042877197
        },
        {
            "text": "prosopagnosia following a large unilateral right-hemispheric lesion in frontal,",
            "probability": 5.493025136907903e-06,
            "start_logit": 6.594987869262695,
            "end_logit": -3.8057920932769775
        },
        {
            "text": "prosopagnosia following a large unilateral right-hemispheric lesion in frontal",
            "probability": 3.7665988436155755e-06,
            "start_logit": 6.594987869262695,
            "end_logit": -4.183098793029785
        },
        {
            "text": "pro",
            "probability": 1.7694525532568e-06,
            "start_logit": 6.594987869262695,
            "end_logit": -4.938601016998291
        },
        {
            "text": "we report a follow-up examination on M.T., suffering from acquired",
            "probability": 1.3533729878084417e-06,
            "start_logit": -4.958098411560059,
            "end_logit": 6.346415042877197
        },
        {
            "text": "acquired prosopagnosia following a large unilateral right-hemispheric lesion",
            "probability": 1.3453090797824366e-06,
            "start_logit": 8.33240795135498,
            "end_logit": -6.950067520141602
        },
        {
            "text": "Here we report a follow-up examination on M.T., suffering from acquired prosopagnosia",
            "probability": 1.1863581832105413e-06,
            "start_logit": -3.5372793674468994,
            "end_logit": 4.79388427734375
        },
        {
            "text": "report a follow-up examination on M.T., suffering from acquired",
            "probability": 1.0543497594102564e-06,
            "start_logit": -5.2077741622924805,
            "end_logit": 6.346415042877197
        },
        {
            "text": "M.T., suffering from acquired",
            "probability": 9.959508913884566e-07,
            "start_logit": -5.264755725860596,
            "end_logit": 6.346415042877197
        },
        {
            "text": "from acquired",
            "probability": 8.903222902577477e-07,
            "start_logit": -5.376870155334473,
            "end_logit": 6.346415042877197
        },
        {
            "text": "a follow-up examination on M.T., suffering from acquired",
            "probability": 3.235052423308082e-07,
            "start_logit": -6.389238357543945,
            "end_logit": 6.346415042877197
        },
        {
            "text": "we report a follow-up examination on M.T., suffering from acquired prosopagnosia",
            "probability": 2.865246295000541e-07,
            "start_logit": -4.958098411560059,
            "end_logit": 4.79388427734375
        },
        {
            "text": "suffering from acquired",
            "probability": 2.689921507072436e-07,
            "start_logit": -6.5737714767456055,
            "end_logit": 6.346415042877197
        },
        {
            "text": "prosopagnosia following a large unilateral right-hemispheric lesion",
            "probability": 2.367391690707832e-07,
            "start_logit": 6.594987869262695,
            "end_logit": -6.950067520141602
        }
    ],
    "643bc8f957b1c7a31500002b_001": [
        {
            "text": "A promoter is a short region of DNA (100-1,000 bp) where transcription of a gene by RNA polymerase begins.",
            "probability": 0.5393705814176646,
            "start_logit": 1.9403709173202515,
            "end_logit": 0.19069421291351318
        },
        {
            "text": "directly upstream or at the 5' end of the transcription initiation site.",
            "probability": 0.11654090408491946,
            "start_logit": 0.4165274500846863,
            "end_logit": 0.18237712979316711
        },
        {
            "text": "5' end of the transcription initiation site.",
            "probability": 0.10959571480923408,
            "start_logit": 0.3550834059715271,
            "end_logit": 0.18237712979316711
        },
        {
            "text": "directly upstream or at the 5' end of the transcription initiation site",
            "probability": 0.06733697996913125,
            "start_logit": 0.4165274500846863,
            "end_logit": -0.36615562438964844
        },
        {
            "text": "5' end of the transcription initiation site",
            "probability": 0.06332407072657144,
            "start_logit": 0.3550834059715271,
            "end_logit": -0.36615562438964844
        },
        {
            "text": "A promoter is a short region of DNA (100-1,000 bp",
            "probability": 0.035344253432746095,
            "start_logit": 1.9403709173202515,
            "end_logit": -2.5345728397369385
        },
        {
            "text": "A promoter is a short region of DNA (100-1,000 bp)",
            "probability": 0.02268709973359153,
            "start_logit": 1.9403709173202515,
            "end_logit": -2.977912187576294
        },
        {
            "text": "upstream or at the 5' end of the transcription initiation site.",
            "probability": 0.005205745290302326,
            "start_logit": -2.6919519901275635,
            "end_logit": 0.18237712979316711
        },
        {
            "text": "at the 5' end of the transcription initiation site.",
            "probability": 0.004568646656546986,
            "start_logit": -2.822497844696045,
            "end_logit": 0.18237712979316711
        },
        {
            "text": "the 5' end of the transcription initiation site.",
            "probability": 0.004485966296585697,
            "start_logit": -2.8407609462738037,
            "end_logit": 0.18237712979316711
        },
        {
            "text": "100-1,000 bp) where transcription of a gene by RNA polymerase begins.",
            "probability": 0.004327150215140307,
            "start_logit": -2.885122776031494,
            "end_logit": 0.19069421291351318
        },
        {
            "text": "directly upstream",
            "probability": 0.003997733457407228,
            "start_logit": 0.4165274500846863,
            "end_logit": -3.1901376247406006
        },
        {
            "text": "A promoter",
            "probability": 0.003511455624201871,
            "start_logit": 1.9403709173202515,
            "end_logit": -4.843677997589111
        },
        {
            "text": "It is typically located directly upstream or at the 5' end of the transcription initiation site.",
            "probability": 0.0034236800151044703,
            "start_logit": -3.1109988689422607,
            "end_logit": 0.18237712979316711
        },
        {
            "text": "1,000 bp) where transcription of a gene by RNA polymerase begins.",
            "probability": 0.0031540819654214025,
            "start_logit": -3.2013344764709473,
            "end_logit": 0.19069421291351318
        },
        {
            "text": "upstream or at the 5' end of the transcription initiation site",
            "probability": 0.003007863797607585,
            "start_logit": -2.6919519901275635,
            "end_logit": -0.36615562438964844
        },
        {
            "text": "promoter is a short region of DNA (100-1,000 bp) where transcription of a gene by RNA polymerase begins.",
            "probability": 0.002908152778362024,
            "start_logit": -3.2825138568878174,
            "end_logit": 0.19069421291351318
        },
        {
            "text": "at the 5' end of the transcription initiation site",
            "probability": 0.002639750144496706,
            "start_logit": -2.822497844696045,
            "end_logit": -0.36615562438964844
        },
        {
            "text": "the 5' end of the transcription initiation site",
            "probability": 0.002591977683949317,
            "start_logit": -2.8407609462738037,
            "end_logit": -0.36615562438964844
        },
        {
            "text": "It is typically located directly upstream or at the 5' end of the transcription initiation site",
            "probability": 0.0019781919010154387,
            "start_logit": -3.1109988689422607,
            "end_logit": -0.36615562438964844
        }
    ],
    "643bc8f957b1c7a31500002b_002": [
        {
            "text": "Promoters mark the start of every transcript and are an important class of regulatory elements.",
            "probability": 0.6076610940122269,
            "start_logit": 6.880527973175049,
            "end_logit": 1.7096720933914185
        },
        {
            "text": "Promoters",
            "probability": 0.38596337786230794,
            "start_logit": 6.880527973175049,
            "end_logit": 1.255797266960144
        },
        {
            "text": "Promoters mark the start of every transcript and are an important class of regulatory elements",
            "probability": 0.0028715262267808572,
            "start_logit": 6.880527973175049,
            "end_logit": -3.645101547241211
        },
        {
            "text": "Pro",
            "probability": 0.0011895824381011762,
            "start_logit": 6.880527973175049,
            "end_logit": -4.526342868804932
        },
        {
            "text": "Promote",
            "probability": 0.0010690101559948798,
            "start_logit": 6.880527973175049,
            "end_logit": -4.633212089538574
        },
        {
            "text": "Promoters mark the start of every transcript",
            "probability": 0.0007568299736873785,
            "start_logit": 6.880527973175049,
            "end_logit": -4.978561878204346
        },
        {
            "text": "Promoters mark the start of every transcript and",
            "probability": 0.0003215144071876475,
            "start_logit": 6.880527973175049,
            "end_logit": -5.834658145904541
        },
        {
            "text": "Promoters mark the start of every transcript and are an important class",
            "probability": 5.393981774932502e-05,
            "start_logit": 6.880527973175049,
            "end_logit": -7.619831562042236
        },
        {
            "text": "Promoters mark the start",
            "probability": 5.2518780343084564e-05,
            "start_logit": 6.880527973175049,
            "end_logit": -7.646529674530029
        },
        {
            "text": "Promoters mark the start of every transcript and are an important class of regulatory",
            "probability": 4.8723152504454e-05,
            "start_logit": 6.880527973175049,
            "end_logit": -7.721546173095703
        },
        {
            "text": "the start of every transcript and are an important class of regulatory elements.",
            "probability": 2.6490181897569995e-06,
            "start_logit": -5.462655544281006,
            "end_logit": 1.7096720933914185
        },
        {
            "text": ".",
            "probability": 2.4327368530549354e-06,
            "start_logit": -5.54782772064209,
            "end_logit": 1.7096720933914185
        },
        {
            "text": "mark the start of every transcript and are an important class of regulatory elements.",
            "probability": 2.0743431945814957e-06,
            "start_logit": -5.707200050354004,
            "end_logit": 1.7096720933914185
        },
        {
            "text": "are an important class of regulatory elements.",
            "probability": 8.695264941048094e-07,
            "start_logit": -6.576651096343994,
            "end_logit": 1.7096720933914185
        },
        {
            "text": "transcript and are an important class of regulatory elements.",
            "probability": 7.935399098419028e-07,
            "start_logit": -6.66809606552124,
            "end_logit": 1.7096720933914185
        },
        {
            "text": "an important class of regulatory elements.",
            "probability": 7.12852893540865e-07,
            "start_logit": -6.775324821472168,
            "end_logit": 1.7096720933914185
        },
        {
            "text": "regulatory elements.",
            "probability": 7.112343601643145e-07,
            "start_logit": -6.777597904205322,
            "end_logit": 1.7096720933914185
        },
        {
            "text": "start of every transcript and are an important class of regulatory elements.",
            "probability": 6.130355178826124e-07,
            "start_logit": -6.926177024841309,
            "end_logit": 1.7096720933914185
        },
        {
            "text": "important class of regulatory elements.",
            "probability": 5.989522221508274e-07,
            "start_logit": -6.949418067932129,
            "end_logit": 1.7096720933914185
        },
        {
            "text": "and are an important class of regulatory elements.",
            "probability": 4.27933481606473e-07,
            "start_logit": -7.285632133483887,
            "end_logit": 1.7096720933914185
        }
    ],
    "64403be357b1c7a31500004e_001": [
        {
            "text": "24 weeks",
            "probability": 0.9916698458549307,
            "start_logit": 8.93502140045166,
            "end_logit": 7.629842281341553
        },
        {
            "text": "24",
            "probability": 0.007375633777636365,
            "start_logit": 8.93502140045166,
            "end_logit": 2.7286338806152344
        },
        {
            "text": "0 and 12 weeks with follow up lasting 24 weeks",
            "probability": 0.0005890915248083519,
            "start_logit": 1.5064574480056763,
            "end_logit": 7.629842281341553
        },
        {
            "text": "12 weeks with follow up lasting 24 weeks",
            "probability": 0.00030891902059181585,
            "start_logit": 0.8609550595283508,
            "end_logit": 7.629842281341553
        },
        {
            "text": "weeks",
            "probability": 3.1936915281829e-05,
            "start_logit": -1.408361554145813,
            "end_logit": 7.629842281341553
        },
        {
            "text": "0 and 12 weeks with follow up lasting 24",
            "probability": 4.381421262990991e-06,
            "start_logit": 1.5064574480056763,
            "end_logit": 2.7286338806152344
        },
        {
            "text": "24 weeks,",
            "probability": 4.0095879600839715e-06,
            "start_logit": 8.93502140045166,
            "end_logit": -4.788614749908447
        },
        {
            "text": "24 weeks, showed the significant improvement in visual acuity and reduction in central subfield thickness,",
            "probability": 3.6215439446835985e-06,
            "start_logit": 8.93502140045166,
            "end_logit": -4.890402793884277
        },
        {
            "text": "0 and 12 weeks",
            "probability": 2.9688540894352943e-06,
            "start_logit": 1.5064574480056763,
            "end_logit": 2.3394367694854736
        },
        {
            "text": "12 weeks with follow up lasting 24",
            "probability": 2.297613033566672e-06,
            "start_logit": 0.8609550595283508,
            "end_logit": 2.7286338806152344
        },
        {
            "text": "two suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks",
            "probability": 2.0371991597952e-06,
            "start_logit": -4.160548210144043,
            "end_logit": 7.629842281341553
        },
        {
            "text": "12 weeks",
            "probability": 1.556864186573943e-06,
            "start_logit": 0.8609550595283508,
            "end_logit": 2.3394367694854736
        },
        {
            "text": "suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks",
            "probability": 1.3405062575750943e-06,
            "start_logit": -4.579076766967773,
            "end_logit": 7.629842281341553
        },
        {
            "text": "at 0 and 12 weeks with follow up lasting 24 weeks",
            "probability": 5.965685565496357e-07,
            "start_logit": -5.38868522644043,
            "end_logit": 7.629842281341553
        },
        {
            "text": "CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks",
            "probability": 5.955158242253793e-07,
            "start_logit": -5.390451431274414,
            "end_logit": 7.629842281341553
        },
        {
            "text": "weeks with follow up lasting 24 weeks",
            "probability": 4.985988319781499e-07,
            "start_logit": -5.568077564239502,
            "end_logit": 7.629842281341553
        },
        {
            "text": "follow up lasting 24 weeks",
            "probability": 2.1761022661574774e-07,
            "start_logit": -6.397173881530762,
            "end_logit": 7.629842281341553
        },
        {
            "text": "lasting 24 weeks",
            "probability": 1.662338469535526e-07,
            "start_logit": -6.6664838790893555,
            "end_logit": 7.629842281341553
        },
        {
            "text": "phase III trial with two suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks",
            "probability": 1.495336501396844e-07,
            "start_logit": -6.772357940673828,
            "end_logit": 7.629842281341553
        },
        {
            "text": "a phase III trial with two suprachoroidal injections of CLS-TA at 0 and 12 weeks with follow up lasting 24 weeks",
            "probability": 1.3525592004818607e-07,
            "start_logit": -6.872710704803467,
            "end_logit": 7.629842281341553
        }
    ],
    "6440396957b1c7a31500004b_001": [
        {
            "text": "Suprachoroidal",
            "probability": 0.9249819473201917,
            "start_logit": 5.357780933380127,
            "end_logit": 2.7565271854400635
        },
        {
            "text": "suprachoroidal",
            "probability": 0.03472311352178634,
            "start_logit": 5.409947395324707,
            "end_logit": -0.5780079364776611
        },
        {
            "text": "suprachoroidal space",
            "probability": 0.02028663713187328,
            "start_logit": 5.409947395324707,
            "end_logit": -1.1154510974884033
        },
        {
            "text": "suprachoroidal space (SCS\u00ae)",
            "probability": 0.010776669329212495,
            "start_logit": 5.409947395324707,
            "end_logit": -1.7480299472808838
        },
        {
            "text": "SCS Microinjector\u00ae. Suprachoroidal",
            "probability": 0.002256869132491814,
            "start_logit": -0.6580147743225098,
            "end_logit": 2.7565271854400635
        },
        {
            "text": "Suprachoroidal (SC)",
            "probability": 0.0014350736154594827,
            "start_logit": 5.357780933380127,
            "end_logit": -3.7120308876037598
        },
        {
            "text": "suprachoroidal space (SCS\u00ae",
            "probability": 0.0011057333383680662,
            "start_logit": 5.409947395324707,
            "end_logit": -4.024904727935791
        },
        {
            "text": "suprachoroidal space (SCS\u00ae) has become a clinical reality after the 2021 FDA approval of CLS-TA",
            "probability": 0.0010536803055517685,
            "start_logit": 5.409947395324707,
            "end_logit": -4.073124408721924
        },
        {
            "text": "Microinjector\u00ae. Suprachoroidal",
            "probability": 0.0009467559904259011,
            "start_logit": -1.5267071723937988,
            "end_logit": 2.7565271854400635
        },
        {
            "text": "suprachoroidal space (SCS",
            "probability": 0.0006832528453038046,
            "start_logit": 5.409947395324707,
            "end_logit": -4.506303787231445
        },
        {
            "text": "microneedle-based device, the SCS Microinjector\u00ae. Suprachoroidal",
            "probability": 0.0005928799819000686,
            "start_logit": -1.9947565793991089,
            "end_logit": 2.7565271854400635
        },
        {
            "text": "Suprachoroidal (SC) delivery",
            "probability": 0.00024166780356622882,
            "start_logit": 5.357780933380127,
            "end_logit": -5.493438243865967
        },
        {
            "text": "Su",
            "probability": 0.00022839029972352635,
            "start_logit": 5.357780933380127,
            "end_logit": -5.549946308135986
        },
        {
            "text": "Suprachoroidal (SC) delivery facilitates targeting, compartmentalization, and durability of small molecule suspensions,",
            "probability": 0.00018879811962863431,
            "start_logit": 5.357780933380127,
            "end_logit": -5.740324020385742
        },
        {
            "text": "su",
            "probability": 0.0001632428010173563,
            "start_logit": 5.409947395324707,
            "end_logit": -5.937930107116699
        },
        {
            "text": "triamcinolone acetonide injectable suspension for suprachoroidal",
            "probability": 0.00014930469899950344,
            "start_logit": -2.307893753051758,
            "end_logit": 1.6906615495681763
        },
        {
            "text": "the SCS Microinjector\u00ae. Suprachoroidal",
            "probability": 8.404187338476966e-05,
            "start_logit": -3.9484333992004395,
            "end_logit": 2.7565271854400635
        },
        {
            "text": "CLS-TA, a triamcinolone acetonide injectable suspension for suprachoroidal",
            "probability": 5.131643308375492e-05,
            "start_logit": -3.3758718967437744,
            "end_logit": 1.6906615495681763
        },
        {
            "text": "SCS\u00ae)",
            "probability": 3.8342385632551005e-05,
            "start_logit": -0.22863547503948212,
            "end_logit": -1.7480299472808838
        },
        {
            "text": "SCS Microinjector",
            "probability": 1.2283072399106263e-05,
            "start_logit": -0.6580147743225098,
            "end_logit": -2.456984519958496
        }
    ],
    "6440396957b1c7a31500004b_002": [
        {
            "text": "Suprachoroidal",
            "probability": 0.9022679161994398,
            "start_logit": 9.830071449279785,
            "end_logit": 6.890940189361572
        },
        {
            "text": "Suprachoroidal delivery",
            "probability": 0.09550970167310009,
            "start_logit": 9.830071449279785,
            "end_logit": 4.645256519317627
        },
        {
            "text": "Su",
            "probability": 0.0015536040014117352,
            "start_logit": 9.830071449279785,
            "end_logit": 0.5266060829162598
        },
        {
            "text": "Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions.",
            "probability": 0.0005969925783360932,
            "start_logit": 9.830071449279785,
            "end_logit": -0.4298219084739685
        },
        {
            "text": "Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions",
            "probability": 3.278605060761751e-05,
            "start_logit": 9.830071449279785,
            "end_logit": -3.33172345161438
        },
        {
            "text": "Supra",
            "probability": 2.992081388283057e-05,
            "start_logit": 9.830071449279785,
            "end_logit": -3.4231722354888916
        },
        {
            "text": "Suprachoroid",
            "probability": 3.4345569642991486e-06,
            "start_logit": 9.830071449279785,
            "end_logit": -5.587838649749756
        },
        {
            "text": "Suprachoroidal delivery enables",
            "probability": 2.750253993842905e-06,
            "start_logit": 9.830071449279785,
            "end_logit": -5.810033321380615
        },
        {
            "text": "Suprachoroidal delivery enables targeting, localization and durability of small molecule",
            "probability": 1.1909423375377072e-06,
            "start_logit": 9.830071449279785,
            "end_logit": -6.646981716156006
        },
        {
            "text": "Suprachoroidal delivery enables targeting, localization and durability",
            "probability": 5.756637704291569e-07,
            "start_logit": 9.830071449279785,
            "end_logit": -7.373958110809326
        },
        {
            "text": "Suprachoroidal delivery enables targeting, localization",
            "probability": 4.844386137445166e-07,
            "start_logit": 9.830071449279785,
            "end_logit": -7.5464911460876465
        },
        {
            "text": "Suprachor",
            "probability": 4.130197321353787e-07,
            "start_logit": 9.830071449279785,
            "end_logit": -7.705986499786377
        },
        {
            "text": "delivery",
            "probability": 2.27235449064362e-07,
            "start_logit": -3.118680238723755,
            "end_logit": 4.645256519317627
        },
        {
            "text": "delivery enables targeting, localization and durability of small molecule suspensions.",
            "probability": 1.4203570344152896e-09,
            "start_logit": -3.118680238723755,
            "end_logit": -0.4298219084739685
        },
        {
            "text": "enables targeting, localization and durability of small molecule suspensions.",
            "probability": 8.263672142554e-10,
            "start_logit": -3.660304546356201,
            "end_logit": -0.4298219084739685
        },
        {
            "text": "small molecule suspensions.",
            "probability": 1.0186202641309588e-10,
            "start_logit": -5.753724575042725,
            "end_logit": -0.4298219084739685
        },
        {
            "text": "delivery enables targeting, localization and durability of small molecule suspensions",
            "probability": 7.800414829446766e-11,
            "start_logit": -3.118680238723755,
            "end_logit": -3.33172345161438
        },
        {
            "text": ".",
            "probability": 5.284282853889433e-11,
            "start_logit": -6.410021781921387,
            "end_logit": -0.4298219084739685
        },
        {
            "text": "targeting, localization and durability of small molecule suspensions.",
            "probability": 4.7544465295241696e-11,
            "start_logit": -6.515678405761719,
            "end_logit": -0.4298219084739685
        },
        {
            "text": "enables targeting, localization and durability of small molecule suspensions",
            "probability": 4.5383005233610344e-11,
            "start_logit": -3.660304546356201,
            "end_logit": -3.33172345161438
        }
    ],
    "6431708a57b1c7a315000017_001": [
        {
            "text": "T1AM",
            "probability": 0.9354332483346393,
            "start_logit": 5.148024559020996,
            "end_logit": 2.0498173236846924
        },
        {
            "text": "T1AM on cardiomyocytes",
            "probability": 0.05428253886352171,
            "start_logit": 5.148024559020996,
            "end_logit": -0.7969898581504822
        },
        {
            "text": "cardiomyocytes",
            "probability": 0.0053847459926149675,
            "start_logit": 2.8373920917510986,
            "end_logit": -0.7969898581504822
        },
        {
            "text": "cardiomyocytes with a focus on the regulation of the intracellular temperature and natriuretic peptide (NP) expression.",
            "probability": 0.0030039997318308627,
            "start_logit": 2.8373920917510986,
            "end_logit": -1.3806153535842896
        },
        {
            "text": "cardiomyocytes with a focus on the regulation of the intracellular temperature and natriuretic peptide (NP) expression. A",
            "probability": 0.000354700014233449,
            "start_logit": 2.8373920917510986,
            "end_logit": -3.517042875289917
        },
        {
            "text": "T",
            "probability": 0.0003495394165046135,
            "start_logit": 5.148024559020996,
            "end_logit": -5.842331409454346
        },
        {
            "text": "We explored the direct impact of T1AM",
            "probability": 0.00026604359920186606,
            "start_logit": -3.017080307006836,
            "end_logit": 2.0498173236846924
        },
        {
            "text": "T1AM on cardiomyocytes with a focus on the regulation of the intracellular temperature and natriuretic peptide (NP",
            "probability": 0.0002571564975234728,
            "start_logit": 5.148024559020996,
            "end_logit": -6.14926290512085
        },
        {
            "text": "T1AM on cardiomyocytes with a focus on the regulation of the intracellular temperature and natriuretic peptide",
            "probability": 0.0002390864196929598,
            "start_logit": 5.148024559020996,
            "end_logit": -6.222122669219971
        },
        {
            "text": "T1",
            "probability": 0.00020934547388131537,
            "start_logit": 5.148024559020996,
            "end_logit": -6.35496187210083
        },
        {
            "text": "T1AM on card",
            "probability": 0.00010237786533657689,
            "start_logit": 5.148024559020996,
            "end_logit": -7.070277214050293
        },
        {
            "text": "cardiomyocytes with a focus on the regulation of the intracellular temperature and natriuretic peptide (NP",
            "probability": 2.5509536740643595e-05,
            "start_logit": 2.8373920917510986,
            "end_logit": -6.14926290512085
        },
        {
            "text": "cardiomyocytes with a focus on the regulation of the intracellular temperature and natriuretic peptide",
            "probability": 2.371701227105797e-05,
            "start_logit": 2.8373920917510986,
            "end_logit": -6.222122669219971
        },
        {
            "text": "cardiomyocytes with a focus on the regulation of the intracellular temperature and natriuretic peptide (NP) expression",
            "probability": 1.887883185217174e-05,
            "start_logit": 2.8373920917510986,
            "end_logit": -6.4502739906311035
        },
        {
            "text": "We explored the direct impact of T1AM on cardiomyocytes",
            "probability": 1.543832447561263e-05,
            "start_logit": -3.017080307006836,
            "end_logit": -0.7969898581504822
        },
        {
            "text": "card",
            "probability": 1.0155729846933722e-05,
            "start_logit": 2.8373920917510986,
            "end_logit": -7.070277214050293
        },
        {
            "text": "cardiomyocytes with a focus on the regulation of the intracellular temperature and natriuretic peptide (NP)",
            "probability": 9.514080740492817e-06,
            "start_logit": 2.8373920917510986,
            "end_logit": -7.135542392730713
        },
        {
            "text": "direct impact of T1AM",
            "probability": 6.799066453893399e-06,
            "start_logit": -6.683955192565918,
            "end_logit": 2.0498173236846924
        },
        {
            "text": "natriuretic peptide (NP) expression.",
            "probability": 4.3568154760664186e-06,
            "start_logit": -3.698566436767578,
            "end_logit": -1.3806153535842896
        },
        {
            "text": "NP) expression.",
            "probability": 2.848393162456911e-06,
            "start_logit": -4.1235527992248535,
            "end_logit": -1.3806153535842896
        }
    ],
    "6431708a57b1c7a315000017_002": [
        {
            "text": "miR-145",
            "probability": 0.9809812298384742,
            "start_logit": 0.5040333271026611,
            "end_logit": 2.9433650970458984
        },
        {
            "text": "145",
            "probability": 0.010790440719080951,
            "start_logit": -4.005859375,
            "end_logit": 2.9433650970458984
        },
        {
            "text": "cardiomyocytes, after up-regulating the expression of miR-145",
            "probability": 0.0025660542447366328,
            "start_logit": -5.442150592803955,
            "end_logit": 2.9433650970458984
        },
        {
            "text": "B-type natriuretic peptide (BNP) induced by PE decreased.",
            "probability": 0.0019514553310772285,
            "start_logit": 0.06412024050951004,
            "end_logit": -2.8366997241973877
        },
        {
            "text": "In hypertrophic cardiomyocytes, after up-regulating the expression of miR-145",
            "probability": 0.0016038971280963406,
            "start_logit": -5.912083625793457,
            "end_logit": 2.9433650970458984
        },
        {
            "text": "hypertrophic cardiomyocytes, after up-regulating the expression of miR-145",
            "probability": 0.001046806275900059,
            "start_logit": -6.338776111602783,
            "end_logit": 2.9433650970458984
        },
        {
            "text": "up-regulating the expression of miR-145",
            "probability": 0.0005568606699124775,
            "start_logit": -6.9699602127075195,
            "end_logit": 2.9433650970458984
        },
        {
            "text": "miR-145, the relative messenger ribonucleic acid (mRNA) and protein expressions of atrial natriuretic peptide",
            "probability": 0.00012751120245121857,
            "start_logit": 0.5040333271026611,
            "end_logit": -6.004739284515381
        },
        {
            "text": "miR-145,",
            "probability": 5.933000639557123e-05,
            "start_logit": 0.5040333271026611,
            "end_logit": -6.7698283195495605
        },
        {
            "text": "miR-145, the relative messenger ribonucleic acid",
            "probability": 5.020305059562412e-05,
            "start_logit": 0.5040333271026611,
            "end_logit": -6.936867713928223
        },
        {
            "text": "B-type natriuretic peptide (BNP) induced by PE",
            "probability": 4.6108189836982634e-05,
            "start_logit": 0.06412024050951004,
            "end_logit": -6.582039833068848
        },
        {
            "text": "B-type",
            "probability": 3.9182934103061196e-05,
            "start_logit": 0.06412024050951004,
            "end_logit": -6.744789123535156
        },
        {
            "text": "mi",
            "probability": 3.534245814326945e-05,
            "start_logit": 0.5040333271026611,
            "end_logit": -7.287858486175537
        },
        {
            "text": "B-type natriuretic peptide",
            "probability": 3.266295673147281e-05,
            "start_logit": 0.06412024050951004,
            "end_logit": -6.926788806915283
        },
        {
            "text": "miR-145, the relative messenger ribonucleic acid (mRNA",
            "probability": 2.9487122969111423e-05,
            "start_logit": 0.5040333271026611,
            "end_logit": -7.468989849090576
        },
        {
            "text": "miR-145, the relative messenger ribonucleic acid (mRNA) and protein expressions",
            "probability": 2.9245405824164667e-05,
            "start_logit": 0.5040333271026611,
            "end_logit": -7.4772210121154785
        },
        {
            "text": "PE decreased.",
            "probability": 2.0258637558483172e-05,
            "start_logit": -4.503629207611084,
            "end_logit": -2.8366997241973877
        },
        {
            "text": "B",
            "probability": 1.887553208003598e-05,
            "start_logit": 0.06412024050951004,
            "end_logit": -7.47516393661499
        },
        {
            "text": "BNP) induced by PE decreased.",
            "probability": 7.925051903642374e-06,
            "start_logit": -5.442181587219238,
            "end_logit": -2.8366997241973877
        },
        {
            "text": "atrial natriuretic peptide",
            "probability": 7.123244129580743e-06,
            "start_logit": -2.380807638168335,
            "end_logit": -6.004739284515381
        }
    ],
    "6431708a57b1c7a315000017_003": [
        {
            "text": "cardiomyocytes",
            "probability": 0.9304124601860065,
            "start_logit": 0.4246577024459839,
            "end_logit": 1.359855055809021
        },
        {
            "text": "Stretching of cultured cardiomyocytes",
            "probability": 0.04359965726910785,
            "start_logit": -2.635921001434326,
            "end_logit": 1.359855055809021
        },
        {
            "text": "cardiomyocytes up-regulates the expression of brain natriuretic peptide (BNP).",
            "probability": 0.01881716475070912,
            "start_logit": 0.4246577024459839,
            "end_logit": -2.541003465652466
        },
        {
            "text": "brain natriuretic peptide (BNP).",
            "probability": 0.0023936060255765716,
            "start_logit": -1.6373107433319092,
            "end_logit": -2.541003465652466
        },
        {
            "text": "cultured cardiomyocytes",
            "probability": 0.001992241850561557,
            "start_logit": -5.721709728240967,
            "end_logit": 1.359855055809021
        },
        {
            "text": "Stretching of cultured cardiomyocytes up-regulates the expression of brain natriuretic peptide (BNP).",
            "probability": 0.0008817830467825393,
            "start_logit": -2.635921001434326,
            "end_logit": -2.541003465652466
        },
        {
            "text": "cardiomyocytes up-regulates the expression of brain natriuretic peptide",
            "probability": 0.000664422999551507,
            "start_logit": 0.4246577024459839,
            "end_logit": -5.884609222412109
        },
        {
            "text": "cardiomy",
            "probability": 0.0002971919897257606,
            "start_logit": 0.4246577024459839,
            "end_logit": -6.689149856567383
        },
        {
            "text": "cardio",
            "probability": 0.00013250021471614398,
            "start_logit": 0.4246577024459839,
            "end_logit": -7.496943950653076
        },
        {
            "text": "cardiomyocytes up-regulates the expression of brain natriuretic peptide (BNP",
            "probability": 0.00012511730662212523,
            "start_logit": 0.4246577024459839,
            "end_logit": -7.554276466369629
        },
        {
            "text": "card",
            "probability": 0.00011900837421338333,
            "start_logit": 0.4246577024459839,
            "end_logit": -7.604334354400635
        },
        {
            "text": "BNP).",
            "probability": 0.0001125527403913994,
            "start_logit": -4.6944451332092285,
            "end_logit": -2.541003465652466
        },
        {
            "text": "cardiomyocytes up-regulate",
            "probability": 0.00010549612518264945,
            "start_logit": 0.4246577024459839,
            "end_logit": -7.724853992462158
        },
        {
            "text": "cardiomyocytes up-regulates the expression of brain natriuretic peptide (BNP). Intracellular calcium",
            "probability": 9.813075596688742e-05,
            "start_logit": 0.4246577024459839,
            "end_logit": -7.797227382659912
        },
        {
            "text": "brain natriuretic peptide",
            "probability": 8.451681835852632e-05,
            "start_logit": -1.6373107433319092,
            "end_logit": -5.884609222412109
        },
        {
            "text": "cultured cardiomyocytes up-regulates the expression of brain natriuretic peptide (BNP).",
            "probability": 4.0292176566272365e-05,
            "start_logit": -5.721709728240967,
            "end_logit": -2.541003465652466
        },
        {
            "text": "BNP). Intracellular calcium-elevating agents such as the calcium ionophore A23187,",
            "probability": 3.9125777805994886e-05,
            "start_logit": -4.6944451332092285,
            "end_logit": -3.5976438522338867
        },
        {
            "text": "brain natriuretic peptide (BNP). Intracellular calcium-elevating agents",
            "probability": 3.577008976129831e-05,
            "start_logit": -1.6373107433319092,
            "end_logit": -6.744447708129883
        },
        {
            "text": "Stretching of cultured cardiomyocytes up-regulates the expression of brain natriuretic peptide",
            "probability": 3.1135239801460684e-05,
            "start_logit": -2.635921001434326,
            "end_logit": -5.884609222412109
        },
        {
            "text": "natriuretic peptide (BNP).",
            "probability": 1.7826262592392402e-05,
            "start_logit": -6.53719425201416,
            "end_logit": -2.541003465652466
        }
    ],
    "640f8641201352f04a00002c_001": [
        {
            "text": "trabeculotomy",
            "probability": 0.3967197923043149,
            "start_logit": -2.4418234825134277,
            "end_logit": -3.5796778202056885
        },
        {
            "text": "This retrospective case series",
            "probability": 0.10374422957785681,
            "start_logit": -3.906465768814087,
            "end_logit": -3.4563372135162354
        },
        {
            "text": "This retrospective case series included patients with PCG who underwent trabeculotomy",
            "probability": 0.09170601141497035,
            "start_logit": -3.906465768814087,
            "end_logit": -3.5796778202056885
        },
        {
            "text": "PCG who underwent trabeculotomy",
            "probability": 0.07054100834423929,
            "start_logit": -4.168859481811523,
            "end_logit": -3.5796778202056885
        },
        {
            "text": "trab",
            "probability": 0.06562501609450659,
            "start_logit": -2.4418234825134277,
            "end_logit": -5.378951072692871
        },
        {
            "text": "trabeculotomy using an illuminated microcatheter",
            "probability": 0.042354635864495005,
            "start_logit": -2.4418234825134277,
            "end_logit": -5.816830158233643
        },
        {
            "text": "the full circumference of Schlemm's canal in a single procedure",
            "probability": 0.037713067649910115,
            "start_logit": -4.161350250244141,
            "end_logit": -4.213374614715576
        },
        {
            "text": "trabeculotomy using an illuminated microcatheter with the intent of catheterizing the full circumference",
            "probability": 0.034907104374392726,
            "start_logit": -2.4418234825134277,
            "end_logit": -6.010217666625977
        },
        {
            "text": "a single procedure",
            "probability": 0.02626008379996386,
            "start_logit": -4.523306846618652,
            "end_logit": -4.213374614715576
        },
        {
            "text": "retrospective case series",
            "probability": 0.01582230781750959,
            "start_logit": -5.786973476409912,
            "end_logit": -3.4563372135162354
        },
        {
            "text": "This retrospective case series included patients with PCG who underwent trab",
            "probability": 0.01516992242840761,
            "start_logit": -3.906465768814087,
            "end_logit": -5.378951072692871
        },
        {
            "text": "This retrospective case series included patients with PCG",
            "probability": 0.014245177497116145,
            "start_logit": -3.906465768814087,
            "end_logit": -5.441847324371338
        },
        {
            "text": "retrospective case series included patients with PCG who underwent trabeculotomy",
            "probability": 0.013986327212876725,
            "start_logit": -5.786973476409912,
            "end_logit": -3.5796778202056885
        },
        {
            "text": "PCG who underwent trab",
            "probability": 0.01166882746390034,
            "start_logit": -4.168859481811523,
            "end_logit": -5.378951072692871
        },
        {
            "text": "trabeculotomy using an illuminated microcatheter with the intent of catheterizing",
            "probability": 0.011569167902286334,
            "start_logit": -2.4418234825134277,
            "end_logit": -7.114564418792725
        },
        {
            "text": "PCG",
            "probability": 0.010957506156736003,
            "start_logit": -4.168859481811523,
            "end_logit": -5.441847324371338
        },
        {
            "text": "trabeculotom",
            "probability": 0.010617001855521172,
            "start_logit": -2.4418234825134277,
            "end_logit": -7.200451374053955
        },
        {
            "text": "This retrospective case series included patients with PCG who underwent trabeculotomy using an illuminated microcatheter",
            "probability": 0.009790725835747636,
            "start_logit": -3.906465768814087,
            "end_logit": -5.816830158233643
        },
        {
            "text": "catheterizing the full circumference of Schlemm's canal in a single procedure",
            "probability": 0.00907098062254882,
            "start_logit": -5.586276531219482,
            "end_logit": -4.213374614715576
        },
        {
            "text": "PCG who underwent trabeculotomy using an illuminated microcatheter",
            "probability": 0.007531105782699976,
            "start_logit": -4.168859481811523,
            "end_logit": -5.816830158233643
        }
    ],
    "640f8641201352f04a00002c_002": [
        {
            "text": "P",
            "probability": 0.25776447529611946,
            "start_logit": -5.39548397064209,
            "end_logit": -3.4105756282806396
        },
        {
            "text": "glaucoma surgery (MIGS) devices on outflow facility.DESIGN:",
            "probability": 0.08786637425731146,
            "start_logit": -6.1148786544799805,
            "end_logit": -3.7674100399017334
        },
        {
            "text": "3 Schlemm's canal (SC) microinvasive glaucoma surgery (MIGS) devices on outflow facility.",
            "probability": 0.07818254725459373,
            "start_logit": -6.231649398803711,
            "end_logit": -3.7674100399017334
        },
        {
            "text": "microinvasive glaucoma surgery (MIGS) devices on outflow facility.",
            "probability": 0.07265292335083397,
            "start_logit": -6.305002212524414,
            "end_logit": -3.7674100399017334
        },
        {
            "text": "outflow facility.DESIGN: Paired comparisons, randomized design, baseline-controlled study.P",
            "probability": 0.05836640663098478,
            "start_logit": -6.880789756774902,
            "end_logit": -3.4105756282806396
        },
        {
            "text": "Paired comparisons, randomized design, baseline-controlled study.P",
            "probability": 0.05303679256209007,
            "start_logit": -6.976544380187988,
            "end_logit": -3.4105756282806396
        },
        {
            "text": "MIGS) devices on outflow facility.DESIGN: Paired comparisons, randomized design, baseline-controlled study.P",
            "probability": 0.049412112238738676,
            "start_logit": -7.047334671020508,
            "end_logit": -3.4105756282806396
        },
        {
            "text": "DESIGN: Paired comparisons, randomized design, baseline-controlled study.P",
            "probability": 0.0453584999603771,
            "start_logit": -7.132932662963867,
            "end_logit": -3.4105756282806396
        },
        {
            "text": "Schlemm's canal (SC) microinvasive glaucoma surgery (MIGS) devices on outflow facility.",
            "probability": 0.04476979447662036,
            "start_logit": -6.7891621589660645,
            "end_logit": -3.7674100399017334
        },
        {
            "text": "outflow facility.",
            "probability": 0.0408499698722355,
            "start_logit": -6.880789756774902,
            "end_logit": -3.7674100399017334
        },
        {
            "text": "baseline-controlled study.P",
            "probability": 0.03843880070381899,
            "start_logit": -7.298462867736816,
            "end_logit": -3.4105756282806396
        },
        {
            "text": "MIGS) devices on outflow facility.",
            "probability": 0.03458296326237168,
            "start_logit": -7.047334671020508,
            "end_logit": -3.7674100399017334
        },
        {
            "text": "randomized design, baseline-controlled study.P",
            "probability": 0.03137816090870126,
            "start_logit": -7.501418113708496,
            "end_logit": -3.4105756282806396
        },
        {
            "text": "glaucoma surgery (MIGS) devices on outflow facility.",
            "probability": 0.029976792810626752,
            "start_logit": -7.190272331237793,
            "end_logit": -3.7674100399017334
        },
        {
            "text": "(SC) microinvasive glaucoma surgery (MIGS) devices on outflow facility.",
            "probability": 0.01981105059123108,
            "start_logit": -7.604455947875977,
            "end_logit": -3.7674100399017334
        },
        {
            "text": "To study the effect of 3 Schlemm's canal (SC)",
            "probability": 0.016032316217453484,
            "start_logit": -5.447755813598633,
            "end_logit": -6.135743618011475
        },
        {
            "text": "To study the effect of 3 Schlemm's canal (SC) microinvasive glaucoma surgery (MIGS) devices",
            "probability": 0.012720599004397672,
            "start_logit": -5.447755813598633,
            "end_logit": -6.367127418518066
        },
        {
            "text": "To study the effect of 3 Schlemm's canal (SC) microinvasive glaucoma surgery (MIGS)",
            "probability": 0.012315401708774919,
            "start_logit": -5.447755813598633,
            "end_logit": -6.399499416351318
        },
        {
            "text": "3 Schlemm's canal (SC) microinvasive glaucoma surgery (MIGS) devices on outflow facility",
            "probability": 0.008544161269579034,
            "start_logit": -6.231649398803711,
            "end_logit": -5.981208324432373
        },
        {
            "text": "microinvasive glaucoma surgery (MIGS) devices on outflow facility",
            "probability": 0.007939857623140006,
            "start_logit": -6.305002212524414,
            "end_logit": -5.981208324432373
        }
    ],
    "640f8641201352f04a00002c_003": [
        {
            "text": "Microinvasive Glaucoma Surgery Devices.",
            "probability": 0.3677399151120981,
            "start_logit": -3.475186824798584,
            "end_logit": 2.1413562297821045
        },
        {
            "text": "Glaucoma Surgery Devices.",
            "probability": 0.33671484062376855,
            "start_logit": -3.563326358795166,
            "end_logit": 2.1413562297821045
        },
        {
            "text": "Outflow Facility Effects of 3 Schlemm's Canal Microinvasive Glaucoma Surgery Devices.",
            "probability": 0.11367036407320251,
            "start_logit": -4.6492600440979,
            "end_logit": 2.1413562297821045
        },
        {
            "text": "3 Schlemm's Canal Microinvasive Glaucoma Surgery Devices.",
            "probability": 0.08886953444284718,
            "start_logit": -4.895393371582031,
            "end_logit": 2.1413562297821045
        },
        {
            "text": "Microinvasive Glaucoma Surgery Devices",
            "probability": 0.028011439924955535,
            "start_logit": -3.475186824798584,
            "end_logit": -0.4334067106246948
        },
        {
            "text": "Glaucoma Surgery Devices",
            "probability": 0.025648201738172904,
            "start_logit": -3.563326358795166,
            "end_logit": -0.4334067106246948
        },
        {
            "text": "Outflow Facility Effects of 3 Schlemm's Canal Microinvasive Glaucoma Surgery Devices",
            "probability": 0.008658485096766654,
            "start_logit": -4.6492600440979,
            "end_logit": -0.4334067106246948
        },
        {
            "text": "Schlemm's Canal Microinvasive Glaucoma Surgery Devices.",
            "probability": 0.008647881899901323,
            "start_logit": -7.225248336791992,
            "end_logit": 2.1413562297821045
        },
        {
            "text": "3 Schlemm's Canal Microinvasive Glaucoma Surgery Devices",
            "probability": 0.006769359329529807,
            "start_logit": -4.895393371582031,
            "end_logit": -0.4334067106246948
        },
        {
            "text": ".",
            "probability": 0.005249484154214938,
            "start_logit": -7.724432945251465,
            "end_logit": 2.1413562297821045
        },
        {
            "text": "of 3 Schlemm's Canal Microinvasive Glaucoma Surgery Devices.",
            "probability": 0.004296654734993,
            "start_logit": -7.9247260093688965,
            "end_logit": 2.1413562297821045
        },
        {
            "text": "Devices.",
            "probability": 0.0040891992174421085,
            "start_logit": -7.974213600158691,
            "end_logit": 2.1413562297821045
        },
        {
            "text": "Schlemm's Canal Microinvasive Glaucoma Surgery Devices",
            "probability": 0.0006587254044569908,
            "start_logit": -7.225248336791992,
            "end_logit": -0.4334067106246948
        },
        {
            "text": "of 3 Schlemm's Canal Microinvasive Glaucoma Surgery Devices",
            "probability": 0.0003272842599934909,
            "start_logit": -7.9247260093688965,
            "end_logit": -0.4334067106246948
        },
        {
            "text": "Devices",
            "probability": 0.000311481983634108,
            "start_logit": -7.974213600158691,
            "end_logit": -0.4334067106246948
        },
        {
            "text": "Microinvasive",
            "probability": 0.00010687064782224633,
            "start_logit": -3.475186824798584,
            "end_logit": -6.002155780792236
        },
        {
            "text": "Microinvasive Glau",
            "probability": 7.2202420523945e-05,
            "start_logit": -3.475186824798584,
            "end_logit": -6.394301414489746
        },
        {
            "text": "Glau",
            "probability": 6.611092655514304e-05,
            "start_logit": -3.563326358795166,
            "end_logit": -6.394301414489746
        },
        {
            "text": "Microinvasive Glaucoma Surgery",
            "probability": 4.800710994200043e-05,
            "start_logit": -3.475186824798584,
            "end_logit": -6.802425861358643
        },
        {
            "text": "Glaucoma Surgery",
            "probability": 4.3956899179684985e-05,
            "start_logit": -3.563326358795166,
            "end_logit": -6.802425861358643
        }
    ],
    "640f8641201352f04a00002c_004": [
        {
            "text": "eyes",
            "probability": 0.9994591167848704,
            "start_logit": 3.989415407180786,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "in eyes",
            "probability": 0.0001481830893027707,
            "start_logit": -4.827105522155762,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "blood reflux from Schlemm's canal (SC) after long-standing glaucoma surgery was reported in eyes",
            "probability": 0.00010093828927989961,
            "start_logit": -5.211044788360596,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "eyes treated with excisional LOT",
            "probability": 7.147812976443006e-05,
            "start_logit": 3.989415407180786,
            "end_logit": -6.537963390350342
        },
        {
            "text": "glaucoma surgery was reported in eyes",
            "probability": 6.255049543807307e-05,
            "start_logit": -5.689579963684082,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "Previously, blood reflux from Schlemm's canal (SC) after long-standing glaucoma surgery was reported in eyes",
            "probability": 5.9591230786687516e-05,
            "start_logit": -5.738045692443848,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "Schlemm's canal (SC) after long-standing glaucoma surgery was reported in eyes",
            "probability": 1.8794502620876414e-05,
            "start_logit": -6.891989707946777,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "eyes treated with excision",
            "probability": 1.856373230092089e-05,
            "start_logit": 3.989415407180786,
            "end_logit": -7.886145114898682
        },
        {
            "text": "long-standing glaucoma surgery was reported in eyes",
            "probability": 1.841496063646763e-05,
            "start_logit": -6.91239070892334,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "(SC) after long-standing glaucoma surgery was reported in eyes",
            "probability": 1.6981507150472475e-05,
            "start_logit": -6.993429183959961,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "after long-standing glaucoma surgery was reported in eyes",
            "probability": 1.366934107391578e-05,
            "start_logit": -7.2103986740112305,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "SC) after long-standing glaucoma surgery was reported in eyes",
            "probability": 1.1671374761392983e-05,
            "start_logit": -7.368414878845215,
            "end_logit": 3.0076146125793457
        },
        {
            "text": "in eyes treated with excisional LOT",
            "probability": 1.0597582140378258e-08,
            "start_logit": -4.827105522155762,
            "end_logit": -6.537963390350342
        },
        {
            "text": "blood reflux",
            "probability": 7.816496203711245e-09,
            "start_logit": -5.211044788360596,
            "end_logit": -6.458413600921631
        },
        {
            "text": "blood reflux from Schlemm's canal (SC",
            "probability": 6.500736457858991e-09,
            "start_logit": -5.211044788360596,
            "end_logit": -6.642734527587891
        },
        {
            "text": "blood reflux from Schlemm's canal (SC)",
            "probability": 4.8700247521871015e-09,
            "start_logit": -5.211044788360596,
            "end_logit": -6.931550979614258
        },
        {
            "text": "Previously, blood reflux",
            "probability": 4.6146475489294815e-09,
            "start_logit": -5.738045692443848,
            "end_logit": -6.458413600921631
        },
        {
            "text": "glaucoma surgery was reported in eyes treated with excisional LOT",
            "probability": 4.4734120232297e-09,
            "start_logit": -5.689579963684082,
            "end_logit": -6.537963390350342
        },
        {
            "text": "blood reflux from",
            "probability": 3.85125586404375e-09,
            "start_logit": -5.211044788360596,
            "end_logit": -7.166250705718994
        },
        {
            "text": "Previously, blood reflux from Schlemm's canal (SC",
            "probability": 3.837858649154371e-09,
            "start_logit": -5.738045692443848,
            "end_logit": -6.642734527587891
        }
    ],
    "640f8641201352f04a00002c_005": [
        {
            "text": "subscleral",
            "probability": 0.9773247630398334,
            "start_logit": 4.822218894958496,
            "end_logit": 2.1299502849578857
        },
        {
            "text": "subscle",
            "probability": 0.010164013084302603,
            "start_logit": 4.822218894958496,
            "end_logit": -2.4360153675079346
        },
        {
            "text": "subscleral removing of the external wall of Schlemm's canal with subsequent laser trabeculopuncture",
            "probability": 0.010045742449601575,
            "start_logit": 4.822218894958496,
            "end_logit": -2.4477198123931885
        },
        {
            "text": "subscleral removing of the external wall",
            "probability": 0.0016546576584957936,
            "start_logit": 4.822218894958496,
            "end_logit": -4.251274585723877
        },
        {
            "text": "sub",
            "probability": 0.0004599467790876335,
            "start_logit": 4.822218894958496,
            "end_logit": -5.531513214111328
        },
        {
            "text": "subscleral removing",
            "probability": 0.000154794015569699,
            "start_logit": 4.822218894958496,
            "end_logit": -6.620528697967529
        },
        {
            "text": "subscleral removing of the external wall of Schlemm's canal with subsequent laser trabeculopunc",
            "probability": 0.0001051374756934285,
            "start_logit": 4.822218894958496,
            "end_logit": -7.007355213165283
        },
        {
            "text": "to comparatively evaluate the hypotensive effect of minimally invasive (type 1) and basic (type 2) subscleral",
            "probability": 3.170307325949936e-05,
            "start_logit": -5.513941764831543,
            "end_logit": 2.1299502849578857
        },
        {
            "text": "hypotensive effect of minimally invasive (type 1) and basic (type 2) subscleral",
            "probability": 2.848620540442514e-05,
            "start_logit": -5.620935440063477,
            "end_logit": 2.1299502849578857
        },
        {
            "text": "minimally invasive (type 1) and basic (type 2) subscleral",
            "probability": 1.6877928592043805e-05,
            "start_logit": -6.144348621368408,
            "end_logit": 2.1299502849578857
        },
        {
            "text": "the hypotensive effect of minimally invasive (type 1) and basic (type 2) subscleral",
            "probability": 8.432576568045391e-06,
            "start_logit": -6.838253021240234,
            "end_logit": 2.1299502849578857
        },
        {
            "text": "AIM: to comparatively evaluate the hypotensive effect of minimally invasive (type 1) and basic (type 2) subscle",
            "probability": 1.340717157478121e-06,
            "start_logit": -4.111185073852539,
            "end_logit": -2.4360153675079346
        },
        {
            "text": "external wall of Schlemm's canal with subsequent laser trabeculopuncture",
            "probability": 9.471944837528936e-07,
            "start_logit": -4.446936130523682,
            "end_logit": -2.4477198123931885
        },
        {
            "text": "external wall of Schlemm's canal with subsequent laser trabeculopuncture in patients with open-angle glaucoma",
            "probability": 8.391411939616003e-07,
            "start_logit": -4.446936130523682,
            "end_logit": -2.568845272064209
        },
        {
            "text": "the external wall of Schlemm's canal with subsequent laser trabeculopuncture",
            "probability": 6.225359848324027e-07,
            "start_logit": -4.866639137268066,
            "end_logit": -2.4477198123931885
        },
        {
            "text": "laser trabeculopuncture",
            "probability": 3.93653765837484e-07,
            "start_logit": -5.3249688148498535,
            "end_logit": -2.4477198123931885
        },
        {
            "text": "laser trabeculopuncture in patients with open-angle glaucoma",
            "probability": 3.487468484439824e-07,
            "start_logit": -5.3249688148498535,
            "end_logit": -2.568845272064209
        },
        {
            "text": "to comparatively evaluate the hypotensive effect of minimally invasive (type 1) and basic (type 2) subscle",
            "probability": 3.2970662732406607e-07,
            "start_logit": -5.513941764831543,
            "end_logit": -2.4360153675079346
        },
        {
            "text": "open-angle glaucoma",
            "probability": 3.277657877803003e-07,
            "start_logit": -5.3870158195495605,
            "end_logit": -2.568845272064209
        },
        {
            "text": "hypotensive effect of minimally invasive (type 1) and basic (type 2) subscle",
            "probability": 2.962517429233581e-07,
            "start_logit": -5.620935440063477,
            "end_logit": -2.4360153675079346
        }
    ],
    "644009c557b1c7a315000041_001": [
        {
            "text": "autosomal recessive",
            "probability": 0.9994472579993363,
            "start_logit": 8.69212818145752,
            "end_logit": 8.845988273620605
        },
        {
            "text": "autosomal recess",
            "probability": 0.0002726006307501789,
            "start_logit": 8.69212818145752,
            "end_logit": 0.6390384435653687
        },
        {
            "text": "auto",
            "probability": 0.0001345894017845305,
            "start_logit": 8.69212818145752,
            "end_logit": -0.06674071401357651
        },
        {
            "text": "recessive",
            "probability": 0.00011499633646446533,
            "start_logit": -0.3779292106628418,
            "end_logit": 8.845988273620605
        },
        {
            "text": "Friedreich's Ataxia (FRDA) is an autosomal recessive",
            "probability": 1.7736957379679038e-05,
            "start_logit": -2.2471790313720703,
            "end_logit": 8.845988273620605
        },
        {
            "text": "FRDA) is an autosomal recessive",
            "probability": 5.353891009102171e-06,
            "start_logit": -3.4450058937072754,
            "end_logit": 8.845988273620605
        },
        {
            "text": "autosomal re",
            "probability": 2.088484734577867e-06,
            "start_logit": 8.69212818145752,
            "end_logit": -4.23253059387207
        },
        {
            "text": "autosomal",
            "probability": 1.8460207664257911e-06,
            "start_logit": 8.69212818145752,
            "end_logit": -4.3559370040893555
        },
        {
            "text": "autoso",
            "probability": 1.3483640807656583e-06,
            "start_logit": 8.69212818145752,
            "end_logit": -4.670077323913574
        },
        {
            "text": "autosomal recessive neurodegenerative disorder,",
            "probability": 8.053699774630332e-07,
            "start_logit": 8.69212818145752,
            "end_logit": -5.185422897338867
        },
        {
            "text": "an autosomal recessive",
            "probability": 4.213025079733579e-07,
            "start_logit": -5.987233638763428,
            "end_logit": 8.845988273620605
        },
        {
            "text": "(FRDA) is an autosomal recessive",
            "probability": 3.7521287093477436e-07,
            "start_logit": -6.103091239929199,
            "end_logit": 8.845988273620605
        },
        {
            "text": "autosomal recessive neurodegenerative disorder",
            "probability": 2.6199313876809173e-07,
            "start_logit": 8.69212818145752,
            "end_logit": -6.308406352996826
        },
        {
            "text": "Ataxia (FRDA) is an autosomal recessive",
            "probability": 1.0431240744191986e-07,
            "start_logit": -7.383194446563721,
            "end_logit": 8.845988273620605
        },
        {
            "text": "autosomal recessive neurodegenerative disorder, affecting dorsal root ganglia (DRG",
            "probability": 7.252066815267427e-08,
            "start_logit": 8.69212818145752,
            "end_logit": -7.59285306930542
        },
        {
            "text": "autosomal recessive neurodegenerative disorder, affecting dorsal root ganglia (DRG), cerebellar dentate nuclei",
            "probability": 6.835591203774275e-08,
            "start_logit": 8.69212818145752,
            "end_logit": -7.651996612548828
        },
        {
            "text": "autosomal recessive neurodegenerative",
            "probability": 6.280209111312879e-08,
            "start_logit": 8.69212818145752,
            "end_logit": -7.736736297607422
        },
        {
            "text": "Friedreich's Ataxia (FRDA) is an autosomal recess",
            "probability": 4.8377798133823655e-09,
            "start_logit": -2.2471790313720703,
            "end_logit": 0.6390384435653687
        },
        {
            "text": "recessive neurodegenerative disorder, affecting dorsal root ganglia (DRG), cerebellar dentate nuclei and heart.",
            "probability": 2.8178131337731727e-09,
            "start_logit": -0.3779292106628418,
            "end_logit": -1.7707061767578125
        },
        {
            "text": "Friedreich's Ataxia (FRDA) is an auto",
            "probability": 2.3885267222478092e-09,
            "start_logit": -2.2471790313720703,
            "end_logit": -0.06674071401357651
        }
    ],
    "64371a4257b1c7a315000029_001": [
        {
            "text": "operons",
            "probability": 0.4414308187786753,
            "start_logit": 8.606922149658203,
            "end_logit": 9.143655776977539
        },
        {
            "text": "polycistronic messages (operons",
            "probability": 0.31679509705979975,
            "start_logit": 8.275156021118164,
            "end_logit": 9.143655776977539
        },
        {
            "text": "operons)",
            "probability": 0.1235671286663588,
            "start_logit": 8.606922149658203,
            "end_logit": 7.870419025421143
        },
        {
            "text": "polycistronic messages (operons)",
            "probability": 0.08867858530486215,
            "start_logit": 8.275156021118164,
            "end_logit": 7.870419025421143
        },
        {
            "text": "(operons",
            "probability": 0.009986002434640108,
            "start_logit": 4.818085193634033,
            "end_logit": 9.143655776977539
        },
        {
            "text": "polycistronic messages",
            "probability": 0.009772633865774448,
            "start_logit": 8.275156021118164,
            "end_logit": 5.664986610412598
        },
        {
            "text": "operon",
            "probability": 0.003386370466826649,
            "start_logit": 8.606922149658203,
            "end_logit": 4.273393154144287
        },
        {
            "text": "(operons)",
            "probability": 0.0027953228347711275,
            "start_logit": 4.818085193634033,
            "end_logit": 7.870419025421143
        },
        {
            "text": "polycistronic messages (operon",
            "probability": 0.002430246179201777,
            "start_logit": 8.275156021118164,
            "end_logit": 4.273393154144287
        },
        {
            "text": "Prokaryotes evolved polycistronic messages (operons",
            "probability": 0.0005788539563628335,
            "start_logit": 1.9701957702636719,
            "end_logit": 9.143655776977539
        },
        {
            "text": "Prokaryotes evolved polycistronic messages (operons)",
            "probability": 0.00016203517802135942,
            "start_logit": 1.9701957702636719,
            "end_logit": 7.870419025421143
        },
        {
            "text": "cotranscription/translation of functionally related genes/proteins. Prokaryotes evolved polycistronic messages (operons",
            "probability": 0.00015127647952989392,
            "start_logit": 0.6282547116279602,
            "end_logit": 9.143655776977539
        },
        {
            "text": "(operon",
            "probability": 7.660612328764274e-05,
            "start_logit": 4.818085193634033,
            "end_logit": 4.273393154144287
        },
        {
            "text": "operons) to confer expression from a single promoter to efficiently cotranslate proteins functioning on the same pathway.",
            "probability": 7.159455792846925e-05,
            "start_logit": 8.606922149658203,
            "end_logit": 0.416898250579834
        },
        {
            "text": "cotranscription/translation of functionally related genes/proteins. Prokaryotes evolved polycistronic messages (operons)",
            "probability": 4.234593375691877e-05,
            "start_logit": 0.6282547116279602,
            "end_logit": 7.870419025421143
        },
        {
            "text": "evolved polycistronic messages (operons",
            "probability": 2.4517432968696997e-05,
            "start_logit": -1.1914700269699097,
            "end_logit": 9.143655776977539
        },
        {
            "text": "Prokaryotes evolved polycistronic messages",
            "probability": 1.7856740302458414e-05,
            "start_logit": 1.9701957702636719,
            "end_logit": 5.664986610412598
        },
        {
            "text": "op",
            "probability": 1.4949609431783008e-05,
            "start_logit": 8.606922149658203,
            "end_logit": -1.1494356393814087
        },
        {
            "text": "polycistronic messages (op",
            "probability": 1.072866408387837e-05,
            "start_logit": 8.275156021118164,
            "end_logit": -1.1494356393814087
        },
        {
            "text": "polycistronic",
            "probability": 7.029733416234415e-06,
            "start_logit": 8.275156021118164,
            "end_logit": -1.572205901145935
        }
    ],
    "64371a4257b1c7a315000029_002": [
        {
            "text": "operons",
            "probability": 0.9891787941376016,
            "start_logit": 7.50917911529541,
            "end_logit": 6.638372898101807
        },
        {
            "text": "operon",
            "probability": 0.005173016891819304,
            "start_logit": 7.50917911529541,
            "end_logit": 1.3849538564682007
        },
        {
            "text": "operons is a fundamental element of how genetic information is organized in prokaryotes. This organization ensures coordinated gene expression by co-transcription",
            "probability": 0.0034565024256362673,
            "start_logit": 7.50917911529541,
            "end_logit": 0.9817550182342529
        },
        {
            "text": "operons is a fundamental element of how genetic information is organized in prokaryotes.",
            "probability": 0.0008040674169466852,
            "start_logit": 7.50917911529541,
            "end_logit": -0.4765743613243103
        },
        {
            "text": "operons is a fundamental element of how genetic information is organized in prokaryotes. This organization ensures coordinated gene expression by co-transcription.",
            "probability": 0.0007924690192352887,
            "start_logit": 7.50917911529541,
            "end_logit": -0.4911040663719177
        },
        {
            "text": "The arrangement of functionally-related genes in operons",
            "probability": 0.0003839909636628504,
            "start_logit": -0.34483224153518677,
            "end_logit": 6.638372898101807
        },
        {
            "text": "in operons",
            "probability": 0.00010194877187472445,
            "start_logit": -1.6709808111190796,
            "end_logit": 6.638372898101807
        },
        {
            "text": "op",
            "probability": 7.840485751440568e-05,
            "start_logit": 7.50917911529541,
            "end_logit": -2.8043715953826904
        },
        {
            "text": "operons is a fundamental element of how genetic information is organized in prokaryotes. This organization ensures coordinated gene expression",
            "probability": 1.8653113770009573e-05,
            "start_logit": 7.50917911529541,
            "end_logit": -4.240244388580322
        },
        {
            "text": "arrangement of functionally-related genes in operons",
            "probability": 4.243866321853772e-06,
            "start_logit": -4.849976539611816,
            "end_logit": 6.638372898101807
        },
        {
            "text": "functionally-related genes in operons",
            "probability": 2.0350024034253316e-06,
            "start_logit": -5.584954261779785,
            "end_logit": 6.638372898101807
        },
        {
            "text": "The arrangement of functionally-related genes in operon",
            "probability": 2.008122043361937e-06,
            "start_logit": -0.34483224153518677,
            "end_logit": 1.3849538564682007
        },
        {
            "text": "co-transcription",
            "probability": 1.1426369755497594e-06,
            "start_logit": -0.5054946541786194,
            "end_logit": 0.9817550182342529
        },
        {
            "text": "operons is a fundamental element of how genetic information",
            "probability": 1.0947319208411954e-06,
            "start_logit": 7.50917911529541,
            "end_logit": -7.075747966766357
        },
        {
            "text": "in operon",
            "probability": 5.331520672842283e-07,
            "start_logit": -1.6709808111190796,
            "end_logit": 1.3849538564682007
        },
        {
            "text": "in operons is a fundamental element of how genetic information is organized in prokaryotes. This organization ensures coordinated gene expression by co-transcription",
            "probability": 3.562411359443318e-07,
            "start_logit": -1.6709808111190796,
            "end_logit": 0.9817550182342529
        },
        {
            "text": "The arrangement of functionally-related genes in operons is a fundamental element of how genetic information is organized in prokaryotes.",
            "probability": 3.1213226983139984e-07,
            "start_logit": -0.34483224153518677,
            "end_logit": -0.4765743613243103
        },
        {
            "text": "co-transcription.",
            "probability": 2.6197129116413405e-07,
            "start_logit": -0.5054946541786194,
            "end_logit": -0.4911040663719177
        },
        {
            "text": "in operons is a fundamental element of how genetic information is organized in prokaryotes.",
            "probability": 8.287044379440412e-08,
            "start_logit": -1.6709808111190796,
            "end_logit": -0.4765743613243103
        },
        {
            "text": "in operons is a fundamental element of how genetic information is organized in prokaryotes. This organization ensures coordinated gene expression by co-transcription.",
            "probability": 8.167506596240927e-08,
            "start_logit": -1.6709808111190796,
            "end_logit": -0.4911040663719177
        }
    ],
    "64371a4257b1c7a315000029_003": [
        {
            "text": "Clustering of functionally related genes in operons",
            "probability": 0.6074437497317002,
            "start_logit": 7.262073516845703,
            "end_logit": 6.5074543952941895
        },
        {
            "text": "operons",
            "probability": 0.37034117597263405,
            "start_logit": 6.767238616943359,
            "end_logit": 6.5074543952941895
        },
        {
            "text": "Clustering of functionally related genes in operon",
            "probability": 0.011975395238480215,
            "start_logit": 7.262073516845703,
            "end_logit": 2.5810489654541016
        },
        {
            "text": "operon",
            "probability": 0.007301057846614962,
            "start_logit": 6.767238616943359,
            "end_logit": 2.5810489654541016
        },
        {
            "text": "Clustering of functionally related genes in operons allows for coregulated gene expression in prokaryotes.",
            "probability": 0.0015535963369864873,
            "start_logit": 7.262073516845703,
            "end_logit": 0.5387672781944275
        },
        {
            "text": "operons allows for coregulated gene expression in prokaryotes.",
            "probability": 0.0009471834958882717,
            "start_logit": 6.767238616943359,
            "end_logit": 0.5387672781944275
        },
        {
            "text": "Clustering of functionally related genes in operons allows for coregulated gene expression",
            "probability": 0.00012381310289872398,
            "start_logit": 7.262073516845703,
            "end_logit": -1.9907872676849365
        },
        {
            "text": "in operons",
            "probability": 8.299819618887077e-05,
            "start_logit": -1.636122465133667,
            "end_logit": 6.5074543952941895
        },
        {
            "text": "operons allows for coregulated gene expression",
            "probability": 7.548532707528371e-05,
            "start_logit": 6.767238616943359,
            "end_logit": -1.9907872676849365
        },
        {
            "text": "Clustering",
            "probability": 4.37727053903019e-05,
            "start_logit": 7.262073516845703,
            "end_logit": -3.030550003051758
        },
        {
            "text": "C",
            "probability": 3.489301092592789e-05,
            "start_logit": 7.262073516845703,
            "end_logit": -3.2572739124298096
        },
        {
            "text": "Clustering of functionally related genes in op",
            "probability": 3.059403029906054e-05,
            "start_logit": 7.262073516845703,
            "end_logit": -3.3887555599212646
        },
        {
            "text": "op",
            "probability": 1.8652310051261348e-05,
            "start_logit": 6.767238616943359,
            "end_logit": -3.3887555599212646
        },
        {
            "text": "Cluster",
            "probability": 1.0851437216587284e-05,
            "start_logit": 7.262073516845703,
            "end_logit": -4.425262928009033
        },
        {
            "text": "Clustering of functionally related genes in operons allows",
            "probability": 5.417533752411556e-06,
            "start_logit": 7.262073516845703,
            "end_logit": -5.119919776916504
        },
        {
            "text": "operons allows",
            "probability": 3.3029162315452316e-06,
            "start_logit": 6.767238616943359,
            "end_logit": -5.119919776916504
        },
        {
            "text": "functionally related genes in operons",
            "probability": 2.6943531883626127e-06,
            "start_logit": -5.063783168792725,
            "end_logit": 6.5074543952941895
        },
        {
            "text": "Clustering of functionally related genes in",
            "probability": 2.2806384458831134e-06,
            "start_logit": 7.262073516845703,
            "end_logit": -5.985105037689209
        },
        {
            "text": "in operon",
            "probability": 1.6362604831832708e-06,
            "start_logit": -1.636122465133667,
            "end_logit": 2.5810489654541016
        },
        {
            "text": "Clustering of functionally related genes",
            "probability": 1.4495555482094344e-06,
            "start_logit": 7.262073516845703,
            "end_logit": -6.438303470611572
        }
    ],
    "6440377c57b1c7a315000049_001": [
        {
            "text": "triamcinolone",
            "probability": 0.5755999848920524,
            "start_logit": 9.162117958068848,
            "end_logit": 8.930482864379883
        },
        {
            "text": "triamcinolone acetonide",
            "probability": 0.42402635711517805,
            "start_logit": 9.162117958068848,
            "end_logit": 8.624865531921387
        },
        {
            "text": "acetonide",
            "probability": 0.000325049164949975,
            "start_logit": 1.9885435104370117,
            "end_logit": 8.624865531921387
        },
        {
            "text": "CLS-TA, a triamcinolone",
            "probability": 1.9851763118858405e-05,
            "start_logit": -1.1127574443817139,
            "end_logit": 8.930482864379883
        },
        {
            "text": "CLS-TA, a triamcinolone acetonide",
            "probability": 1.4624167857095439e-05,
            "start_logit": -1.1127574443817139,
            "end_logit": 8.624865531921387
        },
        {
            "text": "t",
            "probability": 1.0262877964927206e-05,
            "start_logit": 9.162117958068848,
            "end_logit": -2.0041520595550537
        },
        {
            "text": "triamcinolone acetonide injectable suspension for suprachoroidal use (XIPERE",
            "probability": 1.6944305780344492e-06,
            "start_logit": 9.162117958068848,
            "end_logit": -3.8053386211395264
        },
        {
            "text": "triamcinolone acetonide injectable suspension for suprachoroidal use (XIPERE\u00ae",
            "probability": 3.308902324724733e-07,
            "start_logit": 9.162117958068848,
            "end_logit": -5.438653945922852
        },
        {
            "text": "triamcinolone acetonide injectable suspension for suprachoroidal use (XIPERE\u00ae),",
            "probability": 3.0212187190872465e-07,
            "start_logit": 9.162117958068848,
            "end_logit": -5.5296101570129395
        },
        {
            "text": "a triamcinolone",
            "probability": 2.934254878412033e-07,
            "start_logit": -5.327181816101074,
            "end_logit": 8.930482864379883
        },
        {
            "text": "tria",
            "probability": 2.895047427659821e-07,
            "start_logit": 9.162117958068848,
            "end_logit": -5.572268962860107
        },
        {
            "text": "a triamcinolone acetonide",
            "probability": 2.1615730361317338e-07,
            "start_logit": -5.327181816101074,
            "end_logit": 8.624865531921387
        },
        {
            "text": "triamcinolone ace",
            "probability": 1.5054642870701342e-07,
            "start_logit": 9.162117958068848,
            "end_logit": -6.226169109344482
        },
        {
            "text": "triamcin",
            "probability": 1.328273653988668e-07,
            "start_logit": 9.162117958068848,
            "end_logit": -6.351390361785889
        },
        {
            "text": "SCS\u00ae) has become a clinical reality after the 2021 FDA approval of CLS-TA, a triamcinolone",
            "probability": 9.861703521163001e-08,
            "start_logit": -6.4175615310668945,
            "end_logit": 8.930482864379883
        },
        {
            "text": "2021 FDA approval of CLS-TA, a triamcinolone",
            "probability": 9.18901130740669e-08,
            "start_logit": -6.4882121086120605,
            "end_logit": 8.930482864379883
        },
        {
            "text": "triamcinolo",
            "probability": 8.257465239025864e-08,
            "start_logit": 9.162117958068848,
            "end_logit": -6.826737880706787
        },
        {
            "text": "triam",
            "probability": 7.435788076148442e-08,
            "start_logit": 9.162117958068848,
            "end_logit": -6.931550979614258
        },
        {
            "text": "2021 FDA approval of CLS-TA, a triamcinolone acetonide",
            "probability": 6.769254851354039e-08,
            "start_logit": -6.4882121086120605,
            "end_logit": 8.624865531921387
        },
        {
            "text": "the 2021 FDA approval of CLS-TA, a triamcinolone",
            "probability": 4.498263809039423e-08,
            "start_logit": -7.202528953552246,
            "end_logit": 8.930482864379883
        }
    ],
    "6441057657b1c7a315000052_001": [
        {
            "text": "FLACC",
            "probability": 0.7180439126532768,
            "start_logit": 8.953864097595215,
            "end_logit": 10.04180908203125
        },
        {
            "text": "Face, leg, activity, cry, and consolability (FLACC",
            "probability": 0.27896029327122657,
            "start_logit": 8.008402824401855,
            "end_logit": 10.04180908203125
        },
        {
            "text": "FLACC)",
            "probability": 0.0019047164570583567,
            "start_logit": 8.953864097595215,
            "end_logit": 4.109611511230469
        },
        {
            "text": "Face, leg, activity, cry, and consolability (FLACC)",
            "probability": 0.0007399829621786657,
            "start_logit": 8.008402824401855,
            "end_logit": 4.109611511230469
        },
        {
            "text": "Face, leg, activity, cry, and consolability",
            "probability": 0.00010229913850524353,
            "start_logit": 8.008402824401855,
            "end_logit": 2.130885601043701
        },
        {
            "text": "(FLACC)",
            "probability": 9.058076581837519e-05,
            "start_logit": -0.024180015549063683,
            "end_logit": 10.04180908203125
        },
        {
            "text": "(FLACC",
            "probability": 6.2032212277102e-05,
            "start_logit": -0.4027681052684784,
            "end_logit": 10.04180908203125
        },
        {
            "text": "Face",
            "probability": 3.2283767440592184e-05,
            "start_logit": 8.008402824401855,
            "end_logit": 0.9775488972663879
        },
        {
            "text": "FLACC) scores for postoperative pain were also assessed.",
            "probability": 3.0317069571239057e-05,
            "start_logit": 8.953864097595215,
            "end_logit": -0.030766017735004425
        },
        {
            "text": "Face, leg, activity, cry, and consolability (FLACC) scores for postoperative pain were also assessed.",
            "probability": 1.1778191374767351e-05,
            "start_logit": 8.008402824401855,
            "end_logit": -0.030766017735004425
        },
        {
            "text": "FL",
            "probability": 9.70355414905361e-06,
            "start_logit": 8.953864097595215,
            "end_logit": -1.1699846982955933
        },
        {
            "text": "FLACC) scores",
            "probability": 4.107810378088692e-06,
            "start_logit": 8.953864097595215,
            "end_logit": -2.0295867919921875
        },
        {
            "text": "Face, leg, activity, cry, and consolability (FL",
            "probability": 3.7698339384158406e-06,
            "start_logit": 8.008402824401855,
            "end_logit": -1.1699846982955933
        },
        {
            "text": "Face, leg, activity, cry, and consolability (FLACC) scores",
            "probability": 1.5958856660171147e-06,
            "start_logit": 8.008402824401855,
            "end_logit": -2.0295867919921875
        },
        {
            "text": "FLACC) scores for postoperative pain",
            "probability": 1.2894098832636393e-06,
            "start_logit": 8.953864097595215,
            "end_logit": -3.1882922649383545
        },
        {
            "text": "Face, leg, activity, cry, and consolability (FLACC) scores for postoperative pain",
            "probability": 5.009361584208974e-07,
            "start_logit": 8.008402824401855,
            "end_logit": -3.1882922649383545
        },
        {
            "text": "Face, leg, activity, cry, and consolability (",
            "probability": 3.8438906429475805e-07,
            "start_logit": 8.008402824401855,
            "end_logit": -3.453115701675415
        },
        {
            "text": "FLAC",
            "probability": 2.0375687858563257e-07,
            "start_logit": 8.953864097595215,
            "end_logit": -5.033304691314697
        },
        {
            "text": "leg, activity, cry, and consolability (FLACC",
            "probability": 1.687755425289638e-07,
            "start_logit": -6.30960750579834,
            "end_logit": 10.04180908203125
        },
        {
            "text": "Face, leg, activity, cry, and consolability (FLAC",
            "probability": 7.915961350642942e-08,
            "start_logit": 8.008402824401855,
            "end_logit": -5.033304691314697
        }
    ],
    "6441057657b1c7a315000052_002": [
        {
            "text": "FLACC and COMFORT",
            "probability": 0.662224276206424,
            "start_logit": 6.7027130126953125,
            "end_logit": 4.040281772613525
        },
        {
            "text": "FLACC",
            "probability": 0.29330706461397443,
            "start_logit": 6.7027130126953125,
            "end_logit": 3.2258975505828857
        },
        {
            "text": "FLACC and COMFORT scales",
            "probability": 0.03828878323155411,
            "start_logit": 6.7027130126953125,
            "end_logit": 1.189834475517273
        },
        {
            "text": "COMFORT",
            "probability": 0.0035064160692416793,
            "start_logit": 1.4617031812667847,
            "end_logit": 4.040281772613525
        },
        {
            "text": "The FLACC and COMFORT",
            "probability": 0.0015188975738673206,
            "start_logit": 0.6250935196876526,
            "end_logit": 4.040281772613525
        },
        {
            "text": "The FLACC",
            "probability": 0.0006727379301048788,
            "start_logit": 0.6250935196876526,
            "end_logit": 3.2258975505828857
        },
        {
            "text": "COMFORT scales",
            "probability": 0.0002027355529216256,
            "start_logit": 1.4617031812667847,
            "end_logit": 1.189834475517273
        },
        {
            "text": "FL",
            "probability": 0.00013283463295246705,
            "start_logit": 6.7027130126953125,
            "end_logit": -4.473972797393799
        },
        {
            "text": "The FLACC and COMFORT scales",
            "probability": 8.782030808337668e-05,
            "start_logit": 0.6250935196876526,
            "end_logit": 1.189834475517273
        },
        {
            "text": "FLACC and COMFORT scales were utilized to assess pain",
            "probability": 2.251572814542038e-05,
            "start_logit": 6.7027130126953125,
            "end_logit": -6.248863697052002
        },
        {
            "text": "FLACC and COMF",
            "probability": 1.1369584140431293e-05,
            "start_logit": 6.7027130126953125,
            "end_logit": -6.932136058807373
        },
        {
            "text": "FLACC and COMFOR",
            "probability": 8.544009921842072e-06,
            "start_logit": 6.7027130126953125,
            "end_logit": -7.2178473472595215
        },
        {
            "text": "FLAC",
            "probability": 7.787493074567235e-06,
            "start_logit": 6.7027130126953125,
            "end_logit": -7.310558795928955
        },
        {
            "text": "FLACC and COMFORT scales were utilized",
            "probability": 5.097870755872496e-06,
            "start_logit": 6.7027130126953125,
            "end_logit": -7.734254837036133
        },
        {
            "text": "and COMFORT",
            "probability": 2.421555384760904e-06,
            "start_logit": -5.81623649597168,
            "end_logit": 4.040281772613525
        },
        {
            "text": "The FL",
            "probability": 3.046735206882786e-07,
            "start_logit": 0.6250935196876526,
            "end_logit": -4.473972797393799
        },
        {
            "text": "and COMFORT scales",
            "probability": 1.4001058635520528e-07,
            "start_logit": -5.81623649597168,
            "end_logit": 1.189834475517273
        },
        {
            "text": "COMFORT scales were utilized to assess pain",
            "probability": 1.1921869042923695e-07,
            "start_logit": 1.4617031812667847,
            "end_logit": -6.248863697052002
        },
        {
            "text": "scales",
            "probability": 7.353576347479372e-08,
            "start_logit": -6.4601826667785645,
            "end_logit": 1.189834475517273
        },
        {
            "text": "COMF",
            "probability": 6.020089260239791e-08,
            "start_logit": 1.4617031812667847,
            "end_logit": -6.932136058807373
        }
    ],
    "6441057657b1c7a315000052_003": [
        {
            "text": "Wong-Baker Faces Pain Rating Scale",
            "probability": 0.414867482278255,
            "start_logit": 0.7127565741539001,
            "end_logit": -0.7003899812698364
        },
        {
            "text": "Wong-Baker Faces Pain Rating Scale, and the Face, Legs, Activity, Cry, and Consolability (FLACC",
            "probability": 0.2490196164910642,
            "start_logit": 0.7127565741539001,
            "end_logit": -1.2108174562454224
        },
        {
            "text": "Wong-Baker Faces",
            "probability": 0.0896067480134737,
            "start_logit": 0.7127565741539001,
            "end_logit": -2.2329185009002686
        },
        {
            "text": "Face, Legs, Activity, Cry, and Consolability (FLACC",
            "probability": 0.05307211846667766,
            "start_logit": -0.8331233859062195,
            "end_logit": -1.2108174562454224
        },
        {
            "text": "Wong-Baker Faces Pain Rating Scale, and the Face, Legs, Activity, Cry, and Consolability (FLACC)",
            "probability": 0.044920365644842794,
            "start_logit": 0.7127565741539001,
            "end_logit": -2.9234578609466553
        },
        {
            "text": "FLACC",
            "probability": 0.03737396293474027,
            "start_logit": -1.1838008165359497,
            "end_logit": -1.2108174562454224
        },
        {
            "text": "Face, Legs, Activity, Cry, and Consolability (FLACC) scale.",
            "probability": 0.024393028024391084,
            "start_logit": -0.8331233859062195,
            "end_logit": -1.9881718158721924
        },
        {
            "text": "FLACC) scale.",
            "probability": 0.01717783558653455,
            "start_logit": -1.1838008165359497,
            "end_logit": -1.9881718158721924
        },
        {
            "text": "Wong-Baker Faces Pain Rating Scale,",
            "probability": 0.009613375232877594,
            "start_logit": 0.7127565741539001,
            "end_logit": -4.465193748474121
        },
        {
            "text": "Face, Legs, Activity, Cry, and Consolability (FLACC)",
            "probability": 0.009573619141587272,
            "start_logit": -0.8331233859062195,
            "end_logit": -2.9234578609466553
        },
        {
            "text": "Visual Analogue Scale (VAS), the Wong-Baker Faces Pain Rating Scale",
            "probability": 0.009416742294631446,
            "start_logit": -3.0727133750915527,
            "end_logit": -0.7003899812698364
        },
        {
            "text": "Faces Pain Rating Scale",
            "probability": 0.008612934629821184,
            "start_logit": -3.1619374752044678,
            "end_logit": -0.7003899812698364
        },
        {
            "text": "FLACC)",
            "probability": 0.006741846703814109,
            "start_logit": -1.1838008165359497,
            "end_logit": -2.9234578609466553
        },
        {
            "text": "Face, Legs, Activity, Cry, and Consolability (FLACC) scale",
            "probability": 0.006334245280047145,
            "start_logit": -0.8331233859062195,
            "end_logit": -3.336498498916626
        },
        {
            "text": "Faces Pain Rating Scale, and the Face, Legs, Activity, Cry, and Consolability (FLACC",
            "probability": 0.005169818725252969,
            "start_logit": -3.1619374752044678,
            "end_logit": -1.2108174562454224
        },
        {
            "text": "FLACC) scale",
            "probability": 0.004460644405304352,
            "start_logit": -1.1838008165359497,
            "end_logit": -3.336498498916626
        },
        {
            "text": "the Face, Legs, Activity, Cry, and Consolability (FLACC",
            "probability": 0.002703411050234109,
            "start_logit": -3.810260772705078,
            "end_logit": -1.2108174562454224
        },
        {
            "text": "Wong-Baker Faces Pain",
            "probability": 0.0025321396898706546,
            "start_logit": 0.7127565741539001,
            "end_logit": -5.7992844581604
        },
        {
            "text": "Faces Pain Rating Scale, and the Face, Legs, Activity, Cry, and Consolability (FLACC) scale.",
            "probability": 0.0023761541217785847,
            "start_logit": -3.1619374752044678,
            "end_logit": -1.9881718158721924
        },
        {
            "text": "Visual Analogue Scale (VAS), the Wong-Baker Faces",
            "probability": 0.002033911284801334,
            "start_logit": -3.0727133750915527,
            "end_logit": -2.2329185009002686
        }
    ],
    "6441057657b1c7a315000052_004": [
        {
            "text": "FLACC-r",
            "probability": 0.5676521220218095,
            "start_logit": 7.530430316925049,
            "end_logit": 5.187435626983643
        },
        {
            "text": "Face, Legs, Activity, Cry, Consolability-revised scale (FLACC-r",
            "probability": 0.2419086327488825,
            "start_logit": 6.677481651306152,
            "end_logit": 5.187435626983643
        },
        {
            "text": "FLACC",
            "probability": 0.11955068515227425,
            "start_logit": 7.530430316925049,
            "end_logit": 3.629667282104492
        },
        {
            "text": "Face, Legs, Activity, Cry, Consolability-revised scale (FLACC",
            "probability": 0.050947299705976716,
            "start_logit": 6.677481651306152,
            "end_logit": 3.629667282104492
        },
        {
            "text": "Face, Legs, Activity, Cry, Consolability-revised scale",
            "probability": 0.01444735896216217,
            "start_logit": 6.677481651306152,
            "end_logit": 2.369387149810791
        },
        {
            "text": "FLACC-r)",
            "probability": 0.0027404419132711884,
            "start_logit": 7.530430316925049,
            "end_logit": -0.1459539532661438
        },
        {
            "text": "Face, Legs, Activity, Cry, Consolability-revised scale (FLACC-r)",
            "probability": 0.0011678570917800504,
            "start_logit": 6.677481651306152,
            "end_logit": -0.1459539532661438
        },
        {
            "text": "FLACC-r).",
            "probability": 0.0008494272639476548,
            "start_logit": 7.530430316925049,
            "end_logit": -1.3172661066055298
        },
        {
            "text": "Face, Legs, Activity, Cry, Consolability-revised scale (FLACC-r).",
            "probability": 0.000361988936656008,
            "start_logit": 6.677481651306152,
            "end_logit": -1.3172661066055298
        },
        {
            "text": "(FLACC-r",
            "probability": 0.0001005151613116273,
            "start_logit": -1.1085251569747925,
            "end_logit": 5.187435626983643
        },
        {
            "text": "FL",
            "probability": 7.357154628465316e-05,
            "start_logit": 7.530430316925049,
            "end_logit": -3.7635700702667236
        },
        {
            "text": "the Face, Legs, Activity, Cry, Consolability-revised scale (FLACC-r",
            "probability": 5.962982053315418e-05,
            "start_logit": -1.6306779384613037,
            "end_logit": 5.187435626983643
        },
        {
            "text": "Face",
            "probability": 4.426244711774625e-05,
            "start_logit": 6.677481651306152,
            "end_logit": -3.418743133544922
        },
        {
            "text": "Face, Legs, Activity, Cry, Consolability-revised scale (FL",
            "probability": 3.135299152507666e-05,
            "start_logit": 6.677481651306152,
            "end_logit": -3.7635700702667236
        },
        {
            "text": "(FLACC",
            "probability": 2.116905043919615e-05,
            "start_logit": -1.1085251569747925,
            "end_logit": 3.629667282104492
        },
        {
            "text": "Face, Legs, Activity, Cry, Consolability-revised",
            "probability": 1.2832607132377867e-05,
            "start_logit": 6.677481651306152,
            "end_logit": -4.656890392303467
        },
        {
            "text": "the Face, Legs, Activity, Cry, Consolability-revised scale (FLACC",
            "probability": 1.2558370917129843e-05,
            "start_logit": -1.6306779384613037,
            "end_logit": 3.629667282104492
        },
        {
            "text": "r",
            "probability": 1.2395799123029543e-05,
            "start_logit": -3.2014760971069336,
            "end_logit": 5.187435626983643
        },
        {
            "text": "the Face, Legs, Activity, Cry, Consolability-revised scale",
            "probability": 3.561234720325484e-06,
            "start_logit": -1.6306779384613037,
            "end_logit": 2.369387149810791
        },
        {
            "text": "mild) was evaluated by the Face, Legs, Activity, Cry, Consolability-revised scale (FLACC-r",
            "probability": 2.3371741355961627e-06,
            "start_logit": -4.869891166687012,
            "end_logit": 5.187435626983643
        }
    ],
    "6441057657b1c7a315000052_005": [
        {
            "text": "FLACC",
            "probability": 0.9985744093418231,
            "start_logit": 5.868526458740234,
            "end_logit": 5.237109184265137
        },
        {
            "text": "FLACC scale (54%) and the COMFORT Behavioural scale",
            "probability": 0.0006174694001918513,
            "start_logit": 5.868526458740234,
            "end_logit": -2.1513452529907227
        },
        {
            "text": "FLACC scale",
            "probability": 0.0004831455791212962,
            "start_logit": 5.868526458740234,
            "end_logit": -2.3966567516326904
        },
        {
            "text": "FLACC scale (54%) and the COMFORT Behavioural scale (48%), respectively.",
            "probability": 0.00018189859924942474,
            "start_logit": 5.868526458740234,
            "end_logit": -3.373525381088257
        },
        {
            "text": "FLACC scale (54%) and the COMFORT Behavioural",
            "probability": 2.165723743737072e-05,
            "start_logit": 5.868526458740234,
            "end_logit": -5.5016350746154785
        },
        {
            "text": "FLACC scale (54%) and the COMFORT Behavioural scale (48%)",
            "probability": 1.7723182622729018e-05,
            "start_logit": 5.868526458740234,
            "end_logit": -5.702101230621338
        },
        {
            "text": "FL",
            "probability": 1.7056234566553292e-05,
            "start_logit": 5.868526458740234,
            "end_logit": -5.740458965301514
        },
        {
            "text": "FLACC scale (54%) and the COMFORT Behavioural scale (48%),",
            "probability": 1.6141912888872893e-05,
            "start_logit": 5.868526458740234,
            "end_logit": -5.795555591583252
        },
        {
            "text": "PICUs, using the preferred validated FLACC",
            "probability": 1.4933549369749047e-05,
            "start_logit": -5.241947174072266,
            "end_logit": 5.237109184265137
        },
        {
            "text": "FLACC scale (54%",
            "probability": 1.2056907700706444e-05,
            "start_logit": 5.868526458740234,
            "end_logit": -6.087337017059326
        },
        {
            "text": "FLACC scale (54%)",
            "probability": 9.921421706045787e-06,
            "start_logit": 5.868526458740234,
            "end_logit": -6.282278537750244
        },
        {
            "text": "FLACC scale (54%) and the COMFORT Behavioural scale (48%",
            "probability": 9.606157882980038e-06,
            "start_logit": 5.868526458740234,
            "end_logit": -6.314570426940918
        },
        {
            "text": "the preferred validated FLACC",
            "probability": 4.90819627642676e-06,
            "start_logit": -6.354650974273682,
            "end_logit": 5.237109184265137
        },
        {
            "text": "validated FLACC",
            "probability": 4.326602586531042e-06,
            "start_logit": -6.480774879455566,
            "end_logit": 5.237109184265137
        },
        {
            "text": "81%) and sedation (87%) was reported by most of the PICUs, using the preferred validated FLACC",
            "probability": 4.301510122534533e-06,
            "start_logit": -6.486591339111328,
            "end_logit": 5.237109184265137
        },
        {
            "text": "most of the PICUs, using the preferred validated FLACC",
            "probability": 3.689872694177962e-06,
            "start_logit": -6.639965534210205,
            "end_logit": 5.237109184265137
        },
        {
            "text": "sedation (87%) was reported by most of the PICUs, using the preferred validated FLACC",
            "probability": 2.597844979511831e-06,
            "start_logit": -6.990875244140625,
            "end_logit": 5.237109184265137
        },
        {
            "text": "87%) was reported by most of the PICUs, using the preferred validated FLACC",
            "probability": 1.9790276546069806e-06,
            "start_logit": -7.262951850891113,
            "end_logit": 5.237109184265137
        },
        {
            "text": "preferred validated FLACC",
            "probability": 1.6643451389647048e-06,
            "start_logit": -7.436125755310059,
            "end_logit": 5.237109184265137
        },
        {
            "text": "COMFORT Behavioural scale",
            "probability": 5.130759872049076e-07,
            "start_logit": -1.2244343757629395,
            "end_logit": -2.1513452529907227
        }
    ],
    "64257c9c690f196b5100004b_001": [
        {
            "text": "drug-specific liver injury phenotypes",
            "probability": 0.3564357010174505,
            "start_logit": 3.285256862640381,
            "end_logit": 4.963315486907959
        },
        {
            "text": "liver injury phenotypes",
            "probability": 0.32971468938607895,
            "start_logit": 3.2073307037353516,
            "end_logit": 4.963315486907959
        },
        {
            "text": "DILI causality assessment tool",
            "probability": 0.11315663766961839,
            "start_logit": 2.089761734008789,
            "end_logit": 5.011429786682129
        },
        {
            "text": "DILI causality assessment tool (DILI-CAT), which uses drug-specific liver injury phenotypes",
            "probability": 0.10784108767856404,
            "start_logit": 2.089761734008789,
            "end_logit": 4.963315486907959
        },
        {
            "text": "uses drug-specific liver injury phenotypes",
            "probability": 0.07432982214190255,
            "start_logit": 1.7176152467727661,
            "end_logit": 4.963315486907959
        },
        {
            "text": "drug-specific liver injury phenotypes,",
            "probability": 0.0035987303120076654,
            "start_logit": 3.285256862640381,
            "end_logit": 0.36774271726608276
        },
        {
            "text": "liver injury phenotypes,",
            "probability": 0.003328943323075773,
            "start_logit": 3.2073307037353516,
            "end_logit": 0.36774271726608276
        },
        {
            "text": "DILI-CAT), which uses drug-specific liver injury phenotypes",
            "probability": 0.0013441630002269235,
            "start_logit": -2.2951254844665527,
            "end_logit": 4.963315486907959
        },
        {
            "text": "DILI causality assessment tool (DILI-CAT), which uses drug-specific liver injury phenotypes,",
            "probability": 0.0010888106606630982,
            "start_logit": 2.089761734008789,
            "end_logit": 0.36774271726608276
        },
        {
            "text": "We utilised a novel DILI causality assessment tool",
            "probability": 0.0010264446431184299,
            "start_logit": -2.612910270690918,
            "end_logit": 5.011429786682129
        },
        {
            "text": "a novel DILI causality assessment tool",
            "probability": 0.0010200450898563973,
            "start_logit": -2.61916446685791,
            "end_logit": 5.011429786682129
        },
        {
            "text": "drug-specific liver injury phenotypes, to examine potential DILI in early phase ximelagatran clinical development",
            "probability": 0.0010027329402372456,
            "start_logit": 3.285256862640381,
            "end_logit": -0.9101091623306274
        },
        {
            "text": "a novel DILI causality assessment tool (DILI-CAT), which uses drug-specific liver injury phenotypes",
            "probability": 0.0009721283190869086,
            "start_logit": -2.61916446685791,
            "end_logit": 4.963315486907959
        },
        {
            "text": "causality assessment tool",
            "probability": 0.000929775680118635,
            "start_logit": -2.7118232250213623,
            "end_logit": 5.011429786682129
        },
        {
            "text": "liver injury phenotypes, to examine potential DILI in early phase ximelagatran clinical development",
            "probability": 0.0009275607886184405,
            "start_logit": 3.2073307037353516,
            "end_logit": -0.9101091623306274
        },
        {
            "text": "causality assessment tool (DILI-CAT), which uses drug-specific liver injury phenotypes",
            "probability": 0.0008860993283824954,
            "start_logit": -2.7118232250213623,
            "end_logit": 4.963315486907959
        },
        {
            "text": "which uses drug-specific liver injury phenotypes",
            "probability": 0.00088469828767045,
            "start_logit": -2.7134056091308594,
            "end_logit": 4.963315486907959
        },
        {
            "text": "uses drug-specific liver injury phenotypes,",
            "probability": 0.0007504663064464109,
            "start_logit": 1.7176152467727661,
            "end_logit": 0.36774271726608276
        },
        {
            "text": "drug-specific liver injury phenotypes, to examine potential DILI in early phase ximelagatran clinical development.",
            "probability": 0.0003955586911469003,
            "start_logit": 3.285256862640381,
            "end_logit": -1.8402944803237915
        },
        {
            "text": "liver injury phenotypes, to examine potential DILI in early phase ximelagatran clinical development.",
            "probability": 0.00036590473572982235,
            "start_logit": 3.2073307037353516,
            "end_logit": -1.8402944803237915
        }
    ],
    "64257c9c690f196b5100004b_002": [
        {
            "text": "phenotype-based drug-induced liver injury causality assessment tool",
            "probability": 0.5902628166414735,
            "start_logit": 4.894866943359375,
            "end_logit": 6.375735759735107
        },
        {
            "text": "drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development",
            "probability": 0.1774755530202237,
            "start_logit": 2.9445395469665527,
            "end_logit": 7.124328136444092
        },
        {
            "text": "A novel phenotype-based drug-induced liver injury causality assessment tool",
            "probability": 0.13494699271345242,
            "start_logit": 3.4191811084747314,
            "end_logit": 6.375735759735107
        },
        {
            "text": "drug-induced liver injury causality assessment tool",
            "probability": 0.08395160427748401,
            "start_logit": 2.9445395469665527,
            "end_logit": 6.375735759735107
        },
        {
            "text": "allows for signal confirmation in early drug development",
            "probability": 0.005423366373842558,
            "start_logit": -0.5435765981674194,
            "end_logit": 7.124328136444092
        },
        {
            "text": "phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation",
            "probability": 0.002606339065757926,
            "start_logit": 4.894866943359375,
            "end_logit": 0.9531144499778748
        },
        {
            "text": "signal confirmation in early drug development",
            "probability": 0.0012806093397917816,
            "start_logit": -1.986957311630249,
            "end_logit": 7.124328136444092
        },
        {
            "text": "novel phenotype-based drug-induced liver injury causality assessment tool",
            "probability": 0.0006855326960615193,
            "start_logit": -1.86326003074646,
            "end_logit": 6.375735759735107
        },
        {
            "text": "phenotype-based drug-induced liver injury causality assessment",
            "probability": 0.000634975965937705,
            "start_logit": 4.894866943359375,
            "end_logit": -0.45900025963783264
        },
        {
            "text": "A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation",
            "probability": 0.0005958661277646683,
            "start_logit": 3.4191811084747314,
            "end_logit": 0.9531144499778748
        },
        {
            "text": "development",
            "probability": 0.000500480097070096,
            "start_logit": -2.926480770111084,
            "end_logit": 7.124328136444092
        },
        {
            "text": "drug development",
            "probability": 0.0004926983179022909,
            "start_logit": -2.9421515464782715,
            "end_logit": 7.124328136444092
        },
        {
            "text": "drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation",
            "probability": 0.0003706930873715531,
            "start_logit": 2.9445395469665527,
            "end_logit": 0.9531144499778748
        },
        {
            "text": "tool (DILI-CAT) allows for signal confirmation in early drug development",
            "probability": 0.00015161218277483265,
            "start_logit": -4.120722770690918,
            "end_logit": 7.124328136444092
        },
        {
            "text": "A novel phenotype-based drug-induced liver injury causality assessment",
            "probability": 0.00014516939680559276,
            "start_logit": 3.4191811084747314,
            "end_logit": -0.45900025963783264
        },
        {
            "text": "for signal confirmation in early drug development",
            "probability": 0.00012934204144880674,
            "start_logit": -4.279588222503662,
            "end_logit": 7.124328136444092
        },
        {
            "text": "causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development",
            "probability": 9.949619049874571e-05,
            "start_logit": -4.541929244995117,
            "end_logit": 7.124328136444092
        },
        {
            "text": "drug-induced liver injury causality assessment",
            "probability": 9.031104368292655e-05,
            "start_logit": 2.9445395469665527,
            "end_logit": -0.45900025963783264
        },
        {
            "text": "DILI-CAT) allows for signal confirmation in early drug development",
            "probability": 7.886763294959049e-05,
            "start_logit": -4.774277687072754,
            "end_logit": 7.124328136444092
        },
        {
            "text": "early drug development",
            "probability": 7.767378770571295e-05,
            "start_logit": -4.7895307540893555,
            "end_logit": 7.124328136444092
        }
    ],
    "64257c9c690f196b5100004b_003": [
        {
            "text": "early detection of drug's hepatotoxicity in clinical drug development",
            "probability": 0.571869523602937,
            "start_logit": 1.4944275617599487,
            "end_logit": 3.746746778488159
        },
        {
            "text": "early detection of drug's hepatotoxicity",
            "probability": 0.1550167811282569,
            "start_logit": 1.4944275617599487,
            "end_logit": 2.4413692951202393
        },
        {
            "text": "computer-assisted scoring algorithm, is a useful tool for early detection of drug's hepatotoxicity in clinical drug development",
            "probability": 0.13236978868018978,
            "start_logit": 0.03111613728106022,
            "end_logit": 3.746746778488159
        },
        {
            "text": "computer-assisted scoring algorithm",
            "probability": 0.04140107947732461,
            "start_logit": 0.03111613728106022,
            "end_logit": 2.584454298019409
        },
        {
            "text": "computer-assisted scoring algorithm, is a useful tool for early detection of drug's hepatotoxicity",
            "probability": 0.035881503932141366,
            "start_logit": 0.03111613728106022,
            "end_logit": 2.4413692951202393
        },
        {
            "text": "DILI-CAT, a clinically intuitive, data-driven, computer-assisted scoring algorithm",
            "probability": 0.01772950894028825,
            "start_logit": -0.8169603943824768,
            "end_logit": 2.584454298019409
        },
        {
            "text": "hepatotoxicity in clinical drug development",
            "probability": 0.010492174971421759,
            "start_logit": -2.5038535594940186,
            "end_logit": 3.746746778488159
        },
        {
            "text": "a clinically intuitive, data-driven, computer-assisted scoring algorithm",
            "probability": 0.010000763800448138,
            "start_logit": -1.3895293474197388,
            "end_logit": 2.584454298019409
        },
        {
            "text": "drug's hepatotoxicity in clinical drug development",
            "probability": 0.008736956826973102,
            "start_logit": -2.6869213581085205,
            "end_logit": 3.746746778488159
        },
        {
            "text": "early detection of drug's hepatotoxicity in clinical drug development.",
            "probability": 0.0036316114632832584,
            "start_logit": 1.4944275617599487,
            "end_logit": -1.3124876022338867
        },
        {
            "text": "hepatotoxicity",
            "probability": 0.002844115876043003,
            "start_logit": -2.5038535594940186,
            "end_logit": 2.4413692951202393
        },
        {
            "text": "drug's hepatotoxicity",
            "probability": 0.0023683285579566833,
            "start_logit": -2.6869213581085205,
            "end_logit": 2.4413692951202393
        },
        {
            "text": "a useful tool for early detection of drug's hepatotoxicity in clinical drug development",
            "probability": 0.0014196097666298044,
            "start_logit": -4.504101276397705,
            "end_logit": 3.746746778488159
        },
        {
            "text": "scoring algorithm, is a useful tool for early detection of drug's hepatotoxicity in clinical drug development",
            "probability": 0.001372799089244625,
            "start_logit": -4.537631511688232,
            "end_logit": 3.746746778488159
        },
        {
            "text": "computer-assisted scoring algorithm,",
            "probability": 0.001111112096992406,
            "start_logit": 0.03111613728106022,
            "end_logit": -1.0334912538528442
        },
        {
            "text": "hepatotoxicity in clinical drug development.",
            "probability": 0.0008896688219629412,
            "start_logit": -4.971389293670654,
            "end_logit": 3.746746778488159
        },
        {
            "text": "computer-assisted scoring algorithm, is a useful tool for early detection of drug's hepatotoxicity in clinical drug development.",
            "probability": 0.0008406037078785342,
            "start_logit": 0.03111613728106022,
            "end_logit": -1.3124876022338867
        },
        {
            "text": "detection of drug's hepatotoxicity in clinical drug development",
            "probability": 0.0007797525528065957,
            "start_logit": -5.103261947631836,
            "end_logit": 3.746746778488159
        },
        {
            "text": "algorithm, is a useful tool for early detection of drug's hepatotoxicity in clinical drug development",
            "probability": 0.0007684964603585899,
            "start_logit": -5.117802619934082,
            "end_logit": 3.746746778488159
        },
        {
            "text": "DILI-CAT, a clinically intuitive, data-driven, computer-assisted scoring algorithm,",
            "probability": 0.0004758202468628554,
            "start_logit": -0.8169603943824768,
            "end_logit": -1.0334912538528442
        }
    ],
    "6429e85e57b1c7a315000009_001": [
        {
            "text": "riboswitches might be representatives of an ancient form of genetic control.",
            "probability": 0.8455393531158351,
            "start_logit": 1.9825845956802368,
            "end_logit": -1.6852138042449951
        },
        {
            "text": "riboswitches",
            "probability": 0.1393459538717555,
            "start_logit": 1.9825845956802368,
            "end_logit": -3.4882287979125977
        },
        {
            "text": "riboswitches might be representatives of an ancient form of genetic control",
            "probability": 0.006304581680440566,
            "start_logit": 1.9825845956802368,
            "end_logit": -6.583911895751953
        },
        {
            "text": "riboswitch",
            "probability": 0.0035966798331629347,
            "start_logit": 1.9825845956802368,
            "end_logit": -7.145177364349365
        },
        {
            "text": "These results suggest that metabolite-binding mRNAs are possibly involved in eukaryotic gene regulation and that some riboswitches",
            "probability": 0.0019384601835546308,
            "start_logit": -2.2924811840057373,
            "end_logit": -3.4882287979125977
        },
        {
            "text": "some riboswitches might be representatives of an ancient form of genetic control.",
            "probability": 0.0008080704271829555,
            "start_logit": -4.97049617767334,
            "end_logit": -1.6852138042449951
        },
        {
            "text": "These results suggest that metabolite-binding mRNAs are possibly involved in eukaryotic gene regulation",
            "probability": 0.0005651178101943118,
            "start_logit": -2.2924811840057373,
            "end_logit": -4.72084379196167
        },
        {
            "text": "These results suggest that metabolite-binding mRNAs are possibly involved in eukaryotic gene regulation and",
            "probability": 0.00028752373838260433,
            "start_logit": -2.2924811840057373,
            "end_logit": -5.396572589874268
        },
        {
            "text": "eukaryotic gene regulation and that some riboswitches might be representatives of an ancient form of genetic control.",
            "probability": 0.00028030507412661084,
            "start_logit": -6.029266834259033,
            "end_logit": -1.6852138042449951
        },
        {
            "text": "metabolite-binding mRNAs are possibly involved in eukaryotic gene regulation and that some riboswitches",
            "probability": 0.00022953585175361328,
            "start_logit": -4.4260711669921875,
            "end_logit": -3.4882287979125977
        },
        {
            "text": "genetic control.",
            "probability": 0.0001711000765142972,
            "start_logit": -6.522896766662598,
            "end_logit": -1.6852138042449951
        },
        {
            "text": "These",
            "probability": 0.00014962111958223236,
            "start_logit": -2.2924811840057373,
            "end_logit": -6.049771785736084
        },
        {
            "text": "gene regulation and that some riboswitches might be representatives of an ancient form of genetic control.",
            "probability": 0.0001348784015592442,
            "start_logit": -6.760771751403809,
            "end_logit": -1.6852138042449951
        },
        {
            "text": "some riboswitches",
            "probability": 0.00013317102752985642,
            "start_logit": -4.97049617767334,
            "end_logit": -3.4882287979125977
        },
        {
            "text": "that some riboswitches might be representatives of an ancient form of genetic control.",
            "probability": 0.00011279839920613214,
            "start_logit": -6.9395432472229,
            "end_logit": -1.6852138042449951
        },
        {
            "text": "These results",
            "probability": 0.00010392337691774951,
            "start_logit": -2.2924811840057373,
            "end_logit": -6.414224147796631
        },
        {
            "text": "mRNAs are possibly involved in eukaryotic gene regulation and that some riboswitches",
            "probability": 8.748787006058591e-05,
            "start_logit": -5.39063024520874,
            "end_logit": -3.4882287979125977
        },
        {
            "text": "These results suggest that metabolite-binding mRNAs",
            "probability": 7.791537040151017e-05,
            "start_logit": -2.2924811840057373,
            "end_logit": -6.702254772186279
        },
        {
            "text": "metabolite-binding mRNAs are possibly involved in eukaryotic gene regulation",
            "probability": 6.691641077002931e-05,
            "start_logit": -4.4260711669921875,
            "end_logit": -4.72084379196167
        },
        {
            "text": "involved in eukaryotic gene regulation and that some riboswitches might be representatives of an ancient form of genetic control.",
            "probability": 6.660636106953461e-05,
            "start_logit": -7.466345310211182,
            "end_logit": -1.6852138042449951
        }
    ],
    "6429e85e57b1c7a315000009_002": [
        {
            "text": "riboswitches are typically located in noncoding regions of mRNA,",
            "probability": 0.6325700793209948,
            "start_logit": -0.09095292538404465,
            "end_logit": -2.40360689163208
        },
        {
            "text": "mRNAs is widespread in prokaryotes.",
            "probability": 0.09653829053151243,
            "start_logit": -2.0598621368408203,
            "end_logit": -2.314548969268799
        },
        {
            "text": "mRNAs is widespread in prokaryotes. These riboswitches are typically located in noncoding regions of mRNA,",
            "probability": 0.08831251235562852,
            "start_logit": -2.0598621368408203,
            "end_logit": -2.40360689163208
        },
        {
            "text": "riboswitches",
            "probability": 0.04525059694770602,
            "start_logit": -0.09095292538404465,
            "end_logit": -5.041182041168213
        },
        {
            "text": "Genetic control by metabolite-binding mRNAs is widespread in prokaryotes.",
            "probability": 0.03035159467036695,
            "start_logit": -3.2169528007507324,
            "end_logit": -2.314548969268799
        },
        {
            "text": "riboswitches are typically located in noncoding regions of mRNA",
            "probability": 0.018310018132618962,
            "start_logit": -0.09095292538404465,
            "end_logit": -5.945949554443359
        },
        {
            "text": "mRNAs",
            "probability": 0.018272048550787505,
            "start_logit": -2.0598621368408203,
            "end_logit": -3.979116201400757
        },
        {
            "text": "These riboswitches are typically located in noncoding regions of mRNA,",
            "probability": 0.017294217298228273,
            "start_logit": -3.6903717517852783,
            "end_logit": -2.40360689163208
        },
        {
            "text": "metabolite-binding mRNAs is widespread in prokaryotes.",
            "probability": 0.011040859095358149,
            "start_logit": -4.228199005126953,
            "end_logit": -2.314548969268799
        },
        {
            "text": "mRNAs is widespread in prokaryotes. These riboswitches",
            "probability": 0.006317393175367063,
            "start_logit": -2.0598621368408203,
            "end_logit": -5.041182041168213
        },
        {
            "text": "riboswitches are typically located in noncoding regions of mRNA, where",
            "probability": 0.006292691650718127,
            "start_logit": -0.09095292538404465,
            "end_logit": -7.01400899887085
        },
        {
            "text": "Genetic control by metabolite-binding mRNAs",
            "probability": 0.00574472376046205,
            "start_logit": -3.2169528007507324,
            "end_logit": -3.979116201400757
        },
        {
            "text": "riboswitches are typically located in noncoding regions",
            "probability": 0.00547966071754773,
            "start_logit": -0.09095292538404465,
            "end_logit": -7.152354717254639
        },
        {
            "text": "riboswitch",
            "probability": 0.005401947459012997,
            "start_logit": -0.09095292538404465,
            "end_logit": -7.166638374328613
        },
        {
            "text": "mRNA, where they selectively bind their target compound and subsequently modulate gene expression.",
            "probability": 0.002578598886188625,
            "start_logit": -5.6755475997924805,
            "end_logit": -2.32155704498291
        },
        {
            "text": "mRNAs is widespread in prokaryotes. These riboswitches are typically located in noncoding regions of mRNA",
            "probability": 0.002556244367903707,
            "start_logit": -2.0598621368408203,
            "end_logit": -5.945949554443359
        },
        {
            "text": "mRNA,",
            "probability": 0.00237547243427897,
            "start_logit": -5.6755475997924805,
            "end_logit": -2.40360689163208
        },
        {
            "text": "metabolite-binding mRNAs",
            "probability": 0.002089731569950841,
            "start_logit": -4.228199005126953,
            "end_logit": -3.979116201400757
        },
        {
            "text": "Genetic control by metabolite-binding mRNAs is widespread in prokaryotes. These riboswitches",
            "probability": 0.0019861855433362364,
            "start_logit": -3.2169528007507324,
            "end_logit": -5.041182041168213
        },
        {
            "text": "These riboswitches",
            "probability": 0.0012371335320320446,
            "start_logit": -3.6903717517852783,
            "end_logit": -5.041182041168213
        }
    ],
    "6429e85e57b1c7a315000009_003": [
        {
            "text": "metabolism",
            "probability": 0.7889002419818965,
            "start_logit": -0.0012496764538809657,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "riboswitches,\" specifically interact with small ligands and direct expression of the genes involved in their metabolism",
            "probability": 0.19345954514270947,
            "start_logit": -1.4068211317062378,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "direct expression of the genes involved in their metabolism",
            "probability": 0.003695993212700869,
            "start_logit": -5.364640235900879,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "metabolism.",
            "probability": 0.003668326889157146,
            "start_logit": -0.0012496764538809657,
            "end_logit": -2.2401747703552246
        },
        {
            "text": "\"riboswitches,\" specifically interact with small ligands and direct expression of the genes involved in their metabolism",
            "probability": 0.0029516696881812902,
            "start_logit": -5.5895185470581055,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "or \"riboswitches,\" specifically interact with small ligands and direct expression of the genes involved in their metabolism",
            "probability": 0.0016260966683740818,
            "start_logit": -6.185707092285156,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "mRNAs, or \"riboswitches,\" specifically interact with small ligands and direct expression of the genes involved in their metabolism",
            "probability": 0.0013519696882534522,
            "start_logit": -6.370326995849609,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "riboswitches,\" specifically interact with small ligands and direct expression of the genes involved in their metabolism.",
            "probability": 0.0008995723586397345,
            "start_logit": -1.4068211317062378,
            "end_logit": -2.2401747703552246
        },
        {
            "text": "the genes involved in their metabolism",
            "probability": 0.0005771743778769123,
            "start_logit": -7.221500396728516,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "specifically interact with small ligands and direct expression of the genes involved in their metabolism",
            "probability": 0.0005572117170874444,
            "start_logit": -7.256699562072754,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "interact with small ligands and direct expression of the genes involved in their metabolism",
            "probability": 0.0005443054788318193,
            "start_logit": -7.280134201049805,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "small ligands and direct expression of the genes involved in their metabolism",
            "probability": 0.00044716593473686844,
            "start_logit": -7.476715087890625,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "genes involved in their metabolism",
            "probability": 0.0004097582923286595,
            "start_logit": -7.564077377319336,
            "end_logit": 3.1307294368743896
        },
        {
            "text": "riboswitches,",
            "probability": 0.0003168585023901575,
            "start_logit": -1.4068211317062378,
            "end_logit": -3.2836389541625977
        },
        {
            "text": "metabolism. Riboswitches contain sensing \"aptamer\" modules, capable of ligand-induced structural changes,",
            "probability": 0.000163616323105252,
            "start_logit": -0.0012496764538809657,
            "end_logit": -5.350141525268555
        },
        {
            "text": "riboswitches",
            "probability": 0.00015648798970223018,
            "start_logit": -1.4068211317062378,
            "end_logit": -3.989114999771118
        },
        {
            "text": "metabolism. Riboswitches contain sensing \"aptamer\" modules,",
            "probability": 7.255553946109281e-05,
            "start_logit": -0.0012496764538809657,
            "end_logit": -6.163313388824463
        },
        {
            "text": "metabolism. Riboswitches contain sensing \"aptamer\" modules, capable of ligand-induced structural changes, and downstream regions",
            "probability": 6.957228899953846e-05,
            "start_logit": -0.0012496764538809657,
            "end_logit": -6.205299377441406
        },
        {
            "text": "metabolism. Riboswitches contain sensing \"aptamer\" modules, capable of ligand-induced structural changes, and downstream regions,",
            "probability": 6.601851512841013e-05,
            "start_logit": -0.0012496764538809657,
            "end_logit": -6.257730484008789
        },
        {
            "text": "Metabolite-sensing mRNAs, or \"riboswitches,",
            "probability": 6.585941043885289e-05,
            "start_logit": -2.9777541160583496,
            "end_logit": -3.2836389541625977
        }
    ],
    "6429e85e57b1c7a315000009_004": [
        {
            "text": "Riboswitches",
            "probability": 0.7374369876116421,
            "start_logit": 6.796183109283447,
            "end_logit": -1.707161545753479
        },
        {
            "text": "Riboswitches are a class of RNA motifs in the untranslated regions of bacterial messenger RNAs",
            "probability": 0.052627815562152125,
            "start_logit": 6.796183109283447,
            "end_logit": -4.347097396850586
        },
        {
            "text": "Riboswitch",
            "probability": 0.051725375269801324,
            "start_logit": 6.796183109283447,
            "end_logit": -4.364393711090088
        },
        {
            "text": "Riboswitches are a class of RNA motifs in the untranslated regions of bacterial messenger RNAs (mRNAs",
            "probability": 0.04255712187212258,
            "start_logit": 6.796183109283447,
            "end_logit": -4.559494972229004
        },
        {
            "text": "Riboswitches are a class of RNA motifs in the untranslated regions of bacterial messenger RNAs (mRNAs)",
            "probability": 0.03263208893230258,
            "start_logit": 6.796183109283447,
            "end_logit": -4.825046062469482
        },
        {
            "text": "R",
            "probability": 0.03239298437869429,
            "start_logit": 6.796183109283447,
            "end_logit": -4.832400321960449
        },
        {
            "text": "Riboswitches are a class of RNA motifs in the untranslated regions",
            "probability": 0.020234671209741498,
            "start_logit": 6.796183109283447,
            "end_logit": -5.302944660186768
        },
        {
            "text": "Riboswitches are a class of RNA motifs",
            "probability": 0.010496292729434906,
            "start_logit": 6.796183109283447,
            "end_logit": -5.959320068359375
        },
        {
            "text": "Riboswitches are a class of RNA motifs in the untranslated regions of bacterial messenger RNAs (mRNA",
            "probability": 0.010005255224938493,
            "start_logit": 6.796183109283447,
            "end_logit": -6.007231712341309
        },
        {
            "text": "Riboswitches are a class of RNA motifs in the untranslated regions of bacterial messenger RNA",
            "probability": 0.008746089061482516,
            "start_logit": 6.796183109283447,
            "end_logit": -6.141735553741455
        },
        {
            "text": "messenger RNAs (mRNAs) that can adopt different conformations to regulate gene expression.",
            "probability": 0.0005339862114906644,
            "start_logit": -1.862682819366455,
            "end_logit": -0.27886152267456055
        },
        {
            "text": "mRNAs) that can adopt different conformations to regulate gene expression.",
            "probability": 0.0003591789716706353,
            "start_logit": -2.2592320442199707,
            "end_logit": -0.27886152267456055
        },
        {
            "text": "The binding of specific small molecule or ion ligands, or other RNAs, influences the conformation the riboswitch adopts.",
            "probability": 0.0001721362840255065,
            "start_logit": -2.991389274597168,
            "end_logit": -0.28223857283592224
        },
        {
            "text": "bacterial messenger RNAs (mRNAs) that can adopt different conformations to regulate gene expression.",
            "probability": 2.1729748158903287e-05,
            "start_logit": -5.064370632171631,
            "end_logit": -0.27886152267456055
        },
        {
            "text": "riboswitch adopts.",
            "probability": 1.91149383158056e-05,
            "start_logit": -5.189205646514893,
            "end_logit": -0.28223857283592224
        },
        {
            "text": "messenger RNAs",
            "probability": 9.135191411700732e-06,
            "start_logit": -1.862682819366455,
            "end_logit": -4.347097396850586
        },
        {
            "text": "RNA motifs in the untranslated regions of bacterial messenger RNAs (mRNAs) that can adopt different conformations to regulate gene expression.",
            "probability": 8.295821897010502e-06,
            "start_logit": -6.027300834655762,
            "end_logit": -0.27886152267456055
        },
        {
            "text": "(mRNAs) that can adopt different conformations to regulate gene expression.",
            "probability": 7.642884708769414e-06,
            "start_logit": -6.109277725219727,
            "end_logit": -0.27886152267456055
        },
        {
            "text": "messenger RNAs (mRNAs",
            "probability": 7.387109840684743e-06,
            "start_logit": -1.862682819366455,
            "end_logit": -4.559494972229004
        },
        {
            "text": "can adopt different conformations to regulate gene expression.",
            "probability": 6.71098616804832e-06,
            "start_logit": -6.239306926727295,
            "end_logit": -0.27886152267456055
        }
    ],
    "6440393157b1c7a31500004a_001": [
        {
            "text": "2021",
            "probability": 0.9997300167051402,
            "start_logit": 9.581075668334961,
            "end_logit": 10.132338523864746
        },
        {
            "text": "202",
            "probability": 0.00026354764402033233,
            "start_logit": 9.581075668334961,
            "end_logit": 1.8913321495056152
        },
        {
            "text": "2021 FDA approval of CLS-TA",
            "probability": 2.9026819529088786e-06,
            "start_logit": 9.581075668334961,
            "end_logit": -2.617266893386841
        },
        {
            "text": "the 2021",
            "probability": 2.013872668236319e-06,
            "start_logit": -3.5341053009033203,
            "end_logit": 10.132338523864746
        },
        {
            "text": "after the 2021",
            "probability": 1.028052511535018e-06,
            "start_logit": -4.206498622894287,
            "end_logit": 10.132338523864746
        },
        {
            "text": "2021 FDA approval of CLS-TA,",
            "probability": 1.4046592671164395e-07,
            "start_logit": 9.581075668334961,
            "end_logit": -5.645692348480225
        },
        {
            "text": "Drug delivery to the suprachoroidal space (SCS\u00ae) has become a clinical reality after the 2021",
            "probability": 8.871084422945302e-08,
            "start_logit": -6.656538009643555,
            "end_logit": 10.132338523864746
        },
        {
            "text": "SCS\u00ae) has become a clinical reality after the 2021",
            "probability": 6.188144381369422e-08,
            "start_logit": -7.01669979095459,
            "end_logit": 10.132338523864746
        },
        {
            "text": "2021 FDA",
            "probability": 4.408257959672527e-08,
            "start_logit": 9.581075668334961,
            "end_logit": -6.804592609405518
        },
        {
            "text": "suprachoroidal space (SCS\u00ae) has become a clinical reality after the 2021",
            "probability": 3.883246087803916e-08,
            "start_logit": -7.482663631439209,
            "end_logit": 10.132338523864746
        },
        {
            "text": "2021 FDA approval of CLS-TA, a triamcinolone acetonide",
            "probability": 3.8140397967914515e-08,
            "start_logit": 9.581075668334961,
            "end_logit": -6.94938325881958
        },
        {
            "text": "become a clinical reality after the 2021",
            "probability": 3.5922564816777655e-08,
            "start_logit": -7.560554504394531,
            "end_logit": 10.132338523864746
        },
        {
            "text": "2021 FDA approval of CLS-TA, a triamcinolone",
            "probability": 2.3062985023823336e-08,
            "start_logit": 9.581075668334961,
            "end_logit": -7.452428340911865
        },
        {
            "text": "2021 FDA approval of CLS-TA, a triamcinolone acetonide injectable suspension",
            "probability": 1.9077775237307558e-08,
            "start_logit": 9.581075668334961,
            "end_logit": -7.6421332359313965
        },
        {
            "text": "the 202",
            "probability": 5.308947297789917e-10,
            "start_logit": -3.5341053009033203,
            "end_logit": 1.8913321495056152
        },
        {
            "text": "after the 202",
            "probability": 2.7101398659329306e-10,
            "start_logit": -4.206498622894287,
            "end_logit": 1.8913321495056152
        },
        {
            "text": "Drug delivery to the suprachoroidal space (SCS\u00ae) has become a clinical reality after the 202",
            "probability": 2.338584778396484e-11,
            "start_logit": -6.656538009643555,
            "end_logit": 1.8913321495056152
        },
        {
            "text": "SCS\u00ae) has become a clinical reality after the 202",
            "probability": 1.6313112993671135e-11,
            "start_logit": -7.01669979095459,
            "end_logit": 1.8913321495056152
        },
        {
            "text": "CLS-TA",
            "probability": 1.4884170602254137e-11,
            "start_logit": -2.599771738052368,
            "end_logit": -2.617266893386841
        },
        {
            "text": "suprachoroidal space (SCS\u00ae) has become a clinical reality after the 202",
            "probability": 1.0236967386103218e-11,
            "start_logit": -7.482663631439209,
            "end_logit": 1.8913321495056152
        }
    ],
    "6415b3b4690f196b51000009_001": [
        {
            "text": "yellow",
            "probability": 0.5320481489403422,
            "start_logit": 8.196313858032227,
            "end_logit": 7.5495123863220215
        },
        {
            "text": "yellow light",
            "probability": 0.4679082141185966,
            "start_logit": 8.196313858032227,
            "end_logit": 7.421050548553467
        },
        {
            "text": "light",
            "probability": 2.8480342047546962e-05,
            "start_logit": -1.5104994773864746,
            "end_logit": 7.421050548553467
        },
        {
            "text": "yellow light.",
            "probability": 1.1525832568994267e-05,
            "start_logit": 8.196313858032227,
            "end_logit": -3.1903860569000244
        },
        {
            "text": "millisecond-timescale pulses of yellow",
            "probability": 1.4702342950851189e-06,
            "start_logit": -4.602753639221191,
            "end_logit": 7.5495123863220215
        },
        {
            "text": "millisecond-timescale pulses of yellow light",
            "probability": 1.2929933215994117e-06,
            "start_logit": -4.602753639221191,
            "end_logit": 7.421050548553467
        },
        {
            "text": "enables them to be silenced reliably, and reversibly, by millisecond-timescale pulses of yellow",
            "probability": 1.826003039936729e-07,
            "start_logit": -6.688631057739258,
            "end_logit": 7.5495123863220215
        },
        {
            "text": "enables them to be silenced reliably, and reversibly, by millisecond-timescale pulses of yellow light",
            "probability": 1.6058731208699796e-07,
            "start_logit": -6.688631057739258,
            "end_logit": 7.421050548553467
        },
        {
            "text": "pulses of yellow",
            "probability": 1.4589576624657346e-07,
            "start_logit": -6.91303825378418,
            "end_logit": 7.5495123863220215
        },
        {
            "text": "silenced reliably, and reversibly, by millisecond-timescale pulses of yellow",
            "probability": 1.3269570652411265e-07,
            "start_logit": -7.007872104644775,
            "end_logit": 7.5495123863220215
        },
        {
            "text": "pulses of yellow light",
            "probability": 1.283076119480174e-07,
            "start_logit": -6.91303825378418,
            "end_logit": 7.421050548553467
        },
        {
            "text": "silenced reliably, and reversibly, by millisecond-timescale pulses of yellow light",
            "probability": 1.166988573958274e-07,
            "start_logit": -7.007872104644775,
            "end_logit": 7.421050548553467
        },
        {
            "text": "light.",
            "probability": 7.015471069813546e-10,
            "start_logit": -1.5104994773864746,
            "end_logit": -3.1903860569000244
        },
        {
            "text": "millisecond-timescale pulses of yellow light.",
            "probability": 3.184988869164261e-11,
            "start_logit": -4.602753639221191,
            "end_logit": -3.1903860569000244
        },
        {
            "text": "Here we report",
            "probability": 4.116882123294181e-12,
            "start_logit": -4.806358337402344,
            "end_logit": -5.032719135284424
        },
        {
            "text": "enables them to be silenced reliably, and reversibly, by millisecond-timescale pulses of yellow light.",
            "probability": 3.955695617154598e-12,
            "start_logit": -6.688631057739258,
            "end_logit": -3.1903860569000244
        },
        {
            "text": "pulses of yellow light.",
            "probability": 3.1605601441001966e-12,
            "start_logit": -6.91303825378418,
            "end_logit": -3.1903860569000244
        },
        {
            "text": "Here",
            "probability": 3.057327416064457e-12,
            "start_logit": -4.806358337402344,
            "end_logit": -5.3302741050720215
        },
        {
            "text": "silenced reliably, and reversibly, by millisecond-timescale pulses of yellow light.",
            "probability": 2.874605426346131e-12,
            "start_logit": -7.007872104644775,
            "end_logit": -3.1903860569000244
        },
        {
            "text": "we report",
            "probability": 2.707774165658287e-12,
            "start_logit": -5.225327491760254,
            "end_logit": -5.032719135284424
        }
    ],
    "6429fad757b1c7a31500000e_001": [
        {
            "text": "TATA\" box",
            "probability": 0.9948684370261428,
            "start_logit": 7.383122444152832,
            "end_logit": 4.487007141113281
        },
        {
            "text": "TATA\" box, which is located 25-30 nucleotides upstream of the transcription initiation site.",
            "probability": 0.003574693692220865,
            "start_logit": 7.383122444152832,
            "end_logit": -1.141723871231079
        },
        {
            "text": "TATA\" box,",
            "probability": 0.0009102921866835518,
            "start_logit": 7.383122444152832,
            "end_logit": -2.5095930099487305
        },
        {
            "text": "T",
            "probability": 0.00015170241221140803,
            "start_logit": 7.383122444152832,
            "end_logit": -4.301437854766846
        },
        {
            "text": "the \"TATA\" box",
            "probability": 0.0001449517716577283,
            "start_logit": -1.450842261314392,
            "end_logit": 4.487007141113281
        },
        {
            "text": "TATA\" box, which is located 25-30 nucleotides upstream of the transcription initiation site",
            "probability": 7.814088861722288e-05,
            "start_logit": 7.383122444152832,
            "end_logit": -4.964845180511475
        },
        {
            "text": "\"TATA\" box",
            "probability": 7.398186541519752e-05,
            "start_logit": -2.1234233379364014,
            "end_logit": 4.487007141113281
        },
        {
            "text": "TATA\" box, which is located 25-30 nucleotides upstream",
            "probability": 4.179534018553504e-05,
            "start_logit": 7.383122444152832,
            "end_logit": -5.590573787689209
        },
        {
            "text": "TATA\" box, which is located 25-30 nucleotides",
            "probability": 3.8070045605050647e-05,
            "start_logit": 7.383122444152832,
            "end_logit": -5.68393087387085
        },
        {
            "text": "A critical regulatory element in many promoters transcribed by RNA polymerase II is the \"TATA\" box",
            "probability": 2.7228693560430788e-05,
            "start_logit": -3.122972011566162,
            "end_logit": 4.487007141113281
        },
        {
            "text": "TATA",
            "probability": 2.0589668889270834e-05,
            "start_logit": 7.383122444152832,
            "end_logit": -6.298569202423096
        },
        {
            "text": "TATA\"",
            "probability": 1.3802028449339812e-05,
            "start_logit": 7.383122444152832,
            "end_logit": -6.698543071746826
        },
        {
            "text": "TATA\" box, which is located 25-30 nucleotides upstream of the transcription initiation",
            "probability": 1.3548904639391112e-05,
            "start_logit": 7.383122444152832,
            "end_logit": -6.717052936553955
        },
        {
            "text": "TATA\" box, which is located 25-30 nucleotide",
            "probability": 1.2703328233084823e-05,
            "start_logit": 7.383122444152832,
            "end_logit": -6.781494617462158
        },
        {
            "text": "TATA\" box, which",
            "probability": 1.0623729643777799e-05,
            "start_logit": 7.383122444152832,
            "end_logit": -6.960268497467041
        },
        {
            "text": "TATA\" box, which is located 25-30 nucleotides upstream of",
            "probability": 8.996229845962992e-06,
            "start_logit": 7.383122444152832,
            "end_logit": -7.126553058624268
        },
        {
            "text": "box",
            "probability": 6.57679726711856e-06,
            "start_logit": -4.543695449829102,
            "end_logit": 4.487007141113281
        },
        {
            "text": "RNA polymerase II is the \"TATA\" box",
            "probability": 1.960987537874489e-06,
            "start_logit": -5.753795146942139,
            "end_logit": 4.487007141113281
        },
        {
            "text": "many promoters transcribed by RNA polymerase II is the \"TATA\" box",
            "probability": 9.652990642311397e-07,
            "start_logit": -6.462560653686523,
            "end_logit": 4.487007141113281
        },
        {
            "text": "critical regulatory element in many promoters transcribed by RNA polymerase II is the \"TATA\" box",
            "probability": 9.39104130130079e-07,
            "start_logit": -6.490072250366211,
            "end_logit": 4.487007141113281
        }
    ],
    "6429fad757b1c7a31500000e_002": [
        {
            "text": "TATAWAWR",
            "probability": 0.8425283442659627,
            "start_logit": 5.020358562469482,
            "end_logit": 0.191226989030838
        },
        {
            "text": "TATAWAWR).",
            "probability": 0.1475321454026987,
            "start_logit": 5.020358562469482,
            "end_logit": -1.5511342287063599
        },
        {
            "text": "TATAWAWR)",
            "probability": 0.005542040538552361,
            "start_logit": 5.020358562469482,
            "end_logit": -4.832817554473877
        },
        {
            "text": "T",
            "probability": 0.0022551568841220615,
            "start_logit": 5.020358562469482,
            "end_logit": -5.731960773468018
        },
        {
            "text": "TATA-like element and their promoters are generally AT-rich;",
            "probability": 0.001809700890731718,
            "start_logit": 1.5078628063201904,
            "end_logit": -2.4395229816436768
        },
        {
            "text": "TATA-like element",
            "probability": 0.00014409007398451284,
            "start_logit": 1.5078628063201904,
            "end_logit": -4.970001220703125
        },
        {
            "text": "TATA",
            "probability": 2.9850063467215387e-05,
            "start_logit": 1.5078628063201904,
            "end_logit": -6.544252872467041
        },
        {
            "text": "TATA-like element and their promoters",
            "probability": 2.800278972596764e-05,
            "start_logit": 1.5078628063201904,
            "end_logit": -6.60813570022583
        },
        {
            "text": "TATA-like element and their promoters are generally AT-rich",
            "probability": 2.7389476409716725e-05,
            "start_logit": 1.5078628063201904,
            "end_logit": -6.6302809715271
        },
        {
            "text": "TATA-like element and their promoters are generally AT-rich; however, only approximately 10%",
            "probability": 2.34021606595853e-05,
            "start_logit": 1.5078628063201904,
            "end_logit": -6.787611484527588
        },
        {
            "text": "TATA-like element and their promoters are generally AT-rich; however",
            "probability": 1.9929242276609465e-05,
            "start_logit": 1.5078628063201904,
            "end_logit": -6.948251724243164
        },
        {
            "text": "(TATAWAWR).",
            "probability": 1.2865602180150033e-05,
            "start_logit": -6.069246768951416,
            "end_logit": 0.191226989030838
        },
        {
            "text": "10% of these TATA-containing promoters have the canonical TATA box (TATAWAWR",
            "probability": 1.190083638398367e-05,
            "start_logit": -6.147195339202881,
            "end_logit": 0.191226989030838
        },
        {
            "text": "TATA box (TATAWAWR",
            "probability": 1.0543536568774682e-05,
            "start_logit": -6.268290996551514,
            "end_logit": 0.191226989030838
        },
        {
            "text": "only approximately 10% of these TATA-containing promoters have the canonical TATA box (TATAWAWR",
            "probability": 6.039280825843187e-06,
            "start_logit": -6.82551908493042,
            "end_logit": 0.191226989030838
        },
        {
            "text": "(TATAWAWR",
            "probability": 5.399845281490333e-06,
            "start_logit": -6.93743371963501,
            "end_logit": 0.191226989030838
        },
        {
            "text": "approximately 10% of these TATA-containing promoters have the canonical TATA box (TATAWAWR",
            "probability": 5.160478391473211e-06,
            "start_logit": -6.98277473449707,
            "end_logit": 0.191226989030838
        },
        {
            "text": "TATA-containing promoters have the canonical TATA box (TATAWAWR",
            "probability": 4.10847735943978e-06,
            "start_logit": -7.210751533508301,
            "end_logit": 0.191226989030838
        },
        {
            "text": "10% of these TATA-containing promoters have the canonical TATA box (TATAWAWR).",
            "probability": 2.083913183176379e-06,
            "start_logit": -6.147195339202881,
            "end_logit": -1.5511342287063599
        },
        {
            "text": "TATA box (TATAWAWR).",
            "probability": 1.8462412341490391e-06,
            "start_logit": -6.268290996551514,
            "end_logit": -1.5511342287063599
        }
    ],
    "6429fad757b1c7a31500000e_003": [
        {
            "text": "TATA box",
            "probability": 0.9954655576529899,
            "start_logit": 9.710153579711914,
            "end_logit": 8.1187162399292
        },
        {
            "text": "TBP binding to the TATA box",
            "probability": 0.004245705300647213,
            "start_logit": 4.2528510093688965,
            "end_logit": 8.1187162399292
        },
        {
            "text": "TATA box induces a specific downstream unwinding site that is targeted by pluramycin.",
            "probability": 0.00013416159657129553,
            "start_logit": 9.710153579711914,
            "end_logit": -0.7932045459747314
        },
        {
            "text": "T",
            "probability": 9.451738695810768e-05,
            "start_logit": 9.710153579711914,
            "end_logit": -1.1434657573699951
        },
        {
            "text": "TATA",
            "probability": 2.878041794903563e-05,
            "start_logit": 9.710153579711914,
            "end_logit": -2.332554340362549
        },
        {
            "text": "the TATA box",
            "probability": 2.4046049210689736e-05,
            "start_logit": -0.9208415150642395,
            "end_logit": 8.1187162399292
        },
        {
            "text": "box",
            "probability": 4.133507415080494e-06,
            "start_logit": -2.6816859245300293,
            "end_logit": 8.1187162399292
        },
        {
            "text": "TAT",
            "probability": 7.576817923190632e-07,
            "start_logit": 9.710153579711914,
            "end_logit": -5.969741344451904
        },
        {
            "text": "TBP binding to the TATA box induces a specific downstream unwinding site that is targeted by pluramycin.",
            "probability": 5.722052333473132e-07,
            "start_logit": 4.2528510093688965,
            "end_logit": -0.7932045459747314
        },
        {
            "text": "TATA box induces a specific downstream unwinding site",
            "probability": 4.562266951366109e-07,
            "start_logit": 9.710153579711914,
            "end_logit": -6.477015018463135
        },
        {
            "text": "TBP binding to the T",
            "probability": 4.03120899288058e-07,
            "start_logit": 4.2528510093688965,
            "end_logit": -1.1434657573699951
        },
        {
            "text": "TATA box induces a specific downstream unwinding site that is targeted by pluramycin",
            "probability": 3.743228334973114e-07,
            "start_logit": 9.710153579711914,
            "end_logit": -6.674886226654053
        },
        {
            "text": "TATA box induces",
            "probability": 2.130268932483634e-07,
            "start_logit": 9.710153579711914,
            "end_logit": -7.23858642578125
        },
        {
            "text": "TATA box induces a specific downstream unwinding site that",
            "probability": 1.8363365548857833e-07,
            "start_logit": 9.710153579711914,
            "end_logit": -7.387062072753906
        },
        {
            "text": "TBP binding to the TATA",
            "probability": 1.227497748180838e-07,
            "start_logit": 4.2528510093688965,
            "end_logit": -2.332554340362549
        },
        {
            "text": "TBP binding to the",
            "probability": 4.0281698741244845e-09,
            "start_logit": 4.2528510093688965,
            "end_logit": -5.749390125274658
        },
        {
            "text": "the TATA box induces a specific downstream unwinding site that is targeted by pluramycin.",
            "probability": 3.240751353511569e-09,
            "start_logit": -0.9208415150642395,
            "end_logit": -0.7932045459747314
        },
        {
            "text": "TBP binding to the TAT",
            "probability": 3.2315468648030376e-09,
            "start_logit": 4.2528510093688965,
            "end_logit": -5.969741344451904
        },
        {
            "text": "TBP",
            "probability": 2.336890812113241e-09,
            "start_logit": 4.2528510093688965,
            "end_logit": -6.293880939483643
        },
        {
            "text": "the T",
            "probability": 2.2831224250680983e-09,
            "start_logit": -0.9208415150642395,
            "end_logit": -1.1434657573699951
        }
    ],
    "6429fad757b1c7a31500000e_004": [
        {
            "text": "TFIID",
            "probability": 0.8357294155555436,
            "start_logit": 8.305689811706543,
            "end_logit": 1.2216564416885376
        },
        {
            "text": "TFIID multiprotein complex.",
            "probability": 0.0828739583605713,
            "start_logit": 8.305689811706543,
            "end_logit": -1.0893275737762451
        },
        {
            "text": "TATA-binding protein (TBP) is one of the major components of the human TFIID",
            "probability": 0.061085800853348755,
            "start_logit": 5.689664363861084,
            "end_logit": 1.2216564416885376
        },
        {
            "text": "TFIID multiprotein complex. It is important in directing the initiation of RNA transcription at a site immediately downstream of the TATA sequence",
            "probability": 0.0077503794453614334,
            "start_logit": 8.305689811706543,
            "end_logit": -3.458906650543213
        },
        {
            "text": "TATA-binding protein (TBP) is one of the major components of the human TFIID multiprotein complex.",
            "probability": 0.0060574894482771985,
            "start_logit": 5.689664363861084,
            "end_logit": -1.0893275737762451
        },
        {
            "text": "T",
            "probability": 0.004259094326523174,
            "start_logit": 8.305689811706543,
            "end_logit": -4.057591915130615
        },
        {
            "text": "TFIID multiprotein complex. It is important in directing the initiation of RNA transcription",
            "probability": 0.001590665129221189,
            "start_logit": 8.305689811706543,
            "end_logit": -5.042496204376221
        },
        {
            "text": "TATA-binding protein (TBP) is one of the major components of the human T",
            "probability": 0.00031130911872077194,
            "start_logit": 5.689664363861084,
            "end_logit": -4.057591915130615
        },
        {
            "text": "TATA box) found in many eukaryotic promoters.",
            "probability": 0.00011107715405965801,
            "start_logit": 1.6979070901870728,
            "end_logit": -1.0963959693908691
        },
        {
            "text": "TATA box",
            "probability": 7.212828378742617e-05,
            "start_logit": 1.6979070901870728,
            "end_logit": -1.5281747579574585
        },
        {
            "text": "TATA",
            "probability": 4.445333940896554e-05,
            "start_logit": 5.689664363861084,
            "end_logit": -6.0039381980896
        },
        {
            "text": "TATA-binding protein",
            "probability": 3.0610151412680706e-05,
            "start_logit": 5.689664363861084,
            "end_logit": -6.377046585083008
        },
        {
            "text": "The TATA-binding protein (TBP) is one of the major components of the human TFIID",
            "probability": 2.1264625534992408e-05,
            "start_logit": -2.2733254432678223,
            "end_logit": 1.2216564416885376
        },
        {
            "text": "TATA-binding protein (TBP",
            "probability": 1.9033801030651212e-05,
            "start_logit": 5.689664363861084,
            "end_logit": -6.852161884307861
        },
        {
            "text": "TAT",
            "probability": 1.893821718133791e-05,
            "start_logit": 5.689664363861084,
            "end_logit": -6.85719633102417
        },
        {
            "text": "TBP) is one of the major components of the human TFIID",
            "probability": 1.5414223729581927e-05,
            "start_logit": -2.5950796604156494,
            "end_logit": 1.2216564416885376
        },
        {
            "text": "TATA box)",
            "probability": 3.7059399951550632e-06,
            "start_logit": 1.6979070901870728,
            "end_logit": -4.4966840744018555
        },
        {
            "text": "The TATA-binding protein (TBP) is one of the major components of the human TFIID multiprotein complex.",
            "probability": 2.1086773521889737e-06,
            "start_logit": -2.2733254432678223,
            "end_logit": -1.0893275737762451
        },
        {
            "text": "TATA sequence (TATA box) found in many eukaryotic promoters.",
            "probability": 1.6248186380047897e-06,
            "start_logit": -2.5269217491149902,
            "end_logit": -1.0963959693908691
        },
        {
            "text": "TBP) is one of the major components of the human TFIID multiprotein complex.",
            "probability": 1.5285303014932622e-06,
            "start_logit": -2.5950796604156494,
            "end_logit": -1.0893275737762451
        }
    ],
    "64402e7757b1c7a315000044_001": [
        {
            "text": "9",
            "probability": 0.9972899025859264,
            "start_logit": 7.465607643127441,
            "end_logit": 6.70905065536499
        },
        {
            "text": "9 subjects",
            "probability": 0.0020455862038932667,
            "start_logit": 7.465607643127441,
            "end_logit": 0.5196935534477234
        },
        {
            "text": "9 subjects each cohort",
            "probability": 0.00045246453634492656,
            "start_logit": 7.465607643127441,
            "end_logit": -0.9890367388725281
        },
        {
            "text": "9 subjects each cohort)",
            "probability": 0.000124109421107976,
            "start_logit": 7.465607643127441,
            "end_logit": -2.2825825214385986
        },
        {
            "text": "(9",
            "probability": 7.092179528242316e-05,
            "start_logit": -2.085611343383789,
            "end_logit": 6.70905065536499
        },
        {
            "text": "9 subjects each",
            "probability": 1.1960351474512288e-05,
            "start_logit": 7.465607643127441,
            "end_logit": -4.6221489906311035
        },
        {
            "text": "2 doses of RT001 in Friedreich's ataxia patients (9",
            "probability": 1.678714711866459e-06,
            "start_logit": -5.829160690307617,
            "end_logit": 6.70905065536499
        },
        {
            "text": "Friedreich's ataxia patients (9",
            "probability": 1.145116458119475e-06,
            "start_logit": -6.2116827964782715,
            "end_logit": 6.70905065536499
        },
        {
            "text": "RT001 in Friedreich's ataxia patients (9",
            "probability": 8.688562353834257e-07,
            "start_logit": -6.487766742706299,
            "end_logit": 6.70905065536499
        },
        {
            "text": "9 subjects each cohor",
            "probability": 4.983049560491039e-07,
            "start_logit": 7.465607643127441,
            "end_logit": -7.800289154052734
        },
        {
            "text": "in Friedreich's ataxia patients (9",
            "probability": 3.486866797560435e-07,
            "start_logit": -7.400770664215088,
            "end_logit": 6.70905065536499
        },
        {
            "text": "ataxia patients (9",
            "probability": 3.0967661080797233e-07,
            "start_logit": -7.519415855407715,
            "end_logit": 6.70905065536499
        },
        {
            "text": "(9 subjects",
            "probability": 1.4547088625773746e-07,
            "start_logit": -2.085611343383789,
            "end_logit": 0.5196935534477234
        },
        {
            "text": "(9 subjects each cohort",
            "probability": 3.217679948027605e-08,
            "start_logit": -2.085611343383789,
            "end_logit": -0.9890367388725281
        },
        {
            "text": "(9 subjects each cohort)",
            "probability": 8.825982228052826e-09,
            "start_logit": -2.085611343383789,
            "end_logit": -2.2825825214385986
        },
        {
            "text": "each cohort",
            "probability": 5.977908940228233e-09,
            "start_logit": -3.7687861919403076,
            "end_logit": -0.9890367388725281
        },
        {
            "text": "subjects",
            "probability": 5.724504621478738e-09,
            "start_logit": -5.320831298828125,
            "end_logit": 0.5196935534477234
        },
        {
            "text": "2 doses of RT001 in Friedreich's ataxia patients (9 subjects",
            "probability": 3.4432872988712723e-09,
            "start_logit": -5.829160690307617,
            "end_logit": 0.5196935534477234
        },
        {
            "text": "Friedreich's ataxia patients (9 subjects",
            "probability": 2.3487999051293875e-09,
            "start_logit": -6.2116827964782715,
            "end_logit": 0.5196935534477234
        },
        {
            "text": "RT001 in Friedreich's ataxia patients (9 subjects",
            "probability": 1.7821501287223176e-09,
            "start_logit": -6.487766742706299,
            "end_logit": 0.5196935534477234
        }
    ],
    "64402e7757b1c7a315000044_002": [
        {
            "text": "Nineteen",
            "probability": 0.9723879727622032,
            "start_logit": 5.403738498687744,
            "end_logit": 6.017979145050049
        },
        {
            "text": "Nineteen patients enrolled in the trial, and 18",
            "probability": 0.024004872777555225,
            "start_logit": 5.403738498687744,
            "end_logit": 2.316481113433838
        },
        {
            "text": "18",
            "probability": 0.0027479365460798713,
            "start_logit": 3.2363319396972656,
            "end_logit": 2.316481113433838
        },
        {
            "text": "Nine",
            "probability": 0.0003334997753713477,
            "start_logit": 5.403738498687744,
            "end_logit": -1.9598888158798218
        },
        {
            "text": "Nineteen patients enrolled in the trial, and 18 completed all safety and efficacy measurements.",
            "probability": 0.00028544044790798076,
            "start_logit": 5.403738498687744,
            "end_logit": -2.115497589111328
        },
        {
            "text": "Nineteen patients enrolled in the trial,",
            "probability": 8.270036961957809e-05,
            "start_logit": 5.403738498687744,
            "end_logit": -3.354306936264038
        },
        {
            "text": "Nineteen patients enrolled",
            "probability": 4.634986378584624e-05,
            "start_logit": 5.403738498687744,
            "end_logit": -3.9333126544952393
        },
        {
            "text": "Nineteen patients",
            "probability": 3.945633028754136e-05,
            "start_logit": 5.403738498687744,
            "end_logit": -4.09433650970459
        },
        {
            "text": "18 completed all safety and efficacy measurements.",
            "probability": 3.267554241191994e-05,
            "start_logit": 3.2363319396972656,
            "end_logit": -2.115497589111328
        },
        {
            "text": "Nineteen patients enrolled in the trial",
            "probability": 1.7727194864368075e-05,
            "start_logit": 5.403738498687744,
            "end_logit": -4.894431114196777
        },
        {
            "text": "Nineteen patients enrolled in the trial, and 18 completed all safety and efficacy measurements",
            "probability": 8.856905178693813e-06,
            "start_logit": 5.403738498687744,
            "end_logit": -5.588333606719971
        },
        {
            "text": "Nineteen patients enrolled in the trial, and",
            "probability": 7.668946309255322e-06,
            "start_logit": 5.403738498687744,
            "end_logit": -5.732351779937744
        },
        {
            "text": "enrolled in the trial, and 18",
            "probability": 1.656051659134457e-06,
            "start_logit": -4.177837371826172,
            "end_logit": 2.316481113433838
        },
        {
            "text": "and 18",
            "probability": 1.225437994241314e-06,
            "start_logit": -4.478975296020508,
            "end_logit": 2.316481113433838
        },
        {
            "text": "18 completed all safety and efficacy measurements",
            "probability": 1.0138863742886926e-06,
            "start_logit": 3.2363319396972656,
            "end_logit": -5.588333606719971
        },
        {
            "text": "patients enrolled in the trial, and 18",
            "probability": 5.297765712855306e-07,
            "start_logit": -5.317573547363281,
            "end_logit": 2.316481113433838
        },
        {
            "text": "the trial, and 18",
            "probability": 3.6514879677516425e-07,
            "start_logit": -5.689723968505859,
            "end_logit": 2.316481113433838
        },
        {
            "text": "enrolled in the trial, and 18 completed all safety and efficacy measurements.",
            "probability": 1.9692007190476624e-08,
            "start_logit": -4.177837371826172,
            "end_logit": -2.115497589111328
        },
        {
            "text": "all safety and efficacy measurements.",
            "probability": 1.797341538070099e-08,
            "start_logit": -4.269156455993652,
            "end_logit": -2.115497589111328
        },
        {
            "text": "and 18 completed all safety and efficacy measurements.",
            "probability": 1.4571606906692489e-08,
            "start_logit": -4.478975296020508,
            "end_logit": -2.115497589111328
        }
    ],
    "64425ce357b1c7a315000059_001": [
        {
            "text": "1:8000",
            "probability": 0.9761691108082539,
            "start_logit": 9.836195945739746,
            "end_logit": 9.158980369567871
        },
        {
            "text": "8000",
            "probability": 0.019225117144407736,
            "start_logit": 5.908777713775635,
            "end_logit": 9.158980369567871
        },
        {
            "text": "1:8000 incidence",
            "probability": 0.004180229379865409,
            "start_logit": 9.836195945739746,
            "end_logit": 3.7057106494903564
        },
        {
            "text": "1",
            "probability": 0.0002519517080849577,
            "start_logit": 9.836195945739746,
            "end_logit": 0.8968266844749451
        },
        {
            "text": "8000 incidence",
            "probability": 8.232733307025665e-05,
            "start_logit": 5.908777713775635,
            "end_logit": 3.7057106494903564
        },
        {
            "text": "approximate 1:8000",
            "probability": 4.9415852729508885e-05,
            "start_logit": -0.0549238957464695,
            "end_logit": 9.158980369567871
        },
        {
            "text": "1:8000 incidence.",
            "probability": 1.5777843688263978e-05,
            "start_logit": 9.836195945739746,
            "end_logit": -1.8738040924072266
        },
        {
            "text": "1:800",
            "probability": 1.062523300370032e-05,
            "start_logit": 9.836195945739746,
            "end_logit": -2.269179105758667
        },
        {
            "text": "an approximate 1:8000",
            "probability": 7.944315987962662e-06,
            "start_logit": -1.882738471031189,
            "end_logit": 9.158980369567871
        },
        {
            "text": "1:",
            "probability": 4.863958730180343e-06,
            "start_logit": 9.836195945739746,
            "end_logit": -3.050558090209961
        },
        {
            "text": "with an approximate 1:8000",
            "probability": 1.1101506747979427e-06,
            "start_logit": -3.8506994247436523,
            "end_logit": 9.158980369567871
        },
        {
            "text": "FSHD) is in the top three list of all dystrophies with an approximate 1:8000",
            "probability": 4.4276648162285184e-07,
            "start_logit": -4.7699079513549805,
            "end_logit": 9.158980369567871
        },
        {
            "text": "8000 incidence.",
            "probability": 3.1073600858141836e-07,
            "start_logit": 5.908777713775635,
            "end_logit": -1.8738040924072266
        },
        {
            "text": "approximate 1:8000 incidence",
            "probability": 2.1161251377843605e-07,
            "start_logit": -0.0549238957464695,
            "end_logit": 3.7057106494903564
        },
        {
            "text": "800",
            "probability": 2.0925815713799037e-07,
            "start_logit": 5.908777713775635,
            "end_logit": -2.269179105758667
        },
        {
            "text": "in the top three list of all dystrophies with an approximate 1:8000",
            "probability": 1.0869070221743524e-07,
            "start_logit": -6.174444198608398,
            "end_logit": 9.158980369567871
        },
        {
            "text": "top three list of all dystrophies with an approximate 1:8000",
            "probability": 8.308913079824498e-08,
            "start_logit": -6.4430365562438965,
            "end_logit": 9.158980369567871
        },
        {
            "text": ":8000",
            "probability": 5.9423356779545633e-08,
            "start_logit": -6.778263092041016,
            "end_logit": 9.158980369567871
        },
        {
            "text": "dystrophies with an approximate 1:8000",
            "probability": 5.2282007778237186e-08,
            "start_logit": -6.9062981605529785,
            "end_logit": 9.158980369567871
        },
        {
            "text": "(FSHD) is in the top three list of all dystrophies with an approximate 1:8000",
            "probability": 4.841314464824061e-08,
            "start_logit": -6.983179092407227,
            "end_logit": 9.158980369567871
        }
    ],
    "64425ce357b1c7a315000059_002": [
        {
            "text": "1 in 20000",
            "probability": 0.8414037523030103,
            "start_logit": 9.391763687133789,
            "end_logit": 8.003835678100586
        },
        {
            "text": "1 in 20000.",
            "probability": 0.08296824602454221,
            "start_logit": 9.391763687133789,
            "end_logit": 5.687222003936768
        },
        {
            "text": "20000",
            "probability": 0.06064320665442363,
            "start_logit": 6.761699676513672,
            "end_logit": 8.003835678100586
        },
        {
            "text": "20000.",
            "probability": 0.005979840802527609,
            "start_logit": 6.761699676513672,
            "end_logit": 5.687222003936768
        },
        {
            "text": "1",
            "probability": 0.004543838870145088,
            "start_logit": 9.391763687133789,
            "end_logit": 2.782536268234253
        },
        {
            "text": "1 in 20000. Overall lifespan is not affected significantly.",
            "probability": 0.0024213956107654263,
            "start_logit": 9.391763687133789,
            "end_logit": 2.1531081199645996
        },
        {
            "text": "about 1 in 20000",
            "probability": 0.0010833900112394658,
            "start_logit": 2.7367870807647705,
            "end_logit": 8.003835678100586
        },
        {
            "text": "1 in 2000",
            "probability": 0.0003171147691918708,
            "start_logit": 9.391763687133789,
            "end_logit": 0.12027252465486526
        },
        {
            "text": "1 in",
            "probability": 0.00022178755240317196,
            "start_logit": 9.391763687133789,
            "end_logit": -0.2372712790966034
        },
        {
            "text": "20000. Overall lifespan is not affected significantly.",
            "probability": 0.00017451930064947096,
            "start_logit": 6.761699676513672,
            "end_logit": 2.1531081199645996
        },
        {
            "text": "about 1 in 20000.",
            "probability": 0.00010682976959279953,
            "start_logit": 2.7367870807647705,
            "end_logit": 5.687222003936768
        },
        {
            "text": "incidence of about 1 in 20000",
            "probability": 4.48019591878598e-05,
            "start_logit": -0.4488113522529602,
            "end_logit": 8.003835678100586
        },
        {
            "text": "It is present worldwide, with a prevalence of around 4 per 100000 and an incidence of about 1 in 20000",
            "probability": 3.1840987962484805e-05,
            "start_logit": -0.7903088331222534,
            "end_logit": 8.003835678100586
        },
        {
            "text": "2000",
            "probability": 2.285568186335704e-05,
            "start_logit": 6.761699676513672,
            "end_logit": 0.12027252465486526
        },
        {
            "text": "4 per 100000 and an incidence of about 1 in 20000",
            "probability": 9.835671675469751e-06,
            "start_logit": -1.9650474786758423,
            "end_logit": 8.003835678100586
        },
        {
            "text": "in 20000",
            "probability": 8.294165378095953e-06,
            "start_logit": -2.1355109214782715,
            "end_logit": 8.003835678100586
        },
        {
            "text": "about 1",
            "probability": 5.850639043530203e-06,
            "start_logit": 2.7367870807647705,
            "end_logit": 2.782536268234253
        },
        {
            "text": "around 4 per 100000 and an incidence of about 1 in 20000",
            "probability": 5.041700206992265e-06,
            "start_logit": -2.633319854736328,
            "end_logit": 8.003835678100586
        },
        {
            "text": "incidence of about 1 in 20000.",
            "probability": 4.417783926094518e-06,
            "start_logit": -0.4488113522529602,
            "end_logit": 5.687222003936768
        },
        {
            "text": "It is present worldwide, with a prevalence of around 4 per 100000 and an incidence of about 1 in 20000.",
            "probability": 3.139742264881833e-06,
            "start_logit": -0.7903088331222534,
            "end_logit": 5.687222003936768
        }
    ],
    "63f581e933942b094c000007_001": [
        {
            "text": "spinal muscular atrophy",
            "probability": 0.9997605716020095,
            "start_logit": 7.342982292175293,
            "end_logit": 9.675148010253906
        },
        {
            "text": "atrophy-is",
            "probability": 0.000217363255688271,
            "start_logit": -1.0907188653945923,
            "end_logit": 9.675148010253906
        },
        {
            "text": "\u22652 months of age with spinal muscular atrophy",
            "probability": 6.103116040037384e-06,
            "start_logit": -4.66348934173584,
            "end_logit": 9.675148010253906
        },
        {
            "text": "atrophy",
            "probability": 5.000811840286241e-06,
            "start_logit": -4.8626885414123535,
            "end_logit": 9.675148010253906
        },
        {
            "text": "with spinal muscular atrophy",
            "probability": 3.0706926124957328e-06,
            "start_logit": -5.350385665893555,
            "end_logit": 9.675148010253906
        },
        {
            "text": "spinal",
            "probability": 2.3378209649394355e-06,
            "start_logit": 7.342982292175293,
            "end_logit": -3.2909038066864014
        },
        {
            "text": "patients \u22652 months of age with spinal muscular atrophy",
            "probability": 1.5564933908975682e-06,
            "start_logit": -6.029853343963623,
            "end_logit": 9.675148010253906
        },
        {
            "text": "spinal muscular at",
            "probability": 9.538788574341215e-07,
            "start_logit": 7.342982292175293,
            "end_logit": -4.187341690063477
        },
        {
            "text": "European Medicines Agency for the treatment of patients \u22652 months of age with spinal muscular atrophy",
            "probability": 7.370238326612209e-07,
            "start_logit": -6.777423858642578,
            "end_logit": 9.675148010253906
        },
        {
            "text": "spinal muscular atrophy-is presented here as a case study.",
            "probability": 7.015805868875693e-07,
            "start_logit": 7.342982292175293,
            "end_logit": -4.494542598724365
        },
        {
            "text": "muscular atrophy",
            "probability": 5.705479979646971e-07,
            "start_logit": -7.033446788787842,
            "end_logit": 9.675148010253906
        },
        {
            "text": "\u22652 months of age with spinal muscular atrophy-is",
            "probability": 4.628078881930446e-07,
            "start_logit": -7.242732048034668,
            "end_logit": 9.675148010253906
        },
        {
            "text": "spinal muscular atrophy-is presented here as a case study",
            "probability": 1.9262267660975142e-07,
            "start_logit": 7.342982292175293,
            "end_logit": -5.787145137786865
        },
        {
            "text": "spinal muscular atrophy-",
            "probability": 1.0802566735552298e-07,
            "start_logit": 7.342982292175293,
            "end_logit": -6.365509510040283
        },
        {
            "text": "spinal muscular atrop",
            "probability": 8.249785416622496e-08,
            "start_logit": 7.342982292175293,
            "end_logit": -6.635106086730957
        },
        {
            "text": "spinal muscular atrophy-is presented here",
            "probability": 5.456728762072258e-08,
            "start_logit": 7.342982292175293,
            "end_logit": -7.048443794250488
        },
        {
            "text": "spinal muscular atrophy-is",
            "probability": 4.626979858147092e-08,
            "start_logit": 7.342982292175293,
            "end_logit": -7.213388919830322
        },
        {
            "text": "spinal muscular atrophy-is presented",
            "probability": 4.47003663945401e-08,
            "start_logit": 7.342982292175293,
            "end_logit": -7.247896671295166
        },
        {
            "text": "spinal muscular",
            "probability": 4.1532105721339605e-08,
            "start_logit": 7.342982292175293,
            "end_logit": -7.321411609649658
        },
        {
            "text": "atrophy-is presented here as a case study.",
            "probability": 1.5253436155139469e-10,
            "start_logit": -1.0907188653945923,
            "end_logit": -4.494542598724365
        }
    ],
    "63f581e933942b094c000007_002": [
        {
            "text": "spinal muscular atrophy",
            "probability": 0.992164895027431,
            "start_logit": 7.088539123535156,
            "end_logit": 7.8209547996521
        },
        {
            "text": "spinal muscular atrophy.",
            "probability": 0.007276930305836406,
            "start_logit": 7.088539123535156,
            "end_logit": 2.9057745933532715
        },
        {
            "text": "Type 1 or 2 spinal muscular atrophy",
            "probability": 0.00046213556972088507,
            "start_logit": -0.583247184753418,
            "end_logit": 7.8209547996521
        },
        {
            "text": "An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy",
            "probability": 5.235480951236771e-05,
            "start_logit": -2.761061668395996,
            "end_logit": 7.8209547996521
        },
        {
            "text": "atrophy.",
            "probability": 1.5577535000179005e-05,
            "start_logit": -3.973275661468506,
            "end_logit": 7.8209547996521
        },
        {
            "text": "spinal",
            "probability": 1.1491295364702962e-05,
            "start_logit": 7.088539123535156,
            "end_logit": -3.545099973678589
        },
        {
            "text": "Type 1 or 2 spinal muscular atrophy.",
            "probability": 3.3894853058814427e-06,
            "start_logit": -0.583247184753418,
            "end_logit": 2.9057745933532715
        },
        {
            "text": "patients with Type 1 or 2 spinal muscular atrophy",
            "probability": 3.315331461159662e-06,
            "start_logit": -5.520547866821289,
            "end_logit": 7.8209547996521
        },
        {
            "text": "or 2 spinal muscular atrophy",
            "probability": 1.789276201356124e-06,
            "start_logit": -6.137294292449951,
            "end_logit": 7.8209547996521
        },
        {
            "text": "1 or 2 spinal muscular atrophy",
            "probability": 1.5180553702101055e-06,
            "start_logit": -6.301675319671631,
            "end_logit": 7.8209547996521
        },
        {
            "text": "risdiplam for patients with Type 1 or 2 spinal muscular atrophy",
            "probability": 1.3189414364238023e-06,
            "start_logit": -6.4422760009765625,
            "end_logit": 7.8209547996521
        },
        {
            "text": "expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy",
            "probability": 1.0792898032864686e-06,
            "start_logit": -6.6428022384643555,
            "end_logit": 7.8209547996521
        },
        {
            "text": "atrophy",
            "probability": 7.779409934035568e-07,
            "start_logit": -6.970210075378418,
            "end_logit": 7.8209547996521
        },
        {
            "text": "2 spinal muscular atrophy",
            "probability": 7.382598513488041e-07,
            "start_logit": -7.022564888000488,
            "end_logit": 7.8209547996521
        },
        {
            "text": "with Type 1 or 2 spinal muscular atrophy",
            "probability": 6.525940443193407e-07,
            "start_logit": -7.145905494689941,
            "end_logit": 7.8209547996521
        },
        {
            "text": "for patients with Type 1 or 2 spinal muscular atrophy",
            "probability": 6.493397628919538e-07,
            "start_logit": -7.150904655456543,
            "end_logit": 7.8209547996521
        },
        {
            "text": "spinal muscular at",
            "probability": 5.010244546958442e-07,
            "start_logit": 7.088539123535156,
            "end_logit": -6.67779016494751
        },
        {
            "text": "An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy.",
            "probability": 3.839909090779789e-07,
            "start_logit": -2.761061668395996,
            "end_logit": 2.9057745933532715
        },
        {
            "text": "spinal muscular atrop",
            "probability": 3.241856723619013e-07,
            "start_logit": 7.088539123535156,
            "end_logit": -7.113128662109375
        },
        {
            "text": "spinal muscular",
            "probability": 1.7774186799722293e-07,
            "start_logit": 7.088539123535156,
            "end_logit": -7.714112758636475
        }
    ],
    "63f581e933942b094c000007_003": [
        {
            "text": "spinal muscular atrophy",
            "probability": 0.998581790590755,
            "start_logit": 6.662375450134277,
            "end_logit": 5.884997844696045
        },
        {
            "text": "Type 1 or 2 spinal muscular atrophy",
            "probability": 0.0009143409440218872,
            "start_logit": -0.3335123658180237,
            "end_logit": 5.884997844696045
        },
        {
            "text": "spinal muscular atrophy (SMA)",
            "probability": 0.0003453109670844841,
            "start_logit": 6.662375450134277,
            "end_logit": -2.0846481323242188
        },
        {
            "text": "spinal",
            "probability": 8.228915755181424e-05,
            "start_logit": 6.662375450134277,
            "end_logit": -3.5188541412353516
        },
        {
            "text": "spinal muscular atrophy (SMA) who had no satisfactory treatment options access to risdiplam prior to commercial availability.",
            "probability": 3.096422102377739e-05,
            "start_logit": 6.662375450134277,
            "end_logit": -4.496261119842529
        },
        {
            "text": "spinal muscular atrophy (SMA",
            "probability": 1.4825982685974695e-05,
            "start_logit": 6.662375450134277,
            "end_logit": -5.232712268829346
        },
        {
            "text": "atrophy",
            "probability": 1.0270867679695405e-05,
            "start_logit": -4.822404384613037,
            "end_logit": 5.884997844696045
        },
        {
            "text": "NCT04256265) was opened to provide individuals with Type 1 or 2 spinal muscular atrophy",
            "probability": 5.028431716440585e-06,
            "start_logit": -5.53660774230957,
            "end_logit": 5.884997844696045
        },
        {
            "text": "spinal muscular at",
            "probability": 4.248093937180643e-06,
            "start_logit": 6.662375450134277,
            "end_logit": -6.482623100280762
        },
        {
            "text": "EAP; NCT04256265) was opened to provide individuals with Type 1 or 2 spinal muscular atrophy",
            "probability": 2.376430967334043e-06,
            "start_logit": -6.286116123199463,
            "end_logit": 5.884997844696045
        },
        {
            "text": "spinal muscular atrop",
            "probability": 1.9587876725577843e-06,
            "start_logit": 6.662375450134277,
            "end_logit": -7.256767749786377
        },
        {
            "text": "or 2 spinal muscular atrophy",
            "probability": 1.4120335804183634e-06,
            "start_logit": -6.806684970855713,
            "end_logit": 5.884997844696045
        },
        {
            "text": "spinal muscular atrophy (SMA) who had no satisfactory treatment options",
            "probability": 1.3598600177032957e-06,
            "start_logit": 6.662375450134277,
            "end_logit": -7.621711730957031
        },
        {
            "text": "1 or 2 spinal muscular atrophy",
            "probability": 1.2415027715386296e-06,
            "start_logit": -6.935393333435059,
            "end_logit": 5.884997844696045
        },
        {
            "text": "(EAP; NCT04256265) was opened to provide individuals with Type 1 or 2 spinal muscular atrophy",
            "probability": 1.2269674462970785e-06,
            "start_logit": -6.947170257568359,
            "end_logit": 5.884997844696045
        },
        {
            "text": "with Type 1 or 2 spinal muscular atrophy",
            "probability": 9.448909186199764e-07,
            "start_logit": -7.208401679992676,
            "end_logit": 5.884997844696045
        },
        {
            "text": "Type 1 or 2 spinal muscular atrophy (SMA)",
            "probability": 3.161803655946429e-07,
            "start_logit": -0.3335123658180237,
            "end_logit": -2.0846481323242188
        },
        {
            "text": "Type 1 or 2 spinal",
            "probability": 7.534720411252432e-08,
            "start_logit": -0.3335123658180237,
            "end_logit": -3.5188541412353516
        },
        {
            "text": "Type 1 or 2 spinal muscular atrophy (SMA",
            "probability": 1.35752555603148e-08,
            "start_logit": -0.3335123658180237,
            "end_logit": -5.232712268829346
        },
        {
            "text": "Type 1 or 2",
            "probability": 5.1673436759286e-09,
            "start_logit": -0.3335123658180237,
            "end_logit": -6.198602199554443
        }
    ],
    "63f581e933942b094c000007_004": [
        {
            "text": "SMA",
            "probability": 0.9834243732088901,
            "start_logit": -0.6570480465888977,
            "end_logit": -0.18469876050949097
        },
        {
            "text": "SMA therapeutics are shifting the natural history of the disease.",
            "probability": 0.008237198820987368,
            "start_logit": -0.6570480465888977,
            "end_logit": -4.967079162597656
        },
        {
            "text": "SMA therapeutics are shifting the natural history of the disease. With three relatively new available therapies,",
            "probability": 0.0018092231084369565,
            "start_logit": -0.6570480465888977,
            "end_logit": -6.482841968536377
        },
        {
            "text": "Major advances and developments in SMA",
            "probability": 0.001655146160097884,
            "start_logit": -7.044199466705322,
            "end_logit": -0.18469876050949097
        },
        {
            "text": "motor neurons. Major advances and developments in SMA",
            "probability": 0.0015167754005634597,
            "start_logit": -7.131502151489258,
            "end_logit": -0.18469876050949097
        },
        {
            "text": "SMA therapeutics are shifting the natural history of the disease. With three relatively new available therapies",
            "probability": 0.0010857528305105862,
            "start_logit": -0.6570480465888977,
            "end_logit": -6.993465900421143
        },
        {
            "text": "SMN1 produces SMN, a ubiquitously expressed protein,",
            "probability": 0.0009069030440051071,
            "start_logit": -3.738706588745117,
            "end_logit": -4.091800689697266
        },
        {
            "text": "SMN1 produces SMN, a ubiquitously expressed protein, that is essential for the development and survival of motor neurons.",
            "probability": 0.0003799269197438708,
            "start_logit": -3.738706588745117,
            "end_logit": -4.961857318878174
        },
        {
            "text": "SMN1 produces SMN,",
            "probability": 0.00023425019308765513,
            "start_logit": -3.738706588745117,
            "end_logit": -5.445446491241455
        },
        {
            "text": "SMN, a ubiquitously expressed protein,",
            "probability": 0.00015700132240554793,
            "start_logit": -5.492487907409668,
            "end_logit": -4.091800689697266
        },
        {
            "text": "Evrysdi), patients survive longer and have improved outcomes.",
            "probability": 0.00012367136290304963,
            "start_logit": -4.853011131286621,
            "end_logit": -4.969903945922852
        },
        {
            "text": "SMN1 produces SMN",
            "probability": 7.998400834225427e-05,
            "start_logit": -3.738706588745117,
            "end_logit": -6.520009517669678
        },
        {
            "text": "Evrysdi),",
            "probability": 7.338481842320352e-05,
            "start_logit": -4.853011131286621,
            "end_logit": -5.491814613342285
        },
        {
            "text": "Evrysdi",
            "probability": 6.75097806175275e-05,
            "start_logit": -4.853011131286621,
            "end_logit": -5.575259208679199
        },
        {
            "text": "SMN, a ubiquitously expressed protein, that is essential for the development and survival of motor neurons.",
            "probability": 6.577222252318108e-05,
            "start_logit": -5.492487907409668,
            "end_logit": -4.961857318878174
        },
        {
            "text": "Evrysdi)",
            "probability": 5.033168165898577e-05,
            "start_logit": -4.853011131286621,
            "end_logit": -5.868896961212158
        },
        {
            "text": "SMN1",
            "probability": 4.1166585258377885e-05,
            "start_logit": -3.738706588745117,
            "end_logit": -7.18420934677124
        },
        {
            "text": "SMN,",
            "probability": 4.0552945909297986e-05,
            "start_logit": -5.492487907409668,
            "end_logit": -5.445446491241455
        },
        {
            "text": "risdiplam (Evrysdi), patients survive longer and have improved outcomes.",
            "probability": 3.1809585011550494e-05,
            "start_logit": -6.21087121963501,
            "end_logit": -4.969903945922852
        },
        {
            "text": "(Evrysdi), patients survive longer and have improved outcomes.",
            "probability": 1.926600062400112e-05,
            "start_logit": -6.712296962738037,
            "end_logit": -4.969903945922852
        }
    ],
    "6431f7de57b1c7a31500001b_001": [
        {
            "text": "frataxin",
            "probability": 0.9870163571945081,
            "start_logit": 8.081165313720703,
            "end_logit": 5.0937113761901855
        },
        {
            "text": "frataxin (FXN) gene",
            "probability": 0.008971861682923245,
            "start_logit": 8.081165313720703,
            "end_logit": 0.3931179642677307
        },
        {
            "text": "frataxin (FXN",
            "probability": 0.003248066538872968,
            "start_logit": 8.081165313720703,
            "end_logit": -0.6229153275489807
        },
        {
            "text": "frataxin (FXN)",
            "probability": 0.00046982644278521725,
            "start_logit": 8.081165313720703,
            "end_logit": -2.5563671588897705
        },
        {
            "text": "f",
            "probability": 0.0001782550155827265,
            "start_logit": 8.081165313720703,
            "end_logit": -3.52551531791687
        },
        {
            "text": "frataxin (FXN) gene,",
            "probability": 7.642717580243914e-05,
            "start_logit": 8.081165313720703,
            "end_logit": -4.372392177581787
        },
        {
            "text": "frataxin (FXN) gene, which leads to reduced expression of full-length frataxin",
            "probability": 1.0557269538273697e-05,
            "start_logit": 8.081165313720703,
            "end_logit": -6.3519158363342285
        },
        {
            "text": "frataxin (FXN) gene, which leads to reduced expression of full-length frataxin (1-210)",
            "probability": 1.0429607694668293e-05,
            "start_logit": 8.081165313720703,
            "end_logit": -6.364081859588623
        },
        {
            "text": "frataxin (FXN) gene, which leads to reduced expression of full-length frataxin (1-210",
            "probability": 4.95768595692056e-06,
            "start_logit": 8.081165313720703,
            "end_logit": -7.107791423797607
        },
        {
            "text": "FXN) gene",
            "probability": 4.655988221723087e-06,
            "start_logit": 0.5174710154533386,
            "end_logit": 0.3931179642677307
        },
        {
            "text": "frataxin (",
            "probability": 3.090080091771314e-06,
            "start_logit": 8.081165313720703,
            "end_logit": -7.580533504486084
        },
        {
            "text": "FXN",
            "probability": 1.6855988291872545e-06,
            "start_logit": 0.5174710154533386,
            "end_logit": -0.6229153275489807
        },
        {
            "text": "the frataxin",
            "probability": 1.0990388067534722e-06,
            "start_logit": -5.626840591430664,
            "end_logit": 5.0937113761901855
        },
        {
            "text": "guanine-adenine-adenine (GAA) triplet expansion in the frataxin",
            "probability": 8.500780319202064e-07,
            "start_logit": -5.883703708648682,
            "end_logit": 5.0937113761901855
        },
        {
            "text": "intronic guanine-adenine-adenine (GAA) triplet expansion in the frataxin",
            "probability": 6.380588294276911e-07,
            "start_logit": -6.1706013679504395,
            "end_logit": 5.0937113761901855
        },
        {
            "text": "an intronic guanine-adenine-adenine (GAA) triplet expansion in the frataxin",
            "probability": 6.316080883247404e-07,
            "start_logit": -6.180762767791748,
            "end_logit": 5.0937113761901855
        },
        {
            "text": "FXN)",
            "probability": 2.438185586415869e-07,
            "start_logit": 0.5174710154533386,
            "end_logit": -2.5563671588897705
        },
        {
            "text": "in the frataxin",
            "probability": 2.0425905474421047e-07,
            "start_logit": -7.309642791748047,
            "end_logit": 5.0937113761901855
        },
        {
            "text": "FXN) gene, which leads to reduced expression of full-length frataxin (1-210) also known as isoform 1.",
            "probability": 1.2319559475651892e-07,
            "start_logit": 0.5174710154533386,
            "end_logit": -3.239018201828003
        },
        {
            "text": "FXN) gene,",
            "probability": 3.9662228747130435e-08,
            "start_logit": 0.5174710154533386,
            "end_logit": -4.372392177581787
        }
    ],
    "6431f7de57b1c7a31500001b_002": [
        {
            "text": "frataxin",
            "probability": 0.9936994312537579,
            "start_logit": 7.516558647155762,
            "end_logit": 6.452728748321533
        },
        {
            "text": "frataxin (FXN",
            "probability": 0.003324957338584454,
            "start_logit": 7.516558647155762,
            "end_logit": 0.752750813961029
        },
        {
            "text": "frataxin (FXN) gene",
            "probability": 0.0027530265068083596,
            "start_logit": 7.516558647155762,
            "end_logit": 0.563994824886322
        },
        {
            "text": "frataxin (FXN)",
            "probability": 9.109907530060411e-05,
            "start_logit": 7.516558647155762,
            "end_logit": -2.8445136547088623
        },
        {
            "text": "frataxin (FXN) gene.",
            "probability": 7.175234672646412e-05,
            "start_logit": 7.516558647155762,
            "end_logit": -3.0832407474517822
        },
        {
            "text": "f",
            "probability": 3.415764989165324e-05,
            "start_logit": 7.516558647155762,
            "end_logit": -3.825474739074707
        },
        {
            "text": "FXN",
            "probability": 8.970081001662672e-06,
            "start_logit": 1.6012412309646606,
            "end_logit": 0.752750813961029
        },
        {
            "text": "FXN) gene",
            "probability": 7.427124095465495e-06,
            "start_logit": 1.6012412309646606,
            "end_logit": 0.563994824886322
        },
        {
            "text": "FRDA) is an inherited, multisystemic disorder predominantly caused by GAA hyper expansion in intron 1 of frataxin",
            "probability": 4.125975150923152e-06,
            "start_logit": -4.87532901763916,
            "end_logit": 6.452728748321533
        },
        {
            "text": "frataxin (FX",
            "probability": 1.3526635470575057e-06,
            "start_logit": 7.516558647155762,
            "end_logit": -7.054385662078857
        },
        {
            "text": "intron 1 of frataxin",
            "probability": 1.1059581716819662e-06,
            "start_logit": -6.191919326782227,
            "end_logit": 6.452728748321533
        },
        {
            "text": "GAA hyper expansion in intron 1 of frataxin",
            "probability": 7.019865432078984e-07,
            "start_logit": -6.646472454071045,
            "end_logit": 6.452728748321533
        },
        {
            "text": "(FRDA) is an inherited, multisystemic disorder predominantly caused by GAA hyper expansion in intron 1 of frataxin",
            "probability": 4.19683109021384e-07,
            "start_logit": -7.160886764526367,
            "end_logit": 6.452728748321533
        },
        {
            "text": "multisystemic disorder predominantly caused by GAA hyper expansion in intron 1 of frataxin",
            "probability": 3.7591423953824566e-07,
            "start_logit": -7.271025657653809,
            "end_logit": 6.452728748321533
        },
        {
            "text": "by GAA hyper expansion in intron 1 of frataxin",
            "probability": 2.877461146749187e-07,
            "start_logit": -7.538308143615723,
            "end_logit": 6.452728748321533
        },
        {
            "text": "an inherited, multisystemic disorder predominantly caused by GAA hyper expansion in intron 1 of frataxin",
            "probability": 2.772283064490828e-07,
            "start_logit": -7.575545310974121,
            "end_logit": 6.452728748321533
        },
        {
            "text": "FXN)",
            "probability": 2.457673892955515e-07,
            "start_logit": 1.6012412309646606,
            "end_logit": -2.8445136547088623
        },
        {
            "text": "FXN) gene.",
            "probability": 1.93573720398404e-07,
            "start_logit": 1.6012412309646606,
            "end_logit": -3.0832407474517822
        },
        {
            "text": "(FXN",
            "probability": 5.039831503510881e-08,
            "start_logit": -3.580451011657715,
            "end_logit": 0.752750813961029
        },
        {
            "text": "(FXN) gene",
            "probability": 4.172922629112664e-08,
            "start_logit": -3.580451011657715,
            "end_logit": 0.563994824886322
        }
    ],
    "6431f7de57b1c7a31500001b_003": [
        {
            "text": "frataxin",
            "probability": 0.9998338567458037,
            "start_logit": 7.83371114730835,
            "end_logit": 6.25242805480957
        },
        {
            "text": "frataxin.",
            "probability": 9.054444594919824e-05,
            "start_logit": 7.83371114730835,
            "end_logit": -3.0570755004882812
        },
        {
            "text": "f",
            "probability": 6.98618272152054e-05,
            "start_logit": 7.83371114730835,
            "end_logit": -3.316396951675415
        },
        {
            "text": "decreased expression of the mitochondrial protein frataxin",
            "probability": 2.3198549010699855e-06,
            "start_logit": -5.1401286125183105,
            "end_logit": 6.25242805480957
        },
        {
            "text": "mitochondrial protein frataxin",
            "probability": 1.1719874820478557e-06,
            "start_logit": -5.822932243347168,
            "end_logit": 6.25242805480957
        },
        {
            "text": "the mitochondrial protein frataxin",
            "probability": 1.0172290181268375e-06,
            "start_logit": -5.964550971984863,
            "end_logit": 6.25242805480957
        },
        {
            "text": "neuro- and cardio-degenerative disorder caused, in most cases, by decreased expression of the mitochondrial protein frataxin",
            "probability": 3.785634504971475e-07,
            "start_logit": -6.953004837036133,
            "end_logit": 6.25242805480957
        },
        {
            "text": "a neuro- and cardio-degenerative disorder caused, in most cases, by decreased expression of the mitochondrial protein frataxin",
            "probability": 2.3562389124221447e-07,
            "start_logit": -7.427151679992676,
            "end_logit": 6.25242805480957
        },
        {
            "text": "in most cases, by decreased expression of the mitochondrial protein frataxin",
            "probability": 2.071126590243502e-07,
            "start_logit": -7.556125640869141,
            "end_logit": 6.25242805480957
        },
        {
            "text": "most cases, by decreased expression of the mitochondrial protein frataxin",
            "probability": 2.039244274650075e-07,
            "start_logit": -7.571639060974121,
            "end_logit": 6.25242805480957
        },
        {
            "text": "by decreased expression of the mitochondrial protein frataxin",
            "probability": 2.018646873844328e-07,
            "start_logit": -7.581790924072266,
            "end_logit": 6.25242805480957
        },
        {
            "text": "decreased expression of the mitochondrial protein frataxin.",
            "probability": 2.100848808856817e-10,
            "start_logit": -5.1401286125183105,
            "end_logit": -3.0570755004882812
        },
        {
            "text": "decreased expression of the mitochondrial protein f",
            "probability": 1.6209623345861853e-10,
            "start_logit": -5.1401286125183105,
            "end_logit": -3.316396951675415
        },
        {
            "text": "mitochondrial protein frataxin.",
            "probability": 1.0613459076771197e-10,
            "start_logit": -5.822932243347168,
            "end_logit": -3.0570755004882812
        },
        {
            "text": "the mitochondrial protein frataxin.",
            "probability": 9.21197429236065e-11,
            "start_logit": -5.964550971984863,
            "end_logit": -3.0570755004882812
        },
        {
            "text": "mitochondrial protein f",
            "probability": 8.189079257197758e-11,
            "start_logit": -5.822932243347168,
            "end_logit": -3.316396951675415
        },
        {
            "text": "the mitochondrial protein f",
            "probability": 7.107728691441757e-11,
            "start_logit": -5.964550971984863,
            "end_logit": -3.316396951675415
        },
        {
            "text": "Friedreich ataxia, the most common hereditary ataxia,",
            "probability": 3.6377540956398254e-11,
            "start_logit": -4.073068618774414,
            "end_logit": -5.877695560455322
        },
        {
            "text": "neuro- and cardio-degenerative disorder caused, in most cases, by decreased expression of the mitochondrial protein frataxin.",
            "probability": 3.428251369026749e-11,
            "start_logit": -6.953004837036133,
            "end_logit": -3.0570755004882812
        },
        {
            "text": "neuro- and cardio-degenerative disorder caused, in most cases, by decreased expression of the mitochondrial protein f",
            "probability": 2.645152911174878e-11,
            "start_logit": -6.953004837036133,
            "end_logit": -3.316396951675415
        }
    ],
    "6431f7de57b1c7a31500001b_004": [
        {
            "text": "Frataxin",
            "probability": 0.9997646455130285,
            "start_logit": 3.007397174835205,
            "end_logit": 4.960185527801514
        },
        {
            "text": "Simultaneous Quantification of Mitochondrial Mature Frataxin",
            "probability": 9.02172897434044e-05,
            "start_logit": -6.305656909942627,
            "end_logit": 4.960185527801514
        },
        {
            "text": "Mitochondrial Mature Frataxin",
            "probability": 4.7836126845537946e-05,
            "start_logit": -6.940096855163574,
            "end_logit": 4.960185527801514
        },
        {
            "text": "Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich's Ataxia Blood.",
            "probability": 4.127286616725309e-05,
            "start_logit": 3.007397174835205,
            "end_logit": -5.134884357452393
        },
        {
            "text": "Quantification of Mitochondrial Mature Frataxin",
            "probability": 2.23049004780639e-05,
            "start_logit": -7.703071594238281,
            "end_logit": 4.960185527801514
        },
        {
            "text": "Frataxin and Extra-Mitochondrial Frataxin Isoform E",
            "probability": 1.346248468534548e-05,
            "start_logit": 3.007397174835205,
            "end_logit": -6.25518274307251
        },
        {
            "text": "Frataxin and Extra-Mitochondrial Frataxin",
            "probability": 1.0043591978296935e-05,
            "start_logit": 3.007397174835205,
            "end_logit": -6.548154830932617
        },
        {
            "text": "Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich's Ataxia Blood",
            "probability": 3.886483748609886e-06,
            "start_logit": 3.007397174835205,
            "end_logit": -7.497584819793701
        },
        {
            "text": "Fr",
            "probability": 3.578484978806028e-06,
            "start_logit": 3.007397174835205,
            "end_logit": -7.580150127410889
        },
        {
            "text": "Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich's Ataxia",
            "probability": 2.7385005053911595e-06,
            "start_logit": 3.007397174835205,
            "end_logit": -7.847679138183594
        },
        {
            "text": "Friedreich's Ataxia Blood.",
            "probability": 4.023521210388602e-09,
            "start_logit": -6.228405952453613,
            "end_logit": -5.134884357452393
        },
        {
            "text": "Frataxin Isoform E in Friedreich's Ataxia Blood.",
            "probability": 3.4638840601949467e-09,
            "start_logit": -6.378172874450684,
            "end_logit": -5.134884357452393
        },
        {
            "text": "Frataxin Isoform E",
            "probability": 1.1298581960170762e-09,
            "start_logit": -6.378172874450684,
            "end_logit": -6.25518274307251
        },
        {
            "text": "Simultaneous Quantification of Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin",
            "probability": 9.063189538029517e-10,
            "start_logit": -6.305656909942627,
            "end_logit": -6.548154830932617
        },
        {
            "text": "Ataxia Blood.",
            "probability": 8.246813614870252e-10,
            "start_logit": -7.813321590423584,
            "end_logit": -5.134884357452393
        },
        {
            "text": "Mitochondrial Frataxin Isoform E in Friedreich's Ataxia Blood.",
            "probability": 8.239930878680617e-10,
            "start_logit": -7.814156532287598,
            "end_logit": -5.134884357452393
        },
        {
            "text": "Extra-Mitochondrial Frataxin Isoform E in Friedreich's Ataxia Blood.",
            "probability": 8.211822960584494e-10,
            "start_logit": -7.817573547363281,
            "end_logit": -5.134884357452393
        },
        {
            "text": "Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin Isoform E",
            "probability": 6.441447274161548e-10,
            "start_logit": -6.940096855163574,
            "end_logit": -6.25518274307251
        },
        {
            "text": "in Friedreich's Ataxia Blood.",
            "probability": 6.396966216441267e-10,
            "start_logit": -8.0673246383667,
            "end_logit": -5.134884357452393
        },
        {
            "text": "Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin",
            "probability": 4.805596417265773e-10,
            "start_logit": -6.940096855163574,
            "end_logit": -6.548154830932617
        }
    ],
    "6431f7de57b1c7a31500001b_005": [
        {
            "text": "frataxin",
            "probability": 0.9999358019532371,
            "start_logit": 9.107388496398926,
            "end_logit": 9.727449417114258
        },
        {
            "text": "frataxin proteoforms in whole blood from healthy controls and FRDA patients.",
            "probability": 2.3224996682122352e-05,
            "start_logit": 9.107388496398926,
            "end_logit": -0.9427677989006042
        },
        {
            "text": "f",
            "probability": 1.8808313381044188e-05,
            "start_logit": 9.107388496398926,
            "end_logit": -1.1536979675292969
        },
        {
            "text": "We now report a quantitative assay for frataxin",
            "probability": 1.1188651945822552e-05,
            "start_logit": -2.2931578159332275,
            "end_logit": 9.727449417114258
        },
        {
            "text": "frataxin proteoforms in whole blood from healthy controls and FRDA",
            "probability": 8.741859012140606e-06,
            "start_logit": 9.107388496398926,
            "end_logit": -1.9198740720748901
        },
        {
            "text": "now report a quantitative assay for frataxin",
            "probability": 6.229214770292073e-07,
            "start_logit": -5.181392669677734,
            "end_logit": 9.727449417114258
        },
        {
            "text": "a quantitative assay for frataxin",
            "probability": 4.2207360954762277e-07,
            "start_logit": -5.570633411407471,
            "end_logit": 9.727449417114258
        },
        {
            "text": "frataxin proteoforms in whole blood",
            "probability": 2.6099385921875974e-07,
            "start_logit": 9.107388496398926,
            "end_logit": -5.431255340576172
        },
        {
            "text": "report a quantitative assay for frataxin",
            "probability": 2.450621705641713e-07,
            "start_logit": -6.1143012046813965,
            "end_logit": 9.727449417114258
        },
        {
            "text": "frataxin proteoforms in whole blood from healthy controls",
            "probability": 2.0427399072180586e-07,
            "start_logit": 9.107388496398926,
            "end_logit": -5.676290035247803
        },
        {
            "text": "frataxin proteoforms",
            "probability": 1.2969525809463296e-07,
            "start_logit": 9.107388496398926,
            "end_logit": -6.1305646896362305
        },
        {
            "text": "frataxin proteoforms in whole blood from healthy controls and FRDA patients",
            "probability": 1.287016712831565e-07,
            "start_logit": 9.107388496398926,
            "end_logit": -6.1382551193237305
        },
        {
            "text": "assay for frataxin",
            "probability": 1.199081891928682e-07,
            "start_logit": -6.829086780548096,
            "end_logit": 9.727449417114258
        },
        {
            "text": "frataxin proteoforms in whole blood from",
            "probability": 8.169903592123472e-08,
            "start_logit": 9.107388496398926,
            "end_logit": -6.592710018157959
        },
        {
            "text": "FRDA patients.",
            "probability": 1.3262757621526274e-08,
            "start_logit": 1.6393640041351318,
            "end_logit": -0.9427677989006042
        },
        {
            "text": "FRDA",
            "probability": 4.992084986122847e-09,
            "start_logit": 1.6393640041351318,
            "end_logit": -1.9198740720748901
        },
        {
            "text": "We now report a quantitative assay for frataxin proteoforms in whole blood from healthy controls and FRDA patients.",
            "probability": 2.598730876637848e-10,
            "start_logit": -2.2931578159332275,
            "end_logit": -0.9427677989006042
        },
        {
            "text": "We now report a quantitative assay for f",
            "probability": 2.1045318279173065e-10,
            "start_logit": -2.2931578159332275,
            "end_logit": -1.1536979675292969
        },
        {
            "text": "We now report a quantitative assay for frataxin proteoforms in whole blood from healthy controls and FRDA",
            "probability": 9.781589743585114e-11,
            "start_logit": -2.2931578159332275,
            "end_logit": -1.9198740720748901
        },
        {
            "text": "FRDA patients",
            "probability": 7.349577246776465e-11,
            "start_logit": 1.6393640041351318,
            "end_logit": -6.1382551193237305
        }
    ],
    "6431f7de57b1c7a31500001b_006": [
        {
            "text": "frataxin",
            "probability": 0.9997046203922543,
            "start_logit": 8.270708084106445,
            "end_logit": 7.295150279998779
        },
        {
            "text": "frataxin in whole blood from healthy controls and homozygous FRDA",
            "probability": 0.00018305190559298086,
            "start_logit": 8.270708084106445,
            "end_logit": -1.3102951049804688
        },
        {
            "text": "f",
            "probability": 0.00010431469094257974,
            "start_logit": 8.270708084106445,
            "end_logit": -1.8726526498794556
        },
        {
            "text": "frataxin in whole blood from healthy controls",
            "probability": 2.533236521649507e-06,
            "start_logit": 8.270708084106445,
            "end_logit": -5.590567111968994
        },
        {
            "text": "frataxin in whole blood from healthy controls and homozygous FRDA patients",
            "probability": 1.279564859174222e-06,
            "start_logit": 8.270708084106445,
            "end_logit": -6.273544788360596
        },
        {
            "text": "frataxin in whole blood from healthy controls and homozygous FRDA patients were significantly different (p < 0.0001",
            "probability": 1.2473314351346786e-06,
            "start_logit": 8.270708084106445,
            "end_logit": -6.299058437347412
        },
        {
            "text": "frataxin in whole blood from healthy controls and homozygous",
            "probability": 1.2120813034188962e-06,
            "start_logit": 8.270708084106445,
            "end_logit": -6.327725887298584
        },
        {
            "text": "frataxin in whole blood",
            "probability": 6.540325271450467e-07,
            "start_logit": 8.270708084106445,
            "end_logit": -6.944663047790527
        },
        {
            "text": "The mean levels of mature frataxin",
            "probability": 6.069050356932961e-07,
            "start_logit": -6.043889999389648,
            "end_logit": 7.295150279998779
        },
        {
            "text": "mature frataxin",
            "probability": 3.7585804963215916e-07,
            "start_logit": -6.523050785064697,
            "end_logit": 7.295150279998779
        },
        {
            "text": "FRDA",
            "probability": 1.0020710705038705e-07,
            "start_logit": 0.7604221701622009,
            "end_logit": -1.3102951049804688
        },
        {
            "text": "FRDA patients were significantly different (p < 0.0001) at 7.5 \u00b1 1.5 ng/mL",
            "probability": 9.309408284049011e-10,
            "start_logit": 0.7604221701622009,
            "end_logit": -5.989093780517578
        },
        {
            "text": "FRDA patients were significantly different (p < 0.0001) at 7.5 \u00b1 1.5",
            "probability": 7.781191599760865e-10,
            "start_logit": 0.7604221701622009,
            "end_logit": -6.168409824371338
        },
        {
            "text": "FRDA patients",
            "probability": 7.004652172607668e-10,
            "start_logit": 0.7604221701622009,
            "end_logit": -6.273544788360596
        },
        {
            "text": "FRDA patients were significantly different (p < 0.0001",
            "probability": 6.828198496101669e-10,
            "start_logit": 0.7604221701622009,
            "end_logit": -6.299058437347412
        },
        {
            "text": "homozygous FRDA",
            "probability": 3.819446166984339e-10,
            "start_logit": -4.809296607971191,
            "end_logit": -1.3102951049804688
        },
        {
            "text": "The mean levels of mature frataxin in whole blood from healthy controls and homozygous FRDA",
            "probability": 1.111279482273909e-10,
            "start_logit": -6.043889999389648,
            "end_logit": -1.3102951049804688
        },
        {
            "text": "healthy controls and homozygous FRDA",
            "probability": 7.680368616135386e-11,
            "start_logit": -6.4133195877075195,
            "end_logit": -1.3102951049804688
        },
        {
            "text": "mature frataxin in whole blood from healthy controls and homozygous FRDA",
            "probability": 6.882186079187295e-11,
            "start_logit": -6.523050785064697,
            "end_logit": -1.3102951049804688
        },
        {
            "text": "The mean levels of mature f",
            "probability": 6.332781697557915e-11,
            "start_logit": -6.043889999389648,
            "end_logit": -1.8726526498794556
        }
    ],
    "6431f7de57b1c7a31500001b_007": [
        {
            "text": "frataxin",
            "probability": 0.9997709570461936,
            "start_logit": 8.280465126037598,
            "end_logit": 7.907372951507568
        },
        {
            "text": "frataxin in whole blood from healthy controls and homozygous FRDA",
            "probability": 0.00015794563485373026,
            "start_logit": 8.280465126037598,
            "end_logit": -0.8456576466560364
        },
        {
            "text": "f",
            "probability": 6.43739283581526e-05,
            "start_logit": 8.280465126037598,
            "end_logit": -1.7431998252868652
        },
        {
            "text": "frataxin in whole blood from healthy controls",
            "probability": 1.7911941170950346e-06,
            "start_logit": 8.280465126037598,
            "end_logit": -5.325026035308838
        },
        {
            "text": "frataxin in whole blood from healthy controls and homozygous FRDA patients were significantly different (p < 0.0001",
            "probability": 8.20936207745969e-07,
            "start_logit": 8.280465126037598,
            "end_logit": -6.105218410491943
        },
        {
            "text": "frataxin in whole blood from healthy controls and homozygous FRDA patients",
            "probability": 8.145297649862557e-07,
            "start_logit": 8.280465126037598,
            "end_logit": -6.113052845001221
        },
        {
            "text": "he mean levels of total frataxin",
            "probability": 8.005942260420849e-07,
            "start_logit": -5.7572174072265625,
            "end_logit": 7.907372951507568
        },
        {
            "text": "frataxin in whole blood from healthy controls and homozygous",
            "probability": 7.669435046168695e-07,
            "start_logit": 8.280465126037598,
            "end_logit": -6.173250675201416
        },
        {
            "text": "frataxin in whole blood",
            "probability": 5.560583652453213e-07,
            "start_logit": 8.280465126037598,
            "end_logit": -6.494790554046631
        },
        {
            "text": "frataxin in whole blood from healthy controls and homozygous FRDA patients were significantly different (p < 0.0001)",
            "probability": 3.9585750385076693e-07,
            "start_logit": 8.280465126037598,
            "end_logit": -6.834609508514404
        },
        {
            "text": "total frataxin",
            "probability": 3.8284598919202716e-07,
            "start_logit": -6.494938850402832,
            "end_logit": 7.907372951507568
        },
        {
            "text": "mean levels of total frataxin",
            "probability": 2.403568771888296e-07,
            "start_logit": -6.960446834564209,
            "end_logit": 7.907372951507568
        },
        {
            "text": "FRDA",
            "probability": 1.4962109344749466e-07,
            "start_logit": 1.318565011024475,
            "end_logit": -0.8456576466560364
        },
        {
            "text": "FRDA patients were significantly different (p < 0.0001) at 34.2 \u00b1 4.3",
            "probability": 9.577464150049223e-10,
            "start_logit": 1.318565011024475,
            "end_logit": -5.896935939788818
        },
        {
            "text": "FRDA patients were significantly different (p < 0.0001) at 34.2 \u00b1 4.3 ng/mL",
            "probability": 9.239792366066764e-10,
            "start_logit": 1.318565011024475,
            "end_logit": -5.9328293800354
        },
        {
            "text": "FRDA patients were significantly different (p < 0.0001",
            "probability": 7.776686780064603e-10,
            "start_logit": 1.318565011024475,
            "end_logit": -6.105218410491943
        },
        {
            "text": "FRDA patients",
            "probability": 7.715998874906302e-10,
            "start_logit": 1.318565011024475,
            "end_logit": -6.113052845001221
        },
        {
            "text": "homozygous FRDA",
            "probability": 5.204776764671855e-10,
            "start_logit": -4.3425493240356445,
            "end_logit": -0.8456576466560364
        },
        {
            "text": "FRDA patients were significantly different (p < 0.0001)",
            "probability": 3.749937922019676e-10,
            "start_logit": 1.318565011024475,
            "end_logit": -6.834609508514404
        },
        {
            "text": "he mean levels of total frataxin in whole blood from healthy controls and homozygous FRDA",
            "probability": 1.2647933249235746e-10,
            "start_logit": -5.7572174072265625,
            "end_logit": -0.8456576466560364
        }
    ],
    "643f9eeb57b1c7a31500003c_001": [
        {
            "text": "1:5,000 live male births",
            "probability": 0.7812975603660675,
            "start_logit": 9.169906616210938,
            "end_logit": 6.639663219451904
        },
        {
            "text": "1:5,000",
            "probability": 0.211973085480005,
            "start_logit": 9.169906616210938,
            "end_logit": 5.3351664543151855
        },
        {
            "text": "5,000 live male births",
            "probability": 0.003052899817478165,
            "start_logit": 3.62504243850708,
            "end_logit": 6.639663219451904
        },
        {
            "text": "1",
            "probability": 0.0017647637325455966,
            "start_logit": 9.169906616210938,
            "end_logit": 0.5467239618301392
        },
        {
            "text": "5,000",
            "probability": 0.0008282792969031985,
            "start_logit": 3.62504243850708,
            "end_logit": 5.3351664543151855
        },
        {
            "text": "1:5,000 live male births.",
            "probability": 0.0007024881943209502,
            "start_logit": 9.169906616210938,
            "end_logit": -0.37441954016685486
        },
        {
            "text": "overall incidence of 1:5,000 live male births",
            "probability": 0.0002066939463022148,
            "start_logit": 0.9324344396591187,
            "end_logit": 6.639663219451904
        },
        {
            "text": "overall incidence of 1:5,000",
            "probability": 5.607793466959072e-05,
            "start_logit": 0.9324344396591187,
            "end_logit": 5.3351664543151855
        },
        {
            "text": "1:",
            "probability": 4.653225195248811e-05,
            "start_logit": 9.169906616210938,
            "end_logit": -3.088902473449707
        },
        {
            "text": "1:5",
            "probability": 2.767124743494552e-05,
            "start_logit": 9.169906616210938,
            "end_logit": -3.608654260635376
        },
        {
            "text": "1:5,000 live male",
            "probability": 1.245889450716809e-05,
            "start_logit": 9.169906616210938,
            "end_logit": -4.406613349914551
        },
        {
            "text": "an overall incidence of 1:5,000 live male births",
            "probability": 5.80939813761699e-06,
            "start_logit": -2.6393277645111084,
            "end_logit": 6.639663219451904
        },
        {
            "text": "incidence of 1:5,000 live male births",
            "probability": 5.4098031601909025e-06,
            "start_logit": -2.710592031478882,
            "end_logit": 6.639663219451904
        },
        {
            "text": "births",
            "probability": 4.710789637653836e-06,
            "start_logit": -2.8489491939544678,
            "end_logit": 6.639663219451904
        },
        {
            "text": "000 live male births",
            "probability": 3.897007006968807e-06,
            "start_logit": -3.0385959148406982,
            "end_logit": 6.639663219451904
        },
        {
            "text": "with an overall incidence of 1:5,000 live male births",
            "probability": 2.945058686367885e-06,
            "start_logit": -3.318675994873047,
            "end_logit": 6.639663219451904
        },
        {
            "text": "1:5,",
            "probability": 2.9279562537084e-06,
            "start_logit": 9.169906616210938,
            "end_logit": -5.854743480682373
        },
        {
            "text": "5,000 live male births.",
            "probability": 2.7449542773666874e-06,
            "start_logit": 3.62504243850708,
            "end_logit": -0.37441954016685486
        },
        {
            "text": "an overall incidence of 1:5,000",
            "probability": 1.576142190224546e-06,
            "start_logit": -2.6393277645111084,
            "end_logit": 5.3351664543151855
        },
        {
            "text": "incidence of 1:5,000",
            "probability": 1.467728463362742e-06,
            "start_logit": -2.710592031478882,
            "end_logit": 5.3351664543151855
        }
    ],
    "643f9eeb57b1c7a31500003c_002": [
        {
            "text": "19.7",
            "probability": 0.9237975726854795,
            "start_logit": 8.455727577209473,
            "end_logit": 7.336896896362305
        },
        {
            "text": "19.7 per 100,000 male live births",
            "probability": 0.03756917268962036,
            "start_logit": 8.455727577209473,
            "end_logit": 4.13458776473999
        },
        {
            "text": "The cumulative incidence of disease was 19.7",
            "probability": 0.02349616733104896,
            "start_logit": 4.784071922302246,
            "end_logit": 7.336896896362305
        },
        {
            "text": "7",
            "probability": 0.007913543915718541,
            "start_logit": 3.695810317993164,
            "end_logit": 7.336896896362305
        },
        {
            "text": "19",
            "probability": 0.0025500107970571704,
            "start_logit": 8.455727577209473,
            "end_logit": 1.444501519203186
        },
        {
            "text": "19.7 per 100,000 male live births and 1 in 5076 live born males were diagnosed with DMD.",
            "probability": 0.0018130235965396163,
            "start_logit": 8.455727577209473,
            "end_logit": 1.1033998727798462
        },
        {
            "text": "The cumulative incidence of disease was 19.7 per 100,000 male live births",
            "probability": 0.0009555465332500214,
            "start_logit": 4.784071922302246,
            "end_logit": 4.13458776473999
        },
        {
            "text": "19.7 per 100,000 male live births and 1 in 5076",
            "probability": 0.000536696915992184,
            "start_logit": 8.455727577209473,
            "end_logit": -0.11391782015562057
        },
        {
            "text": "19.7 per 100,000",
            "probability": 0.0005255454557973155,
            "start_logit": 8.455727577209473,
            "end_logit": -0.13491466641426086
        },
        {
            "text": "7 per 100,000 male live births",
            "probability": 0.00032182948596872564,
            "start_logit": 3.695810317993164,
            "end_logit": 4.13458776473999
        },
        {
            "text": ".7",
            "probability": 0.0001316509886673411,
            "start_logit": -0.40036627650260925,
            "end_logit": 7.336896896362305
        },
        {
            "text": "19.7 per",
            "probability": 0.00012713368328275118,
            "start_logit": 8.455727577209473,
            "end_logit": -1.554112195968628
        },
        {
            "text": "The cumulative incidence of disease was 19",
            "probability": 6.485780235323904e-05,
            "start_logit": 4.784071922302246,
            "end_logit": 1.444501519203186
        },
        {
            "text": "cumulative incidence of disease was 19.7",
            "probability": 4.295085221818571e-05,
            "start_logit": -1.5204641819000244,
            "end_logit": 7.336896896362305
        },
        {
            "text": "1 in 5076 live born males were diagnosed with DMD.",
            "probability": 3.934888283715607e-05,
            "start_logit": 4.625443935394287,
            "end_logit": 1.1033998727798462
        },
        {
            "text": "19.",
            "probability": 2.9861804250185483e-05,
            "start_logit": 8.455727577209473,
            "end_logit": -3.0027711391448975
        },
        {
            "text": "19.7 per 100,000 male live births and",
            "probability": 2.8154186653202997e-05,
            "start_logit": 8.455727577209473,
            "end_logit": -3.061655282974243
        },
        {
            "text": "19.7 per 100,000 male live births and 1 in",
            "probability": 2.5606701972246578e-05,
            "start_logit": 8.455727577209473,
            "end_logit": -3.1564972400665283
        },
        {
            "text": "19.7 per 100,000 male live births and 1 in 5076 live born males were diagnosed with DMD",
            "probability": 1.5794754348206836e-05,
            "start_logit": 8.455727577209473,
            "end_logit": -3.6396734714508057
        },
        {
            "text": "7 per 100,000 male live births and 1 in 5076 live born males were diagnosed with DMD.",
            "probability": 1.553093694513855e-05,
            "start_logit": 3.695810317993164,
            "end_logit": 1.1033998727798462
        }
    ],
    "6415c252690f196b51000011_001": [
        {
            "text": "Cancer",
            "probability": 0.9139311071361613,
            "start_logit": 2.217097759246826,
            "end_logit": 8.807268142700195
        },
        {
            "text": "Non-muscle Invasive Bladder Cancer",
            "probability": 0.06228338923925116,
            "start_logit": -0.4689626693725586,
            "end_logit": 8.807268142700195
        },
        {
            "text": "Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer",
            "probability": 0.01792849760158881,
            "start_logit": -1.7142659425735474,
            "end_logit": 8.807268142700195
        },
        {
            "text": "Bladder Cancer",
            "probability": 0.004165116280886106,
            "start_logit": -3.1739132404327393,
            "end_logit": 8.807268142700195
        },
        {
            "text": "Treatment of Non-muscle Invasive Bladder Cancer",
            "probability": 0.0008884477092829672,
            "start_logit": -4.718936920166016,
            "end_logit": 8.807268142700195
        },
        {
            "text": "the Treatment of Non-muscle Invasive Bladder Cancer",
            "probability": 0.0003050509728608093,
            "start_logit": -5.787933826446533,
            "end_logit": 8.807268142700195
        },
        {
            "text": "Invasive Bladder Cancer",
            "probability": 0.0001652154807277297,
            "start_logit": -6.401162147521973,
            "end_logit": 8.807268142700195
        },
        {
            "text": "muscle Invasive Bladder Cancer",
            "probability": 0.0001313891709491685,
            "start_logit": -6.6302490234375,
            "end_logit": 8.807268142700195
        },
        {
            "text": "for the Treatment of Non-muscle Invasive Bladder Cancer",
            "probability": 0.0001198778881959222,
            "start_logit": -6.7219390869140625,
            "end_logit": 8.807268142700195
        },
        {
            "text": "Bladder Cancer:",
            "probability": 7.661918577476492e-05,
            "start_logit": -7.169565200805664,
            "end_logit": 8.807268142700195
        },
        {
            "text": "Cancer: History and Current Status.",
            "probability": 3.765387730561767e-06,
            "start_logit": 2.217097759246826,
            "end_logit": -3.5923914909362793
        },
        {
            "text": "Non-muscle Invasive Bladder",
            "probability": 5.733467911166854e-07,
            "start_logit": -0.4689626693725586,
            "end_logit": -2.7884464263916016
        },
        {
            "text": "Non-muscle Invasive Bladder Cancer: History and Current Status.",
            "probability": 2.5660698911339183e-07,
            "start_logit": -0.4689626693725586,
            "end_logit": -3.5923914909362793
        },
        {
            "text": "Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder",
            "probability": 1.6503993592783042e-07,
            "start_logit": -1.7142659425735474,
            "end_logit": -2.7884464263916016
        },
        {
            "text": "Cancer:",
            "probability": 1.4807212954972843e-07,
            "start_logit": 2.217097759246826,
            "end_logit": -6.828298091888428
        },
        {
            "text": "Cancer: History and Current Status",
            "probability": 1.34268569159238e-07,
            "start_logit": 2.217097759246826,
            "end_logit": -6.9261555671691895
        },
        {
            "text": "Cancer: History and",
            "probability": 8.624867028284458e-08,
            "start_logit": 2.217097759246826,
            "end_logit": -7.368762969970703
        },
        {
            "text": "Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer: History and Current Status.",
            "probability": 7.38652447315933e-08,
            "start_logit": -1.7142659425735474,
            "end_logit": -3.5923914909362793
        },
        {
            "text": "Cancer: History",
            "probability": 4.815647997542475e-08,
            "start_logit": 2.217097759246826,
            "end_logit": -7.951541900634766
        },
        {
            "text": "Bladder",
            "probability": 3.8341780745113214e-08,
            "start_logit": -3.1739132404327393,
            "end_logit": -2.7884464263916016
        }
    ],
    "6415c252690f196b51000011_002": [
        {
            "text": "bladder cancer",
            "probability": 0.9735375447225663,
            "start_logit": 7.668552398681641,
            "end_logit": 8.736920356750488
        },
        {
            "text": "bladder",
            "probability": 0.02384894122517165,
            "start_logit": 7.668552398681641,
            "end_logit": 5.027723789215088
        },
        {
            "text": "cancer",
            "probability": 0.0024716003790027697,
            "start_logit": 1.6924818754196167,
            "end_logit": 8.736920356750488
        },
        {
            "text": "non-muscle invasive bladder cancer",
            "probability": 0.00011722159642582805,
            "start_logit": -1.3560731410980225,
            "end_logit": 8.736920356750488
        },
        {
            "text": "bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer",
            "probability": 5.719655374737915e-06,
            "start_logit": -4.376230716705322,
            "end_logit": 8.736920356750488
        },
        {
            "text": "In the past decades, the bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer",
            "probability": 4.315197497329773e-06,
            "start_logit": -4.65799617767334,
            "end_logit": 8.736920356750488
        },
        {
            "text": "non-muscle invasive bladder",
            "probability": 2.8716005650065022e-06,
            "start_logit": -1.3560731410980225,
            "end_logit": 5.027723789215088
        },
        {
            "text": "bladder cancer, especially for intermediate and high-risk groups, is increasingly accepted by multiple guidelines.",
            "probability": 2.6692966490810234e-06,
            "start_logit": 7.668552398681641,
            "end_logit": -4.069956302642822
        },
        {
            "text": "the bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer",
            "probability": 2.387978776467604e-06,
            "start_logit": -5.249691963195801,
            "end_logit": 8.736920356750488
        },
        {
            "text": "BCG) treatment for non-muscle invasive bladder cancer",
            "probability": 2.141026643875936e-06,
            "start_logit": -5.358853816986084,
            "end_logit": 8.736920356750488
        },
        {
            "text": "bladder cancer, especially for intermediate and high-risk groups,",
            "probability": 1.2477902463449456e-06,
            "start_logit": 7.668552398681641,
            "end_logit": -4.830397129058838
        },
        {
            "text": "bladder cancer,",
            "probability": 9.514534805592867e-07,
            "start_logit": 7.668552398681641,
            "end_logit": -5.101535797119141
        },
        {
            "text": "(BCG) treatment for non-muscle invasive bladder cancer",
            "probability": 4.891515236685655e-07,
            "start_logit": -6.835222244262695,
            "end_logit": 8.736920356750488
        },
        {
            "text": "the past decades, the bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer",
            "probability": 4.4129501790778585e-07,
            "start_logit": -6.938180923461914,
            "end_logit": 8.736920356750488
        },
        {
            "text": "past decades, the bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer",
            "probability": 4.1035148782544225e-07,
            "start_logit": -7.010880470275879,
            "end_logit": 8.736920356750488
        },
        {
            "text": "muscle invasive bladder cancer",
            "probability": 3.5904841388442277e-07,
            "start_logit": -7.144437313079834,
            "end_logit": 8.736920356750488
        },
        {
            "text": "bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder cancer,",
            "probability": 3.3530422611283614e-07,
            "start_logit": -7.212856292724609,
            "end_logit": 8.736920356750488
        },
        {
            "text": "bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder",
            "probability": 1.401155256926783e-07,
            "start_logit": -4.376230716705322,
            "end_logit": 5.027723789215088
        },
        {
            "text": "bladder cancer, especially for intermediate and high-risk groups",
            "probability": 1.0710116110791269e-07,
            "start_logit": 7.668552398681641,
            "end_logit": -7.285752773284912
        },
        {
            "text": "In the past decades, the bacillus Calmette-Guerin (BCG) treatment for non-muscle invasive bladder",
            "probability": 1.0571024409557121e-07,
            "start_logit": -4.65799617767334,
            "end_logit": 5.027723789215088
        }
    ],
    "63eeed0af36125a426000007_001": [
        {
            "text": "Multiple Myeloma",
            "probability": 0.9997909086659025,
            "start_logit": 8.490416526794434,
            "end_logit": 9.110527038574219
        },
        {
            "text": "Myeloma.",
            "probability": 6.98625822335429e-05,
            "start_logit": -1.0783547163009644,
            "end_logit": 9.110527038574219
        },
        {
            "text": "Multiple Myeloma.",
            "probability": 5.756468897541142e-05,
            "start_logit": 8.490416526794434,
            "end_logit": -0.6518650650978088
        },
        {
            "text": "Multiple",
            "probability": 5.688083643302101e-05,
            "start_logit": 8.490416526794434,
            "end_logit": -0.6638159155845642
        },
        {
            "text": "Relapsed or Refractory Multiple Myeloma",
            "probability": 1.7436780687774393e-05,
            "start_logit": -2.4663031101226807,
            "end_logit": 9.110527038574219
        },
        {
            "text": "Teclistamab in Relapsed or Refractory Multiple Myeloma",
            "probability": 5.111342672578296e-06,
            "start_logit": -3.693422794342041,
            "end_logit": 9.110527038574219
        },
        {
            "text": "in Relapsed or Refractory Multiple Myeloma",
            "probability": 4.7150984705519573e-07,
            "start_logit": -6.076700210571289,
            "end_logit": 9.110527038574219
        },
        {
            "text": "or Refractory Multiple Myeloma",
            "probability": 3.317125456483248e-07,
            "start_logit": -6.428371429443359,
            "end_logit": 9.110527038574219
        },
        {
            "text": "Refractory Multiple Myeloma",
            "probability": 3.0932074406805573e-07,
            "start_logit": -6.498261451721191,
            "end_logit": 9.110527038574219
        },
        {
            "text": "Myeloma",
            "probability": 2.8464632135319103e-07,
            "start_logit": -6.581392765045166,
            "end_logit": 9.110527038574219
        },
        {
            "text": "Multiple Myelo",
            "probability": 2.801118497879328e-07,
            "start_logit": 8.490416526794434,
            "end_logit": -5.9773406982421875
        },
        {
            "text": "Relapsed or Refractory Multiple Myeloma.",
            "probability": 2.45746384798878e-07,
            "start_logit": -6.728340148925781,
            "end_logit": 9.110527038574219
        },
        {
            "text": "Refractory Multiple Myeloma.",
            "probability": 1.627348981886727e-07,
            "start_logit": -7.140517711639404,
            "end_logit": 9.110527038574219
        },
        {
            "text": "Multiple My",
            "probability": 1.4767031285921036e-07,
            "start_logit": 8.490416526794434,
            "end_logit": -6.617547512054443
        },
        {
            "text": "Relapsed or Refractory Multiple",
            "probability": 9.920260942792672e-10,
            "start_logit": -2.4663031101226807,
            "end_logit": -0.6638159155845642
        },
        {
            "text": "Teclistamab in Relapsed or Refractory Multiple Myeloma.",
            "probability": 2.9429438559942017e-10,
            "start_logit": -3.693422794342041,
            "end_logit": -0.6518650650978088
        },
        {
            "text": "Teclistamab in Relapsed or Refractory Multiple",
            "probability": 2.907982499060726e-10,
            "start_logit": -3.693422794342041,
            "end_logit": -0.6638159155845642
        },
        {
            "text": "in Relapsed or Refractory Multiple Myeloma.",
            "probability": 2.7147994104881613e-11,
            "start_logit": -6.076700210571289,
            "end_logit": -0.6518650650978088
        },
        {
            "text": "in Relapsed or Refractory Multiple",
            "probability": 2.682548346303044e-11,
            "start_logit": -6.076700210571289,
            "end_logit": -0.6638159155845642
        },
        {
            "text": "or Refractory Multiple Myeloma.",
            "probability": 1.9098922938764872e-11,
            "start_logit": -6.428371429443359,
            "end_logit": -0.6518650650978088
        }
    ],
    "63eeed0af36125a426000007_002": [
        {
            "text": "multiple myeloma",
            "probability": 0.9997365310960793,
            "start_logit": 8.46584415435791,
            "end_logit": 9.269671440124512
        },
        {
            "text": "myeloma.",
            "probability": 0.00021890156882935536,
            "start_logit": 0.03921927139163017,
            "end_logit": 9.269671440124512
        },
        {
            "text": "multiple",
            "probability": 3.643335167153843e-05,
            "start_logit": 8.46584415435791,
            "end_logit": -0.9500910043716431
        },
        {
            "text": "relapsed or refractory multiple myeloma",
            "probability": 1.8012467022736971e-06,
            "start_logit": -4.760923862457275,
            "end_logit": 9.269671440124512
        },
        {
            "text": "multiple myeloma.",
            "probability": 1.4608699734540485e-06,
            "start_logit": 8.46584415435791,
            "end_logit": -4.166543483734131
        },
        {
            "text": "myeloma",
            "probability": 1.015081946177801e-06,
            "start_logit": -5.334433555603027,
            "end_logit": 9.269671440124512
        },
        {
            "text": "teclistamab showed promising efficacy in patients with relapsed or refractory multiple myeloma",
            "probability": 9.62347493475565e-07,
            "start_logit": -5.387782573699951,
            "end_logit": 9.269671440124512
        },
        {
            "text": "patients with relapsed or refractory multiple myeloma",
            "probability": 6.668252983969768e-07,
            "start_logit": -5.754630088806152,
            "end_logit": 9.269671440124512
        },
        {
            "text": "multiple myelo",
            "probability": 3.965646212804793e-07,
            "start_logit": 8.46584415435791,
            "end_logit": -5.470491886138916
        },
        {
            "text": "or refractory multiple myeloma",
            "probability": 3.4934781617141867e-07,
            "start_logit": -6.401090145111084,
            "end_logit": 9.269671440124512
        },
        {
            "text": "in patients with relapsed or refractory multiple myeloma",
            "probability": 3.3420006849768474e-07,
            "start_logit": -6.445418357849121,
            "end_logit": 9.269671440124512
        },
        {
            "text": "promising efficacy in patients with relapsed or refractory multiple myeloma",
            "probability": 2.6828362680588026e-07,
            "start_logit": -6.66511344909668,
            "end_logit": 9.269671440124512
        },
        {
            "text": "showed promising efficacy in patients with relapsed or refractory multiple myeloma",
            "probability": 2.4562664737434523e-07,
            "start_logit": -6.753345489501953,
            "end_logit": 9.269671440124512
        },
        {
            "text": "refractory multiple myeloma",
            "probability": 1.860203736970669e-07,
            "start_logit": -7.031301975250244,
            "end_logit": 9.269671440124512
        },
        {
            "text": "efficacy in patients with relapsed or refractory multiple myeloma",
            "probability": 1.74545353762789e-07,
            "start_logit": -7.094973564147949,
            "end_logit": 9.269671440124512
        },
        {
            "text": "with relapsed or refractory multiple myeloma",
            "probability": 1.7090102206205832e-07,
            "start_logit": -7.1160736083984375,
            "end_logit": 9.269671440124512
        },
        {
            "text": "multiple my",
            "probability": 1.0199746135533551e-07,
            "start_logit": 8.46584415435791,
            "end_logit": -6.828382968902588
        },
        {
            "text": "relapsed or refractory multiple",
            "probability": 6.564274937436449e-11,
            "start_logit": -4.760923862457275,
            "end_logit": -0.9500910043716431
        },
        {
            "text": "teclistamab showed promising efficacy in patients with relapsed or refractory multiple",
            "probability": 3.507078472122893e-11,
            "start_logit": -5.387782573699951,
            "end_logit": -0.9500910043716431
        },
        {
            "text": "patients with relapsed or refractory multiple",
            "probability": 2.4301083179725055e-11,
            "start_logit": -5.754630088806152,
            "end_logit": -0.9500910043716431
        }
    ],
    "63eeed0af36125a426000007_003": [
        {
            "text": "multiple myeloma",
            "probability": 0.9997334412750882,
            "start_logit": 9.010601997375488,
            "end_logit": 9.496163368225098
        },
        {
            "text": "myeloma.",
            "probability": 0.0001831200195255974,
            "start_logit": 0.40549981594085693,
            "end_logit": 9.496163368225098
        },
        {
            "text": "multiple",
            "probability": 7.839913497829271e-05,
            "start_logit": 9.010601997375488,
            "end_logit": 0.042732298374176025
        },
        {
            "text": "multiple myeloma.",
            "probability": 2.0108995849971474e-06,
            "start_logit": 9.010601997375488,
            "end_logit": -3.6204984188079834
        },
        {
            "text": "myeloma",
            "probability": 1.0564253263173084e-06,
            "start_logit": -4.749751091003418,
            "end_logit": 9.496163368225098
        },
        {
            "text": "multiple myelo",
            "probability": 4.7595754040677614e-07,
            "start_logit": 9.010601997375488,
            "end_logit": -5.061507225036621
        },
        {
            "text": "patients with triple-class-exposed relapsed or refractory multiple myeloma",
            "probability": 3.821196173377897e-07,
            "start_logit": -5.766663551330566,
            "end_logit": 9.496163368225098
        },
        {
            "text": "triple-class-exposed relapsed or refractory multiple myeloma",
            "probability": 2.520608143711782e-07,
            "start_logit": -6.182726860046387,
            "end_logit": 9.496163368225098
        },
        {
            "text": "relapsed or refractory multiple myeloma",
            "probability": 2.172080623996074e-07,
            "start_logit": -6.331541538238525,
            "end_logit": 9.496163368225098
        },
        {
            "text": "or refractory multiple myeloma",
            "probability": 1.242480039487926e-07,
            "start_logit": -6.890117645263672,
            "end_logit": 9.496163368225098
        },
        {
            "text": "multiple my",
            "probability": 1.1128637695718446e-07,
            "start_logit": 9.010601997375488,
            "end_logit": -6.514729022979736
        },
        {
            "text": "a high rate of deep and durable response in patients with triple-class-exposed relapsed or refractory multiple myeloma",
            "probability": 1.0824718853084366e-07,
            "start_logit": -7.027979850769043,
            "end_logit": 9.496163368225098
        },
        {
            "text": "in patients with triple-class-exposed relapsed or refractory multiple myeloma",
            "probability": 1.0617688643983574e-07,
            "start_logit": -7.047290802001953,
            "end_logit": 9.496163368225098
        },
        {
            "text": "high rate of deep and durable response in patients with triple-class-exposed relapsed or refractory multiple myeloma",
            "probability": 9.96470705845501e-08,
            "start_logit": -7.110762596130371,
            "end_logit": 9.496163368225098
        },
        {
            "text": "refractory multiple myeloma",
            "probability": 9.520893689992562e-08,
            "start_logit": -7.156323432922363,
            "end_logit": 9.496163368225098
        },
        {
            "text": "patients with triple-class-exposed relapsed or refractory multiple",
            "probability": 2.996583511231739e-11,
            "start_logit": -5.766663551330566,
            "end_logit": 0.042732298374176025
        },
        {
            "text": "triple-class-exposed relapsed or refractory multiple",
            "probability": 1.9766618773320414e-11,
            "start_logit": -6.182726860046387,
            "end_logit": 0.042732298374176025
        },
        {
            "text": "relapsed or refractory multiple",
            "probability": 1.703346462105046e-11,
            "start_logit": -6.331541538238525,
            "end_logit": 0.042732298374176025
        },
        {
            "text": "or refractory multiple",
            "probability": 9.743533256165732e-12,
            "start_logit": -6.890117645263672,
            "end_logit": 0.042732298374176025
        },
        {
            "text": "a high rate of deep and durable response in patients with triple-class-exposed relapsed or refractory multiple",
            "probability": 8.488748694678459e-12,
            "start_logit": -7.027979850769043,
            "end_logit": 0.042732298374176025
        }
    ],
    "63eeed0af36125a426000007_004": [
        {
            "text": "Multiple Myeloma",
            "probability": 0.9995421858534637,
            "start_logit": 9.457934379577637,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Multiple Myeloma.",
            "probability": 0.0003398723203670527,
            "start_logit": 9.457934379577637,
            "end_logit": 1.561859130859375
        },
        {
            "text": "Myeloma.",
            "probability": 6.928729380340427e-05,
            "start_logit": -0.11885672062635422,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Multiple",
            "probability": 4.7301395410115e-05,
            "start_logit": 9.457934379577637,
            "end_logit": -0.4101710915565491
        },
        {
            "text": "Myeloma",
            "probability": 3.7898177347298875e-07,
            "start_logit": -5.327385425567627,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Teclistamab for Multiple Myeloma",
            "probability": 2.361255390538464e-07,
            "start_logit": -5.800509929656982,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma",
            "probability": 2.3151021108179438e-07,
            "start_logit": -5.820249557495117,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Multiple Myelo",
            "probability": 1.2130811071321558e-07,
            "start_logit": 9.457934379577637,
            "end_logit": -6.376132488250732
        },
        {
            "text": "Multiple My",
            "probability": 1.1680091460802838e-07,
            "start_logit": 9.457934379577637,
            "end_logit": -6.413995265960693
        },
        {
            "text": "for Multiple Myeloma",
            "probability": 7.172946193021924e-08,
            "start_logit": -6.991971969604492,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma",
            "probability": 5.713924892928854e-08,
            "start_logit": -7.219382286071777,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Therapeutic Dosing Range of Teclistamab for Multiple Myeloma",
            "probability": 5.6102518549227275e-08,
            "start_logit": -7.237692832946777,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Dosing Range of Teclistamab for Multiple Myeloma",
            "probability": 4.568971517848775e-08,
            "start_logit": -7.443000316619873,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma",
            "probability": 3.7512022416617634e-08,
            "start_logit": -7.640212059020996,
            "end_logit": 9.548341751098633
        },
        {
            "text": "Teclistamab for Multiple Myeloma.",
            "probability": 8.028929243004177e-11,
            "start_logit": -5.800509929656982,
            "end_logit": 1.561859130859375
        },
        {
            "text": "Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.",
            "probability": 7.871995173655528e-11,
            "start_logit": -5.820249557495117,
            "end_logit": 1.561859130859375
        },
        {
            "text": "for Multiple Myeloma.",
            "probability": 2.4390024763274787e-11,
            "start_logit": -6.991971969604492,
            "end_logit": 1.561859130859375
        },
        {
            "text": "Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.",
            "probability": 1.9428943963026463e-11,
            "start_logit": -7.219382286071777,
            "end_logit": 1.561859130859375
        },
        {
            "text": "Therapeutic Dosing Range of Teclistamab for Multiple Myeloma.",
            "probability": 1.9076426615731536e-11,
            "start_logit": -7.237692832946777,
            "end_logit": 1.561859130859375
        },
        {
            "text": "Dosing Range of Teclistamab for Multiple Myeloma.",
            "probability": 1.5535782015406536e-11,
            "start_logit": -7.443000316619873,
            "end_logit": 1.561859130859375
        }
    ],
    "63eeed0af36125a426000007_005": [
        {
            "text": "multiple myeloma",
            "probability": 0.999696693605386,
            "start_logit": 7.91098690032959,
            "end_logit": 8.621572494506836
        },
        {
            "text": "myeloma",
            "probability": 0.000272884426377583,
            "start_logit": -0.29517194628715515,
            "end_logit": 8.621572494506836
        },
        {
            "text": "multiple",
            "probability": 2.0548442542106456e-05,
            "start_logit": 7.91098690032959,
            "end_logit": -2.170849561691284
        },
        {
            "text": "multiple myeloma cells in preclinical studies.",
            "probability": 6.343091675745443e-06,
            "start_logit": 7.91098690032959,
            "end_logit": -3.34626841545105
        },
        {
            "text": "T-cell-mediated cytotoxicity of multiple myeloma",
            "probability": 9.858124276713583e-07,
            "start_logit": -5.918509483337402,
            "end_logit": 8.621572494506836
        },
        {
            "text": "potent T-cell-mediated cytotoxicity of multiple myeloma",
            "probability": 6.975346667221367e-07,
            "start_logit": -6.264423370361328,
            "end_logit": 8.621572494506836
        },
        {
            "text": "CD3 bispecific antibody, displayed potent T-cell-mediated cytotoxicity of multiple myeloma",
            "probability": 5.843469784740154e-07,
            "start_logit": -6.44148063659668,
            "end_logit": 8.621572494506836
        },
        {
            "text": "displayed potent T-cell-mediated cytotoxicity of multiple myeloma",
            "probability": 3.580328980623837e-07,
            "start_logit": -6.9313507080078125,
            "end_logit": 8.621572494506836
        },
        {
            "text": "multiple myeloma cells",
            "probability": 3.1037659976719125e-07,
            "start_logit": 7.91098690032959,
            "end_logit": -6.363603591918945
        },
        {
            "text": "multiple myelo",
            "probability": 2.8008345019371027e-07,
            "start_logit": 7.91098690032959,
            "end_logit": -6.466302394866943
        },
        {
            "text": "multiple my",
            "probability": 1.7139880016550645e-07,
            "start_logit": 7.91098690032959,
            "end_logit": -6.957396984100342
        },
        {
            "text": "multiple myeloma cells in preclinical studies",
            "probability": 1.4095694443432797e-07,
            "start_logit": 7.91098690032959,
            "end_logit": -7.15293550491333
        },
        {
            "text": "myeloma cells in preclinical studies.",
            "probability": 1.7314560951018545e-09,
            "start_logit": -0.29517194628715515,
            "end_logit": -3.34626841545105
        },
        {
            "text": "myeloma cells",
            "probability": 8.472263730615817e-11,
            "start_logit": -0.29517194628715515,
            "end_logit": -6.363603591918945
        },
        {
            "text": "T-cell-mediated cytotoxicity of multiple",
            "probability": 2.026305594174093e-11,
            "start_logit": -5.918509483337402,
            "end_logit": -2.170849561691284
        },
        {
            "text": "potent T-cell-mediated cytotoxicity of multiple",
            "probability": 1.433759970594143e-11,
            "start_logit": -6.264423370361328,
            "end_logit": -2.170849561691284
        },
        {
            "text": "CD3 bispecific antibody, displayed potent T-cell-mediated cytotoxicity of multiple",
            "probability": 1.2011063344145216e-11,
            "start_logit": -6.44148063659668,
            "end_logit": -2.170849561691284
        },
        {
            "text": "BACKGROUND: Teclistamab (JNJ-64007957",
            "probability": 1.1629215920846156e-11,
            "start_logit": -3.9588096141815186,
            "end_logit": -4.68582820892334
        },
        {
            "text": "Teclistamab (JNJ-64007957",
            "probability": 9.474376607125077e-12,
            "start_logit": -4.163739204406738,
            "end_logit": -4.68582820892334
        },
        {
            "text": "displayed potent T-cell-mediated cytotoxicity of multiple",
            "probability": 7.359250541767633e-12,
            "start_logit": -6.9313507080078125,
            "end_logit": -2.170849561691284
        }
    ],
    "63f03ea0f36125a426000020_001": [
        {
            "text": "rCDI",
            "probability": 0.9178053991413656,
            "start_logit": -1.3135430812835693,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "SER-109, an investigational oral microbiome therapeutic, was superior to placebo in reducing rCDI",
            "probability": 0.019307230012371508,
            "start_logit": -5.175048828125,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "ECOSPOR III, SER-109, an investigational oral microbiome therapeutic, was superior to placebo in reducing rCDI",
            "probability": 0.014376548375480625,
            "start_logit": -5.469930171966553,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "rCDI.",
            "probability": 0.012216971789609617,
            "start_logit": -5.632702350616455,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "oral microbiome therapeutic, was superior to placebo in reducing rCDI",
            "probability": 0.007420349134253886,
            "start_logit": -6.131302356719971,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "reducing rCDI",
            "probability": 0.0058693719535967874,
            "start_logit": -6.365780830383301,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "investigational oral microbiome therapeutic, was superior to placebo in reducing rCDI",
            "probability": 0.005303880979721508,
            "start_logit": -6.467089653015137,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "an investigational oral microbiome therapeutic, was superior to placebo in reducing rCDI",
            "probability": 0.003854881781686499,
            "start_logit": -6.786188125610352,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "placebo in reducing rCDI",
            "probability": 0.003406333128101501,
            "start_logit": -6.9098920822143555,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "microbiome therapeutic, was superior to placebo in reducing rCDI",
            "probability": 0.00332644986556458,
            "start_logit": -6.93362283706665,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "in reducing rCDI",
            "probability": 0.002919244140447275,
            "start_logit": -7.06420373916626,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "superior to placebo in reducing rCDI",
            "probability": 0.002303417476743747,
            "start_logit": -7.3011345863342285,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "was superior to placebo in reducing rCDI",
            "probability": 0.0015960092746014516,
            "start_logit": -7.668022155761719,
            "end_logit": 1.2844417095184326
        },
        {
            "text": "rCD",
            "probability": 7.589040010418692e-05,
            "start_logit": -1.3135430812835693,
            "end_logit": -8.116008758544922
        },
        {
            "text": "SER-109, an investigational oral microbiome therapeutic, was superior to placebo in reducing rCDI.",
            "probability": 6.947320173273984e-05,
            "start_logit": -5.175048828125,
            "end_logit": -4.3428521156311035
        },
        {
            "text": "r",
            "probability": 6.777296985847454e-05,
            "start_logit": -1.3135430812835693,
            "end_logit": -8.229135513305664
        },
        {
            "text": "oral microbiome therapeutic, was superior to placebo in reducing rCDI.",
            "probability": 2.670064074448041e-05,
            "start_logit": -6.131302356719971,
            "end_logit": -4.3428521156311035
        },
        {
            "text": "reducing rCDI.",
            "probability": 2.1119759878316657e-05,
            "start_logit": -6.365780830383301,
            "end_logit": -4.3428521156311035
        },
        {
            "text": "investigational oral microbiome therapeutic, was superior to placebo in reducing rCDI.",
            "probability": 1.908495382478608e-05,
            "start_logit": -6.467089653015137,
            "end_logit": -4.3428521156311035
        },
        {
            "text": "an investigational oral microbiome therapeutic, was superior to placebo in reducing rCDI.",
            "probability": 1.3871020312254235e-05,
            "start_logit": -6.786188125610352,
            "end_logit": -4.3428521156311035
        }
    ],
    "63f03ea0f36125a426000020_002": [
        {
            "text": "Clostridioides difficile",
            "probability": 0.9992110988670988,
            "start_logit": 10.331205368041992,
            "end_logit": 10.40368366241455
        },
        {
            "text": "Clostridioides difficile Infection",
            "probability": 0.0003597196415477902,
            "start_logit": 10.331205368041992,
            "end_logit": 2.474287271499634
        },
        {
            "text": "Clostridioides diffici",
            "probability": 0.00013920023597881572,
            "start_logit": 10.331205368041992,
            "end_logit": 1.5248757600784302
        },
        {
            "text": "C",
            "probability": 0.00013329294178536622,
            "start_logit": 10.331205368041992,
            "end_logit": 1.4815115928649902
        },
        {
            "text": "difficile",
            "probability": 0.0001266167222806096,
            "start_logit": 1.3576486110687256,
            "end_logit": 10.40368366241455
        },
        {
            "text": "Clostridioides difficile Infect",
            "probability": 1.2387893175936527e-05,
            "start_logit": 10.331205368041992,
            "end_logit": -0.8943180441856384
        },
        {
            "text": "SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile",
            "probability": 5.670915726035527e-06,
            "start_logit": -1.7481653690338135,
            "end_logit": 10.40368366241455
        },
        {
            "text": "Clostridioides difficile Infection.",
            "probability": 5.225059080421999e-06,
            "start_logit": 10.331205368041992,
            "end_logit": -1.7575715780258179
        },
        {
            "text": "Oral Microbiome Therapy for Recurrent Clostridioides difficile",
            "probability": 4.2113539298422465e-06,
            "start_logit": -2.045731782913208,
            "end_logit": 10.40368366241455
        },
        {
            "text": "Clos",
            "probability": 2.0547619607632477e-06,
            "start_logit": 10.331205368041992,
            "end_logit": -2.690877676010132
        },
        {
            "text": "Recurrent Clostridioides difficile",
            "probability": 2.5363263637218406e-07,
            "start_logit": -4.855384349822998,
            "end_logit": 10.40368366241455
        },
        {
            "text": "Clostridioides",
            "probability": 7.276124225558125e-08,
            "start_logit": 10.331205368041992,
            "end_logit": -6.031609535217285
        },
        {
            "text": "an Oral Microbiome Therapy for Recurrent Clostridioides difficile",
            "probability": 5.793435610678389e-08,
            "start_logit": -6.331960678100586,
            "end_logit": 10.40368366241455
        },
        {
            "text": "difficile Infection.",
            "probability": 4.5582482024446515e-08,
            "start_logit": 1.3576486110687256,
            "end_logit": 2.474287271499634
        },
        {
            "text": "Clostridioides di",
            "probability": 3.890621223417957e-08,
            "start_logit": 10.331205368041992,
            "end_logit": -6.657639026641846
        },
        {
            "text": "Clostridioides diff",
            "probability": 1.8736874804597484e-08,
            "start_logit": 10.331205368041992,
            "end_logit": -7.388299465179443
        },
        {
            "text": "Clostri",
            "probability": 1.575413874771726e-08,
            "start_logit": 10.331205368041992,
            "end_logit": -7.561689853668213
        },
        {
            "text": "Clostridioides difficile In",
            "probability": 1.474183994785964e-08,
            "start_logit": 10.331205368041992,
            "end_logit": -7.628103256225586
        },
        {
            "text": "SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection",
            "probability": 2.0415503536040594e-09,
            "start_logit": -1.7481653690338135,
            "end_logit": 2.474287271499634
        },
        {
            "text": "Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection",
            "probability": 1.5161027812754732e-09,
            "start_logit": -2.045731782913208,
            "end_logit": 2.474287271499634
        }
    ],
    "63f03ea0f36125a426000020_003": [
        {
            "text": "C. difficile",
            "probability": 0.9997679469713732,
            "start_logit": 9.923335075378418,
            "end_logit": 10.310916900634766
        },
        {
            "text": "difficile",
            "probability": 0.0001445690796678296,
            "start_logit": 1.0818140506744385,
            "end_logit": 10.310916900634766
        },
        {
            "text": "C. diffici",
            "probability": 4.909890700550568e-05,
            "start_logit": 9.923335075378418,
            "end_logit": 0.3894751965999603
        },
        {
            "text": "C",
            "probability": 3.0055433617897007e-05,
            "start_logit": 9.923335075378418,
            "end_logit": -0.1013181135058403
        },
        {
            "text": "C. difficile infection",
            "probability": 4.3260117725907645e-06,
            "start_logit": 9.923335075378418,
            "end_logit": -2.039715528488159
        },
        {
            "text": "C. difficile infection.",
            "probability": 3.0493572052630004e-06,
            "start_logit": 9.923335075378418,
            "end_logit": -2.3894307613372803
        },
        {
            "text": "microbiome therapeutic composed of purified Firmicutes spores for the treatment of recurrent C. difficile",
            "probability": 1.2939337639827602e-07,
            "start_logit": -5.9368414878845215,
            "end_logit": 10.310916900634766
        },
        {
            "text": "C. di",
            "probability": 1.206221520390674e-07,
            "start_logit": 9.923335075378418,
            "end_logit": -5.6194539070129395
        },
        {
            "text": "Firmicutes spores for the treatment of recurrent C. difficile",
            "probability": 9.553065019766605e-08,
            "start_logit": -6.240251541137695,
            "end_logit": 10.310916900634766
        },
        {
            "text": ". difficile",
            "probability": 9.340209017438676e-08,
            "start_logit": -6.262784957885742,
            "end_logit": 10.310916900634766
        },
        {
            "text": "recurrent C. difficile",
            "probability": 9.12178136313639e-08,
            "start_logit": -6.2864484786987305,
            "end_logit": 10.310916900634766
        },
        {
            "text": "treatment of recurrent C. difficile",
            "probability": 7.012706721699072e-08,
            "start_logit": -6.549389839172363,
            "end_logit": 10.310916900634766
        },
        {
            "text": "the treatment of recurrent C. difficile",
            "probability": 6.383546922059329e-08,
            "start_logit": -6.643389701843262,
            "end_logit": 10.310916900634766
        },
        {
            "text": "investigational microbiome therapeutic composed of purified Firmicutes spores for the treatment of recurrent C. difficile",
            "probability": 5.829577817803605e-08,
            "start_logit": -6.734169006347656,
            "end_logit": 10.310916900634766
        },
        {
            "text": "C.",
            "probability": 5.361265545024906e-08,
            "start_logit": 9.923335075378418,
            "end_logit": -6.430331707000732
        },
        {
            "text": "C. diff",
            "probability": 4.906691558425188e-08,
            "start_logit": 9.923335075378418,
            "end_logit": -6.518931865692139
        },
        {
            "text": "purified Firmicutes spores for the treatment of recurrent C. difficile",
            "probability": 4.609260687817964e-08,
            "start_logit": -6.969046115875244,
            "end_logit": 10.310916900634766
        },
        {
            "text": "for the treatment of recurrent C. difficile",
            "probability": 4.489097358719725e-08,
            "start_logit": -6.995461940765381,
            "end_logit": 10.310916900634766
        },
        {
            "text": "an investigational microbiome therapeutic composed of purified Firmicutes spores for the treatment of recurrent C. difficile",
            "probability": 3.752625644944893e-08,
            "start_logit": -7.174657821655273,
            "end_logit": 10.310916900634766
        },
        {
            "text": "difficile infection.",
            "probability": 6.255527019947064e-10,
            "start_logit": 1.0818140506744385,
            "end_logit": -2.039715528488159
        }
    ],
    "63f03ea0f36125a426000020_004": [
        {
            "text": "Clostridioides difficile",
            "probability": 0.9997855481129322,
            "start_logit": 10.277056694030762,
            "end_logit": 10.700611114501953
        },
        {
            "text": "Clostridioides difficile recurrence, inactivate porcine epidemic diarrhea virus",
            "probability": 0.00012162475702966026,
            "start_logit": 10.277056694030762,
            "end_logit": 1.6862555742263794
        },
        {
            "text": "difficile",
            "probability": 7.02173692146884e-05,
            "start_logit": 0.7133563160896301,
            "end_logit": 10.700611114501953
        },
        {
            "text": "C",
            "probability": 1.849330534880815e-05,
            "start_logit": 10.277056694030762,
            "end_logit": -0.19727617502212524
        },
        {
            "text": "Clostridioides diffici",
            "probability": 2.4232626101683315e-06,
            "start_logit": 10.277056694030762,
            "end_logit": -2.229570150375366
        },
        {
            "text": "Clostridioides difficile recurrence, inactivate porcine epidemic diarrhea virus,",
            "probability": 3.9469110714748335e-07,
            "start_logit": 10.277056694030762,
            "end_logit": -4.044336795806885
        },
        {
            "text": "Clostridioides difficile recurrence,",
            "probability": 3.281001966636328e-07,
            "start_logit": 10.277056694030762,
            "end_logit": -4.229121208190918
        },
        {
            "text": "Clostridioides difficile recurrence, inactivate porcine epidemic diarrhea",
            "probability": 3.073908734136396e-07,
            "start_logit": 10.277056694030762,
            "end_logit": -4.294320106506348
        },
        {
            "text": "a purified investigational microbiome therapeutic developed to reduce risk of Clostridioides difficile",
            "probability": 1.570154680617943e-07,
            "start_logit": -5.389650344848633,
            "end_logit": 10.700611114501953
        },
        {
            "text": "SER-109, a purified investigational microbiome therapeutic developed to reduce risk of Clostridioides difficile",
            "probability": 1.0748745864587351e-07,
            "start_logit": -5.768620491027832,
            "end_logit": 10.700611114501953
        },
        {
            "text": "Clos",
            "probability": 9.532324346808685e-08,
            "start_logit": 10.277056694030762,
            "end_logit": -5.4651665687561035
        },
        {
            "text": "Clostridioides difficile recurrence",
            "probability": 7.252868153250723e-08,
            "start_logit": 10.277056694030762,
            "end_logit": -5.738458156585693
        },
        {
            "text": "to reduce risk of Clostridioides difficile",
            "probability": 6.35794406772932e-08,
            "start_logit": -6.293704509735107,
            "end_logit": 10.700611114501953
        },
        {
            "text": "microbiome therapeutic developed to reduce risk of Clostridioides difficile",
            "probability": 5.790859609543291e-08,
            "start_logit": -6.387128829956055,
            "end_logit": 10.700611114501953
        },
        {
            "text": "reduce risk of Clostridioides difficile",
            "probability": 4.0799797000802696e-08,
            "start_logit": -6.7373175621032715,
            "end_logit": 10.700611114501953
        },
        {
            "text": "Clostridioides di",
            "probability": 2.371431462433949e-08,
            "start_logit": 10.277056694030762,
            "end_logit": -6.856361389160156
        },
        {
            "text": "Clostridioides",
            "probability": 1.6686337455716388e-08,
            "start_logit": 10.277056694030762,
            "end_logit": -7.207849979400635
        },
        {
            "text": "porcine epidemic diarrhea virus",
            "probability": 1.585044339695443e-08,
            "start_logit": 1.331558346748352,
            "end_logit": 1.6862555742263794
        },
        {
            "text": "difficile recurrence, inactivate porcine epidemic diarrhea virus,",
            "probability": 8.542002318514964e-09,
            "start_logit": 0.7133563160896301,
            "end_logit": 1.6862555742263794
        },
        {
            "text": "SARS-CoV-2",
            "probability": 3.5749041003207995e-09,
            "start_logit": 2.735470771789551,
            "end_logit": -1.2069159746170044
        }
    ],
    "64179113690f196b5100002e_001": [
        {
            "text": "Xp21 chromosome locus",
            "probability": 0.7850337574149342,
            "start_logit": 8.86852741241455,
            "end_logit": 6.394114017486572
        },
        {
            "text": "Xp21",
            "probability": 0.1928981379255091,
            "start_logit": 8.86852741241455,
            "end_logit": 4.990549564361572
        },
        {
            "text": "Xp21 chromosome",
            "probability": 0.012210471257450029,
            "start_logit": 8.86852741241455,
            "end_logit": 2.2306811809539795
        },
        {
            "text": "Xp21 chromosome locus.",
            "probability": 0.005881044693737309,
            "start_logit": 8.86852741241455,
            "end_logit": 1.5001217126846313
        },
        {
            "text": "X",
            "probability": 0.0037425427811065104,
            "start_logit": 8.86852741241455,
            "end_logit": 1.0481525659561157
        },
        {
            "text": "the Xp21 chromosome locus",
            "probability": 0.0001313605597640444,
            "start_logit": 0.1729913204908371,
            "end_logit": 6.394114017486572
        },
        {
            "text": "the Xp21",
            "probability": 3.227785701697351e-05,
            "start_logit": 0.1729913204908371,
            "end_logit": 4.990549564361572
        },
        {
            "text": "Xp21 chromosome lo",
            "probability": 1.8717984628754985e-05,
            "start_logit": 8.86852741241455,
            "end_logit": -4.24988317489624
        },
        {
            "text": "Xp",
            "probability": 1.439607946592202e-05,
            "start_logit": 8.86852741241455,
            "end_logit": -4.512412071228027
        },
        {
            "text": "The dystrophin gene (DMD) is the largest gene in the human genome, mapping on the Xp21 chromosome locus",
            "probability": 1.2581463972032986e-05,
            "start_logit": -2.172729969024658,
            "end_logit": 6.394114017486572
        },
        {
            "text": "mapping on the Xp21 chromosome locus",
            "probability": 8.245194510344502e-06,
            "start_logit": -2.5953240394592285,
            "end_logit": 6.394114017486572
        },
        {
            "text": "on the Xp21 chromosome locus",
            "probability": 3.948818365257757e-06,
            "start_logit": -3.331538200378418,
            "end_logit": 6.394114017486572
        },
        {
            "text": "The dystrophin gene (DMD) is the largest gene in the human genome, mapping on the Xp21",
            "probability": 3.0915116065502757e-06,
            "start_logit": -2.172729969024658,
            "end_logit": 4.990549564361572
        },
        {
            "text": "the Xp21 chromosome",
            "probability": 2.0431915496770423e-06,
            "start_logit": 0.1729913204908371,
            "end_logit": 2.2306811809539795
        },
        {
            "text": "mapping on the Xp21",
            "probability": 2.0260054460797225e-06,
            "start_logit": -2.5953240394592285,
            "end_logit": 4.990549564361572
        },
        {
            "text": "dystrophin gene (DMD) is the largest gene in the human genome, mapping on the Xp21 chromosome locus",
            "probability": 1.7518556251080757e-06,
            "start_logit": -4.1442790031433105,
            "end_logit": 6.394114017486572
        },
        {
            "text": "locus.",
            "probability": 1.0247780101348074e-06,
            "start_logit": -4.680478572845459,
            "end_logit": 6.394114017486572
        },
        {
            "text": "the Xp21 chromosome locus.",
            "probability": 9.840816597627747e-07,
            "start_logit": 0.1729913204908371,
            "end_logit": 1.5001217126846313
        },
        {
            "text": "on the Xp21",
            "probability": 9.70301853225482e-07,
            "start_logit": -3.331538200378418,
            "end_logit": 4.990549564361572
        },
        {
            "text": "the X",
            "probability": 6.262437889115955e-07,
            "start_logit": 0.1729913204908371,
            "end_logit": 1.0481525659561157
        }
    ],
    "64179113690f196b5100002e_002": [
        {
            "text": "Xp21",
            "probability": 0.994922898904506,
            "start_logit": 9.169047355651855,
            "end_logit": 8.407842636108398
        },
        {
            "text": "X",
            "probability": 0.004988102280983838,
            "start_logit": 9.169047355651855,
            "end_logit": 3.1122329235076904
        },
        {
            "text": "Xp21.",
            "probability": 6.612379648364646e-05,
            "start_logit": 9.169047355651855,
            "end_logit": -1.211049199104309
        },
        {
            "text": "Xp",
            "probability": 1.4409867427265613e-05,
            "start_logit": 9.169047355651855,
            "end_logit": -2.7346646785736084
        },
        {
            "text": "at Xp21",
            "probability": 3.037534258944745e-06,
            "start_logit": -3.530327081680298,
            "end_logit": 8.407842636108398
        },
        {
            "text": "DMD gene located at Xp21",
            "probability": 1.903248360767346e-06,
            "start_logit": -3.9978110790252686,
            "end_logit": 8.407842636108398
        },
        {
            "text": "located at Xp21",
            "probability": 1.2659413724128961e-06,
            "start_logit": -4.405557155609131,
            "end_logit": 8.407842636108398
        },
        {
            "text": "the DMD gene located at Xp21",
            "probability": 8.608371954198994e-07,
            "start_logit": -4.791223049163818,
            "end_logit": 8.407842636108398
        },
        {
            "text": "X-linked recessive disorders caused by mutations of the DMD gene located at Xp21",
            "probability": 6.599200893647287e-07,
            "start_logit": -5.057009696960449,
            "end_logit": 8.407842636108398
        },
        {
            "text": "mutations of the DMD gene located at Xp21",
            "probability": 5.78938879776449e-07,
            "start_logit": -5.187931537628174,
            "end_logit": 8.407842636108398
        },
        {
            "text": "BMD) are X-linked recessive disorders caused by mutations of the DMD gene located at Xp21",
            "probability": 1.155973928478223e-07,
            "start_logit": -6.799015045166016,
            "end_logit": 8.407842636108398
        },
        {
            "text": "at X",
            "probability": 1.5228849976507676e-08,
            "start_logit": -3.530327081680298,
            "end_logit": 3.1122329235076904
        },
        {
            "text": "DMD gene located at X",
            "probability": 9.542043408665737e-09,
            "start_logit": -3.9978110790252686,
            "end_logit": 3.1122329235076904
        },
        {
            "text": "located at X",
            "probability": 6.346868741565336e-09,
            "start_logit": -4.405557155609131,
            "end_logit": 3.1122329235076904
        },
        {
            "text": "the DMD gene located at X",
            "probability": 4.315856015333173e-09,
            "start_logit": -4.791223049163818,
            "end_logit": 3.1122329235076904
        },
        {
            "text": "X-linked recessive disorders caused by mutations of the DMD gene located at X",
            "probability": 3.308546729250834e-09,
            "start_logit": -5.057009696960449,
            "end_logit": 3.1122329235076904
        },
        {
            "text": "mutations of the DMD gene located at X",
            "probability": 2.9025428502478455e-09,
            "start_logit": -5.187931537628174,
            "end_logit": 3.1122329235076904
        },
        {
            "text": "Becker muscular dystrophy (BMD) are X-linked recessive disorders caused by mutations of the DMD gene located at X",
            "probability": 7.069098381324067e-10,
            "start_logit": -6.60037088394165,
            "end_logit": 3.1122329235076904
        },
        {
            "text": "BMD) are X-linked recessive disorders caused by mutations of the DMD gene located at X",
            "probability": 5.795540735617857e-10,
            "start_logit": -6.799015045166016,
            "end_logit": 3.1122329235076904
        },
        {
            "text": "at Xp21.",
            "probability": 2.0187825345232536e-10,
            "start_logit": -3.530327081680298,
            "end_logit": -1.211049199104309
        }
    ],
    "64179113690f196b5100002e_003": [
        {
            "text": "Xp21",
            "probability": 0.6711400940028013,
            "start_logit": 7.24234676361084,
            "end_logit": 5.180347442626953
        },
        {
            "text": "Xp21)",
            "probability": 0.10665921883010313,
            "start_logit": 7.24234676361084,
            "end_logit": 3.341008424758911
        },
        {
            "text": "X chromosome (Xp21",
            "probability": 0.08872987711130403,
            "start_logit": 5.218965530395508,
            "end_logit": 5.180347442626953
        },
        {
            "text": "Xp21).",
            "probability": 0.048553202699784755,
            "start_logit": 7.24234676361084,
            "end_logit": 2.554029703140259
        },
        {
            "text": "X",
            "probability": 0.04724492582611394,
            "start_logit": 5.218965530395508,
            "end_logit": 4.550096035003662
        },
        {
            "text": "X chromosome (Xp21)",
            "probability": 0.014101168242145332,
            "start_logit": 5.218965530395508,
            "end_logit": 3.341008424758911
        },
        {
            "text": "X chromosome",
            "probability": 0.010459668832733473,
            "start_logit": 5.218965530395508,
            "end_logit": 3.0422775745391846
        },
        {
            "text": "X chromosome (Xp21).",
            "probability": 0.006419106453941275,
            "start_logit": 5.218965530395508,
            "end_logit": 2.554029703140259
        },
        {
            "text": "(Xp21",
            "probability": 0.003455471824193609,
            "start_logit": 1.973327875137329,
            "end_logit": 5.180347442626953
        },
        {
            "text": "X chromosome (X",
            "probability": 0.0012822762145300345,
            "start_logit": 5.218965530395508,
            "end_logit": 0.9433875679969788
        },
        {
            "text": "(Xp21)",
            "probability": 0.0005491520008285832,
            "start_logit": 1.973327875137329,
            "end_logit": 3.341008424758911
        },
        {
            "text": "dystrophin gene, located on the X chromosome (Xp21",
            "probability": 0.00029337728107660757,
            "start_logit": -0.4929269850254059,
            "end_logit": 5.180347442626953
        },
        {
            "text": "(Xp21).",
            "probability": 0.0002499839085798486,
            "start_logit": 1.973327875137329,
            "end_logit": 2.554029703140259
        },
        {
            "text": "X chromosome (",
            "probability": 0.00019270310539839519,
            "start_logit": 5.218965530395508,
            "end_logit": -0.9518538117408752
        },
        {
            "text": "the X chromosome (Xp21",
            "probability": 0.000183584743560592,
            "start_logit": -0.9617100358009338,
            "end_logit": 5.180347442626953
        },
        {
            "text": "dystrophin gene, located on the X",
            "probability": 0.00015621105691541063,
            "start_logit": -0.4929269850254059,
            "end_logit": 4.550096035003662
        },
        {
            "text": "The disease is caused by deletion, duplication or point mutation of the dystrophin gene, located on the X",
            "probability": 0.00010329899364126391,
            "start_logit": -0.9065073728561401,
            "end_logit": 4.550096035003662
        },
        {
            "text": "the X",
            "probability": 9.775115073636606e-05,
            "start_logit": -0.9617100358009338,
            "end_logit": 4.550096035003662
        },
        {
            "text": "on the X chromosome (Xp21",
            "probability": 7.899111091922158e-05,
            "start_logit": -1.8050510883331299,
            "end_logit": 5.180347442626953
        },
        {
            "text": "(X",
            "probability": 4.993661069296905e-05,
            "start_logit": 1.973327875137329,
            "end_logit": 0.9433875679969788
        }
    ],
    "6415c9e9690f196b51000018_001": [
        {
            "text": "mTNBC",
            "probability": 0.9989559127269302,
            "start_logit": 4.858996391296387,
            "end_logit": 6.413232326507568
        },
        {
            "text": "mTNBC,",
            "probability": 0.0006440342484266354,
            "start_logit": -2.487717628479004,
            "end_logit": 6.413232326507568
        },
        {
            "text": "The combination of chemotherapy and immunotherapy is a potential therapeutic option for PD-L1-positive mTNBC",
            "probability": 0.00024178547433058125,
            "start_logit": -3.467418670654297,
            "end_logit": 6.413232326507568
        },
        {
            "text": "PD-L1-positive mTNBC",
            "probability": 9.814539735108146e-05,
            "start_logit": -4.369019508361816,
            "end_logit": 6.413232326507568
        },
        {
            "text": "chemotherapy and immunotherapy is a potential therapeutic option for PD-L1-positive mTNBC",
            "probability": 1.404945065683717e-05,
            "start_logit": -6.3128862380981445,
            "end_logit": 6.413232326507568
        },
        {
            "text": "positive mTNBC",
            "probability": 1.0907722010358236e-05,
            "start_logit": -6.565998554229736,
            "end_logit": 6.413232326507568
        },
        {
            "text": "m",
            "probability": 1.0386144142464244e-05,
            "start_logit": 4.858996391296387,
            "end_logit": -5.060760974884033
        },
        {
            "text": "-positive mTNBC",
            "probability": 7.667667810439082e-06,
            "start_logit": -6.91845703125,
            "end_logit": 6.413232326507568
        },
        {
            "text": "combination of chemotherapy and immunotherapy is a potential therapeutic option for PD-L1-positive mTNBC",
            "probability": 6.316090806076922e-06,
            "start_logit": -7.112369060516357,
            "end_logit": 6.413232326507568
        },
        {
            "text": "for PD-L1-positive mTNBC",
            "probability": 5.700001969376938e-06,
            "start_logit": -7.21500301361084,
            "end_logit": 6.413232326507568
        },
        {
            "text": "mTNBC, as the FDA recently approved atezolizumab (Tecentriq) and pembrolizumab",
            "probability": 1.6958374848467837e-06,
            "start_logit": 4.858996391296387,
            "end_logit": -6.873056888580322
        },
        {
            "text": "mTNBC, as the FDA recently approved atezolizumab",
            "probability": 1.5497602842238036e-06,
            "start_logit": 4.858996391296387,
            "end_logit": -6.963133335113525
        },
        {
            "text": "mTNBC, as the FDA recently approved atezolizumab (Tecentriq)",
            "probability": 7.452848542136675e-07,
            "start_logit": 4.858996391296387,
            "end_logit": -7.6952223777771
        },
        {
            "text": "mTNBC, as the FDA recently approved atezolizumab (Tecentriq",
            "probability": 6.037665288038539e-07,
            "start_logit": 4.858996391296387,
            "end_logit": -7.905801296234131
        },
        {
            "text": "mTNBC, as",
            "probability": 4.736322680323655e-07,
            "start_logit": 4.858996391296387,
            "end_logit": -8.148557662963867
        },
        {
            "text": "The combination of chemotherapy and immunotherapy is a potential therapeutic option for PD-L1-positive mTNBC,",
            "probability": 1.588761244854037e-08,
            "start_logit": -3.467418670654297,
            "end_logit": -3.217034101486206
        },
        {
            "text": "PD-L1-positive mTNBC,",
            "probability": 6.449088974592556e-09,
            "start_logit": -4.369019508361816,
            "end_logit": -3.217034101486206
        },
        {
            "text": "The combination of chemotherapy and immunotherapy is a potential therapeutic option for PD-L1-positive m",
            "probability": 2.5138434599144916e-09,
            "start_logit": -3.467418670654297,
            "end_logit": -5.060760974884033
        },
        {
            "text": "PD-L1-positive m",
            "probability": 1.0204176488881805e-09,
            "start_logit": -4.369019508361816,
            "end_logit": -5.060760974884033
        },
        {
            "text": "chemotherapy and immunotherapy is a potential therapeutic option for PD-L1-positive mTNBC,",
            "probability": 9.23182948722275e-10,
            "start_logit": -6.3128862380981445,
            "end_logit": -3.217034101486206
        }
    ]
}
